0001136261-13-000356.txt : 20130809 0001136261-13-000356.hdr.sgml : 20130809 20130809165251 ACCESSION NUMBER: 0001136261-13-000356 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20130630 FILED AS OF DATE: 20130809 DATE AS OF CHANGE: 20130809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MICROVISION INC CENTRAL INDEX KEY: 0000065770 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC COMPONENTS, NEC [3679] IRS NUMBER: 911600822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34170 FILM NUMBER: 131027203 BUSINESS ADDRESS: STREET 1: 6222 185TH AVE NE CITY: REDMOND STATE: WA ZIP: 98052 BUSINESS PHONE: 425-936-6847 MAIL ADDRESS: STREET 1: 6222 185TH AVE NE CITY: REDMOND STATE: WA ZIP: 98052 10-Q 1 form10q.htm 10-Q June 30, 2013 10-Q Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549




FORM 10-Q



[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2013

OR

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________to _________

Commission file number    001-34170

MicroVision, Inc.
(Exact name of Registrant as Specified in its Charter)

 
Delaware
91-1600822
  (State or Other Jurisdiction of Incorporation or Organization) 
(I.R.S. Employer Identification Number)

6244 185th Avenue NE, Suite 100
Redmond, Washington    98052

(Address of Principal Executive Offices, including Zip Code)

(425) 936-6847
(Registrant's Telephone Number, including Area Code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file reports), and (2) has been subject to such filing requirements for the past 90 days. YES    x        NO    ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES    x        NO    ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer    ¨

Accelerated filer    ¨

Non-accelerated filer    ¨
(Do not check if a smaller reporting company)

Smaller reporting company    x

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934). YES    ¨        NO    x

As of August 6, 2013, 27,939,000 shares of the Company's common stock, $0.001 par value, were outstanding.



 

Page

Part I: Financial Information

 

Item 1. Financial Statements:

 
   

Consolidated Balance Sheets as of June 30, 2013 and December 31, 2012 (unaudited)

2

Consolidated Statements of Operations for the three and six months ended June 30, 2013 and 2012 (unaudited)

3

Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2013 and 2012 (unaudited)

4

Consolidated Statements of Cash Flows for the six months ended June 30, 2013 and 2012 (unaudited)

5

Notes to Consolidated Financial Statements (unaudited)

6

   

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

11

Item 3. Quantitative and Qualitative Disclosures About Market Risk

18

Item 4. Controls and Procedures

18

   

Part II: Other Information

 

Item 1A. Risk Factors

18

Item 6. Exhibits

24

Signatures

25

Exhibit Index

26

1


MicroVision, Inc.
Consolidated Balance Sheets
(In thousands, except per share data)
(Unaudited)

          June 30,         December 31,
      2013     2012
Assets            
Current assets            
     Cash and cash equivalents   $ 6,003    $ 6,850 
     Accounts receivable, net of allowances of $347 and $332     1,088      1,115 
     Costs and estimated earnings in excess of billings on uncompleted contracts     12      12 
     Inventory     44      497 
     Other current assets     305      1,221 
          Total current assets     7,452      9,695 
             
Property and equipment, net     1,191      1,205 
Restricted investments     435      436 
Intangible assets     1,501      1,580 
Other assets     18      22 
               Total assets   $ 10,597    $ 12,938 
             
Liabilities and Shareholders' Equity            
Current liabilities            
     Accounts payable   $ 2,106    $ 3,035 
     Accrued liabilities     3,253      4,007 
     Deferred revenue     28      609 
     Billings in excess of costs and estimated earnings on uncompleted contracts     863      98 
     Warrant liability     3,755     
     Current portion of capital lease obligations     43      48 
     Current portion of long-term debt     17      67 
          Total current liabilities     10,065      7,864 
Capital lease obligations, net of current portion         20 
Deferred rent, net of current portion     330     
          Total liabilities     10,395      7,884 
             
Commitments and contingencies            
             
Shareholders' Equity            
     Preferred stock, par value $.001; 25,000 shares authorized; 0 and            
          0 shares issued and outstanding        
     Common stock, par value $.001; 100,000 shares authorized; 27,925 and            
          25,237 shares issued and outstanding     28      25 
     Additonal paid-in capital     444,795      442,560 
     Accumulated deficit     (444,621)     (437,531)
          Total shareholders' equity     202      5,054 
               Total liabilities and shareholders' equity   $ 10,597    $ 12,938 

The accompanying notes are an integral part of these financial statements.

2


MicroVision, Inc.
Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)

      Three Months Ended     Six Months Ended
      June 30,     June 30,
      2013     2012     2013     2012
Product revenue   $ 917    $ 750    $ 2,136    $ 2,279 
Contract revenue     73      545      355      746 
Development revenue     880          1,180     
     Total revenue     1,870      1,295      3,671      3,025 
                         
Cost of product revenue     837      (281)     1,501      3,894 
Cost of contract revenue     26      248      163      403 
     Total cost of revenue     863      (33)     1,664      4,297 
                         
Gross margin     1,007      1,328      2,007      (1,272)
                         
Research and development expense     2,339      3,227      4,591      7,167 
Sales, marketing, general and administrative expense     2,101      3,064      4,504      6,352 
Gain on disposal of fixed assets         (1)     (2)     (1)
     Total operating expenses     4,440      6,290      9,093      13,518 
Loss from operations     (3,433)     (4,962)     (7,086)     (14,790)
Other income (expense)     (3)     (9)     (4)     16 
Net loss   $ (3,436)   $ (4,971)   $ (7,090)   $ (14,774)
                         
Net loss per share - basic and diluted   $ (0.13)   $ (0.26)   $ (0.27)   $ (0.82)
                         
Weighted-average shares outstanding - basic and diluted     26,493      19,167      25,870      18,097 

The accompanying notes are an integral part of these financial statements.

3


MicroVision, Inc.
Consolidated Statements of Comprehensive Loss
(In thousands)
(Unaudited)

      Three Months Ended     Six Months Ended
      June 30,     June 30,
      2013     2012     2013     2012
Net loss   $ (3,436)   $ (4,971)   $ (7,090)   $ (14,774)
                         
Other comprehensive gain (loss):                        
Unrealized gain (loss) on investment securities,                         
     available-for-sale         (2)        
Less: reclassification adjustment for losses realized                        
     in net loss         32          32 
Comprehensive loss   $ (3,436)   $ (4,941)   $ (7,090)   $ (14,739)

The accompanying notes are an integral part of these financial statements.

4


MicroVision, Inc.
Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)

      Six Months Ended
      June 30,
      2013     2012
Cash flows from operating activities            
     Net loss   $ (7,090)   $ (14,774)
     Adjustments to reconcile net loss to net cash used in operations:            
          Depreciation     486      880 
          Amortization of intangible assets     79      92 
          Gain on disposal of property and equipment     (2)     (1)
          Realized loss on sale of short-term investments         32 
          Non-cash stock-based compensation expense     481      854 
          Inventory write-downs     303      1,094 
          Non-cash deferred rent         (88)
          Change in:            
               Accounts receivable, net     27      (95)
               Costs and estimated earnings in excess of billings on uncompleted contracts         58 
               Inventory     150      2,294 
               Other current assets     899      301 
               Other assets         12 
               Accounts payable     (1,046)     (2,976)
               Accrued liabilities     (771)     (726)
               Deferred revenue     (581)    
               Billings in excess of costs and estimated earnings on uncompleted contracts     765      31 
               Net cash used in operating activities     (6,296)     (13,012)
             
Cash flows from investing activities            
     Sales of investment securities         11 
     Decrease in restricted investment         350 
     Proceeds on sale of property and equipment        
     Purchases of property and equipment     (86)     (400)
               Net cash used in investing activities     (83)     (38)
             
Cash flows from financing activities            
     Principal payments under capital leases and long-term debt     (75)     (66)
     Net proceeds from issuance of common stock and warrants     5,607      14,805 
               Net cash provided by financing activities     5,532      14,739 
Net increase (decrease) in cash and cash equivalents     (847)     1,689 
Cash and cash equivalents at beginning of period     6,850      13,075 
Cash and cash equivalents at end of period   $ 6,003    $ 14,764 
             
Supplemental disclosure of cash flow information            
     Cash paid for interest   $   $ 17 
             
Supplemental schedule of non-cash investing and financing activities            
     Other non-cash additions to property and equipment   $ 386    $ 12 
     Warrant liability   $ 3,755    $ -  

The accompanying notes are an integral part of these financial statements.

5


MicroVision, Inc.
Notes to Consolidated Financial Statements
June 30, 2013
(Unaudited)

1. MANAGEMENT'S STATEMENT AND PRINCIPLES OF CONSOLIDATION

Management's Statement

The Consolidated Balance Sheet as of June 30, 2013, the Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended June 30, 2013 and 2012, and Consolidated Statements of Cash Flows for the six months ended June 30, 2013 and 2012 have been prepared by MicroVision, Inc. ("we" or "us") and have not been audited. In the opinion of management, all adjustments necessary to state fairly the financial position at June 30, 2013 and the results of operations, comprehensive loss and cash flows for all periods presented have been made and consist of normal recurring adjustments. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the rules of the Securities and Exchange Commission (the "SEC"). The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. You should read these condensed consolidated financial statements in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012. The results of operations for the three and six months ended June 30, 2013 are not necessarily indicative of the operating results that may be attained for the entire fiscal year.

We have incurred significant losses since inception. We have funded operations to date primarily through the sale of common stock, convertible preferred stock, warrants, the issuance of convertible debt and, to a lesser extent, from contract revenues, collaborative research and development agreements and product sales. At June 30, 2013, we had $6.0 million in cash and cash equivalents and a working capital deficit of $2.6 million.

Based on our current operating plan, we anticipate that we have sufficient cash and cash equivalents to fund our operations through October of 2013. We will require additional cash to fund our operating plan past that time.

We plan to obtain additional cash through the issuance of equity or debt securities. There can be no assurance that additional cash will be available or that, if available, it will be available on terms acceptable to us on a timely basis. If adequate funds are not available on a timely basis, we intend to consider limiting our operations substantially to extend our funds as we pursue other financing opportunities and business relationships. This limitation of operations could include delaying development projects and reductions in staff and operating costs, including research and development, and capital expenditures.

We are introducing new technology into an emerging market which creates significant uncertainty about our ability to accurately project revenue, costs and cash flows. Our capital requirements will depend on many factors, including, but not limited to, the rate at which we can, directly or through arrangements with OEMs, introduce products incorporating the PicoP display engine and image capture technologies and the market acceptance and competitive position of such products. If revenues are less than anticipated, if the mix of revenues vary from anticipated amounts or if expenses exceed the amounts budgeted, we may require additional capital earlier than expected to further the development of our technologies, for expenses associated with product development, and to respond to competitive pressures or to meet unanticipated development difficulties. In addition, our operating plan provides for the development of strategic relationships with systems and equipment manufacturers that may require additional investments by us.

In May 2013, we raised $5.85 million before issuance costs of approximately $362,000 from the sale of 2.6 million shares of common stock and warrants to purchase up to an aggregate of 2.0 million shares of our common stock in a registered direct offering. The warrants have an exercise price of $2.886 per share, a five year term, and are exercisable beginning on the date of issuance. Each warrant to purchase a share of common stock may also be exchanged during its term for a number of shares of common stock (but not more than one share of common stock for each warrant so exchanged) with a value determined by a negotiated formula if, among other things, our common stock is then trading at a price at or lower than the warrant exercise price per share. Subject to limitations in the warrants, we may require the warrants be exercised for cash if the closing bid price of our stock is over $3.61 for 20 consecutive trading days and the average daily dollar volume over that period is equal to or exceeds $300,000.

6


We have received a report from our independent registered public accounting firm regarding the consolidated financial statements for the year ended December 31, 2012 that includes an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. These consolidated financial statements are prepared assuming the Company will continue as a going concern.

Principles of Consolidation

Our condensed consolidated financial statements include the accounts of MicroVision, Inc. and MicroVision Innovations Singapore Pte. Ltd. ("MicroVision Singapore"), a wholly owned foreign subsidiary. MicroVision Singapore was incorporated in April 2011 and is engaged in operational support functions for MicroVision, Inc. There were no material intercompany accounts and transactions during the three and six months ended June 30, 2013.

2. NET LOSS PER SHARE

Basic net loss per share is calculated using the weighted-average number of common shares outstanding during the reporting periods. Diluted net loss per share is calculated using the weighted-average number of common shares outstanding and taking into account the dilutive effect of all potentially dilutive securities, including common stock equivalents and convertible securities outstanding. Potentially dilutive common stock equivalents primarily consist of warrants, employee stock options and nonvested equity shares. Diluted net loss per share for the three and six months ended June 30, 2013 and 2012 is equal to basic net loss per share because the effect of all potential common stock outstanding during the periods, including options, warrants and nonvested equity shares is anti-dilutive. The components of basic and diluted net loss per share were as follows (in thousands, except loss per share data):

      Three Months Ended     Six Months Ended
      June 30,     June 30,
      2013     2012     2013     2012
Numerator:                        
Net loss available for common shareholders - basic and diluted   $ (3,436)   $ (4,971)   $ (7,090)   $ (14,774)
                         
Denominator:                        
Weighted-average common shares outstanding - basic and diluted       26,493      19,167      25,870      18,097 
                         
Net loss per share - basic and diluted     $ (0.13)   $ (0.26)   $ (0.27)   $ (0.82)

We excluded the following convertible securities from diluted net loss per share, as the effect of including them would have been anti-dilutive:

      Three Months Ended     Six Months Ended
      June 30,     June 30,
      2013     2012     2013     2012
Publicly Traded Warrants Exercisable     753,000      753,000      753,000      753,000 
Options and Private Warrants Exercisable     7,612,000      5,302,000      7,612,000      5,302,000 
Nonvested Equity Shares     215,000      80,000      215,000      80,000 
                         
Total     8,580,000      6,135,000      8,580,000      6,135,000 

7


3. KEY ACCOUNTING POLICY - REVENUE RECOGNITION

We evaluate the performance criteria and terms of our collaborative research and development agreements to determine whether revenue should be recognized under a performance-based method or milestone method. Significant items included in our evaluation are the following:

  • the nature of our obligation under the agreement,
  • whether provisions leading to variable revenues exist
  • whether any payments are required to be repaid,
  • whether the deliverables should be treated as one unit of accounting or separated into multiple units,
  • whether substantive milestones exist,
  • whether milestone payments are commensurate with either our level of effort or the increase in value of the customer's rights, and
  • whether a licensing agreement exists.

In March 2013, we entered into and began work under a $4.6 million collaborative research and development agreement with a customer researching and developing commercial applications for our technology. Our contributions under the collaborative agreement include research services, components, and prototype devices and fixtures. Development revenues to be realized are subject to successful completion of the deliverables as defined in the collaborative research and development agreement.

Based on the terms of this agreement, we recognize development revenue as work progresses on the agreement and as our customer accepts the deliverables using a proportional method based on the lesser of the cumulative proportion of total planned costs to be incurred under the agreement or the cash payments received plus outstanding billings for work accepted by the customer. Since our collaborative agreements generally require some level of technology development, the actual costs required to complete a contract can vary from our estimates. The proportional revenue recognition method we use for collaborative research and development agreements includes adjustments for revisions to estimated total agreement costs. Each period, we evaluate total estimated costs for each agreement and include any significant revisions in the period we become aware of changes in estimated total costs. The costs for work performed under collaborative research and development agreements are expensed in the periods incurred and included in the Statement of Operations in research and development expense.

For the three and six months ended June 30, 2013, two commercial customers accounted for approximately 93% and 89% of our total revenue. The accounts receivable balance from these customers was approximately 98% of our net accounts receivable balance at June 30, 2013.

4. INVENTORY

Inventory consists of the following:

          June 30,         December 31,
      2013     2012
Raw materials   $ 11,000    $ 361,000 
Finished goods     33,000      136,000 
    $ 44,000    $ 497,000 

The inventory at June 30, 2013 and December 31, 2012 consisted of components supplied under our "Image by PicoP®" ingredient brand business model, and finished goods primarily composed of our accessory pico projectors. Inventory is stated at the lower of cost or market. Management periodically assesses the need to provide for obsolescence of inventory and adjusts the carrying value of inventory to its net realizable value when required. In addition, we reduce the value of our inventory to our estimated scrap value when management determines that it is not probable that the inventory will be consumed through normal production during the next twelve months. During the six months ended June 30, 2013, we recorded inventory write-downs of $303,000. In 2012, we recorded inventory write-downs of $1,094,000. At June 30, 2013 and December 31, 2012, we have aggregate write-downs recorded of $10,279,000 and $9,916,000, respectively, offsetting inventory on hand deemed to be obsolete or scrap inventory.

8


5. SHARE-BASED COMPENSATION

We use the straight-line attribution method to allocate the fair value of share-based compensation awards over the requisite service period for each award. The following table shows the amount of stock-based compensation expense included in the consolidated statements of operations:

      Three Months Ended     Six Months Ended
      June 30,     June 30,
      2013     2012     2013     2012
Cost of contract revenue   $   $ 4,000    $ 4,000    $ 10,000 
Cost of product revenue             1,000      20,000 
Research and development expense     (72,000)     87,000      88,000      224,000 
Sales, marketing, general and administrative expense     168,000      390,000      388,000      600,000 
Total share-based employee compensation expense   $ 96,000    $ 481,000    $ 481,000    $ 854,000 

Options Activity and Positions

The following table summarizes shares, weighted average exercise price, weighted average remaining contractual term and aggregate intrinsic value of options outstanding and options exercisable as of June 30, 2013:

              Weighted      
              Average      
          Weighted   Remaining      
          Average   Contractual     Aggregate
          Exercise   Term     Intrinsic
Options   Shares     Price   (years)     Value
Outstanding as of June 30, 2013   1,255,000    $ 12.63    6.9    $ 376,000 
                     
Exercisable as of June 30, 2013   770,000    $ 18.80    5.6    $ 97,000 

As of June 30, 2013, our unamortized share-based employee compensation was $941,000 which we plan to amortize over the next 1.9 years and our unamortized nonvested equity share-based employee compensation was $366,000 which we plan to amortize over the next 0.9 years.

6. COMMITMENTS AND CONTINGENCIES

Litigation

We are subject to various claims and pending or threatened lawsuits in the normal course of business. We are not currently party to any legal proceedings that management believes are reasonably possible to have a material adverse effect on our consolidated financial position, results of operations or cash flows.

Adverse purchase commitments

We have periodically entered into noncancelable purchase contracts in order to ensure the availability of materials to support production of products based on our PicoP display technology. We periodically assess the need to provide for impairment on these purchase contracts and record a loss on purchase commitments when required. As of June 30, 2013 and December 31, 2012 we had approximately $500,000 and $634,000, respectively, accrued for adverse purchase commitments related to these purchase contracts.

9


7. COMMON STOCK AND WARRANTS

In May 2013, we raised $5.85 million before issuance costs of approximately $362,000 from the sale of 2.6 million shares of common stock and warrants to purchase up to an aggregate of 2.0 million shares of our common stock in a registered direct offering. The warrants have an exercise price of $2.886 per share, a five year term, and are exercisable beginning on the date of issuance. Each warrant to purchase a share of common stock may also be exchanged during its term for a number of shares of common stock (but not more than one share of common stock for each warrant so exchanged) with a value determined by a negotiated formula if, among other things, our common stock is then trading at a price at or lower than the warrant exercise price per share. Subject to limitations in the warrants, we may require the warrants be exercised for cash if the closing bid price of our stock is over $3.61 for 20 consecutive trading days and the average daily dollar volume over that period is equal to or exceeds $300,000.

Based on the terms of the agreement, we have determined that the warrant instruments should be classified as a liability given that the warrants could result in the issuance of a variable number of common shares based on a conditional exercise provision that is outside of our control at any point when the share price of our common stock is equal to or less than the stated exercise price of $2.886 per share. At the date of issuance, and as of June 30, 2013, our common stock was trading at a value less than the stated exercise price, as such upon expiration of the 45 day lock up period, the holders may elect to exchange the warrants for a variable number of shares of common stock as determined by a negotiated formula included in the warrant agreement. However, the agreement contains a limit that restricts the number of shares that may be issued under this exchange provision, such that we will not issue any more common shares than could be issued on a one-for-one basis upon exercise of the warrants. As of June 30, 2013, based upon the terms of the agreement and the quoted market price of our common stock, if the exchange feature were to be fully exercised, we would be required to issue approximately 1,490,000 shares of common stock, equal to an estimated fair market value of $3,755,000, which we believe is the best indication of the fair value of the warrant obligation as of June 30, 2013. Changes in the market value of our common stock will increase or decrease the number of shares to be issued under this exchange feature; however the aggregate fair market value of shares to be issued under this provision will not change significantly due to the negotiated and fixed exchange formula in the agreement. Due to the limiting provisions on the exchange agreement, the maximum number of shares of common stock that we could be required to issue is 1,976,352.

At each balance sheet date, we will evaluate the fair value of the warrants and any change in value will be recorded as a non-operating gain or loss on the statement of operations. We will re-assess the appropriate valuation model for determining the estimated fair value of the warrant instruments, which may include a binomial valuation model to take into consideration the other features of the warrants. Determination of the fair market value of the warrant instruments includes consideration of Level 3 inputs. Level 3 inputs are unobservable inputs for which there is little or no market data, which requires us to develop our own assumptions, which are significant to the measurement of the fair values.

10


8. NEW ACCOUNTING PRONOUNCEMENTS

In July 2012, the Financial Accounting Standards Board ("FASB") issued guidance that will allow an entity to first assess qualitative factors to determine whether it is necessary to perform a quantitative impairment test for indefinite-lived intangible assets. Under this guidance, an entity would not be required to calculate the fair value of an indefinite-lived intangible asset unless the entity determines, based on qualitative assessment, that it is not more likely than not, the indefinite-lived intangible asset is impaired. This guidance is effective for impairment tests performed for fiscal years beginning after September 15, 2012, with early adoption permitted. We do not expect the implementation of this guidance will have a material impact on our financial statements.

In February 2013, the FASB issued guidance that requires disclosure of amounts reclassified out of accumulated other comprehensive income in its entirety, by component, on the face of the statement of operations or in the notes thereto. Amounts that are not required to be reclassified in their entirety to net income must be cross-referenced to other disclosures that provide additional detail. This standard is effective prospectively for annual and interim reporting periods beginning after December 15, 2012. We do not expect the implementation of this guidance will have a material impact on our financial statements.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

The information set forth in this report in Item 2, "Management's Discussion and Analysis of Financial Condition and Results of Operations," and Item 3, "Quantitative and Qualitative Disclosure about Market Risk," includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is subject to the safe harbor created by that section. Such statements may include, but are not limited to, projections of revenues, income or loss, capital expenditures, plans for product development and cooperative arrangements, future operations, financing needs or plans of MicroVision , as well as assumptions relating to the foregoing. The words "anticipate," "believe," "estimate," "expect," "goal," "may," "plan," "project," "will," and similar expressions identify forward-looking statements, which speak only as of the date the statement was made. Factors that could cause actual results to differ materially from those projected in our forward-looking statements include the following: our ability to obtain financing; market acceptance of our technologies and products; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified in this report under the caption "Item 1A - Risk Factors."

11


Overview

We are developing our proprietary PicoP® display technology, which can be used by our customers to create high-resolution miniature laser display and imaging engines. Our PicoP display technology utilizes our widely patented expertise in two dimensional Micro- Electrical Mechanical Systems (MEMS), lasers, optics and electronics to create a high quality video or still image from a small form factor device with lower power needs than conventional display technologies. Our strategy is to develop and supply PicoP display technology directly or through licensing arrangements to original equipment manufacturers (OEMs) in market segments including consumer electronics, automotive, and industrial for integration into their products.

During 2012, we aligned our operations to our ingredient brand strategy, simplifying our operations and resulting in an expected significant reduction to our future cash requirements. Our strategy is to focus our efforts on licensing our technology to partners who will produce display engines based on PicoP display technology and incorporate the engine into their products. Our development efforts are focused on supporting our customers in their manufacturing and integration and optimizing PicoP display technology for specific applications.

The primary objective for consumer applications is to provide users of mobile consumer devices such as smartphones, media players, tablet PCs and other consumer electronics products with a large screen viewing experience produced by a small projector either embedded in the device or via an attached accessory. These potential products would allow users to watch movies and videos, play video games, and display images and other data onto a variety of surfaces, freeing users from the limitations of a small, palm-sized screen. PicoP display technology could be further modified to be embedded into a pair of glasses to provide the mobile user with a see-through or occluded personal display to view movies, play games or access other content.

PicoP display technology is currently sold by Pioneer Corporation as part of an aftermarket high-resolution head-up display (HUD) that projects point-by-point navigation, critical operational, safety and other information important to the vehicle operator. With some modification PicoP display technology could also be embedded into a vehicle or integrated into a portable standalone HUD.

Devices enabled by PicoP display technology can be used in field-based professions such as service repair or sales to view and share information such as schematics for equipment repair, sales data, orders or contact information within a CRM application on a larger, more user-friendly display. We also see potential for embedding PicoP display technology in industrial products where our displays could be used for 3D measuring and digital signage, enhancing the overall user experience of these applications. We continue to enter into a limited number of contracts with commercial and U.S. government customers to develop advanced prototypes and demonstration units based on our light scanning technologies.

We develop and procure intellectual property rights relating to our technology as a key aspect of our business strategy. We generate intellectual property from our internal research and development activities and our ongoing performance on development contracts. We also have acquired exclusive rights to various technologies under licensing and acquisition agreements.

In 2012, we reduced our sales and marketing effort for the SHOWWX ™ line of pico projectors and we do not expect to increase our investment in the SHOWWX™ product in the future.

We have incurred substantial losses since inception and expect to incur a substantial loss during the fiscal year ending December 31, 2013.

12


Results of Operations

Product revenue.

(in thousands)     2013     2012     $ change     % change
                         
Three months ended June 30   $ 917    $ 750    $ 167      22.3 
                         
                         
                         
(in thousands)     2013     2012     $ change     % change
                         
Six months ended June 30   $ 2,136    $ 2,279    $ (143)     (6.3)

Product revenue during the three and six months ended June 30, 2013 primarily includes sales of components to Pioneer under our "Image by PicoP" ingredient brand business model. Product revenue during the three and six months ended June 30, 2012 included sales of components to Pioneer, sales of our SHOWWX™ line of accessory pico projectors and sales of our PicoP display engines.

Our product sales generally include acceptance provisions. We recognize product revenue upon acceptance of the product by the customer or expiration of the contractual acceptance period, after which there are no rights of return. Provisions are made for warranties at the time revenue is recorded. Warranty expense was not material for any periods presented.

Pioneer has reported a group net loss for the period April to December 2012. The group net loss has been attributed in part due to lower financial performance for its car navigation system business. As a result of this performance, we have reduced our expectations for significant 2013 follow-on orders for their after-market HUD product.

Product revenue was higher during the three months ended June 30, 2013 than the same period in 2012, due to higher sales of components to Pioneer. These increases were partially offset by lower sales of our accessory pico projectors. Product revenue was lower during the six months ended June 30, 2013 than the same period in 2012, due to decreased sales of our PicoP display engines and finished units. These decreases were partially offset by increased component sales. The backlog of product orders at June 30, 2013 was approximately $282,000, compared to $4.4 million at June 30, 2012. The product backlog is scheduled for delivery within one year.

Contract revenue.

            % of           % of            
            contract           contract            
(in thousands)     2013     revenue     2012     revenue     $ change     % change
Three months ended June 30                                    
Government revenue   $     -     $ 53      9.7    $ (53)     (100.0)
Commercial revenue     73      100.0      492      90.3      (419)     (85.2)
Total contract revenue   $ 73      100.0    $ 545      100.0    $ (472)     (86.6)
                                     
            % of           % of            
            contract           contract            
(in thousands)     2013     revenue     2012     revenue     $ change     % change
Six months ended June 30                                    
Government revenue   $     -     $ 156      20.9    $ (156)     (100.0)
Commercial revenue     355      100.0      590      79.1      (235)     (39.8)
Total contract revenue   $ 355      100.0    $ 746      100.0    $ (391)     (52.4)

13


We earn contract revenue from the sale of prototype units and evaluation kits based on our PicoP display engine and sales of test equipment built specifically for use in PicoP display engine production and from performance on long-term, cost plus fixed fee, and fixed price contracts with commercial customers and the U.S. government. Our contract revenue from sales of prototype units and evaluation kits may vary substantially due to the timing of orders from customers and potential constraints on resources. Our contract revenue from long-term contracts in a particular period is dependent upon when we enter into a contract, the value of the contracts we have entered into, and the availability of technical resources to perform work on the contracts.

We recognize contract revenue on the sale of prototype units and evaluation kits, upon acceptance of the deliverables by the customer or expiration of the contractual acceptance period, after which there are no rights of return. While we anticipate future revenue from these units, quarterly revenue may vary substantially due to the timing of orders from customers and potential constraints on resources.

We recognize contract revenue as work progresses on long-term, cost plus fixed fee, and fixed price contracts using the percentage-of-completion method, which relies on estimates of total expected contract revenue and costs. We have developed processes that allow us to make reasonable estimates of the cost to complete a contract. When we begin work on the contract and at the end of each accounting period, we estimate the costs required to complete the contract and compare these estimates to costs incurred to date. Since our contracts generally require some level of technology development, the actual costs required to complete a contract can vary from our estimates. Recognized revenues are subject to revisions as actual cost becomes certain. Revisions in revenue estimates are reflected in the period in which the facts that give rise to the revision become known. In the future, revisions in these estimates could significantly impact recognized revenue in any one reporting period.

Contract revenue was lower during the three and six months ended June 30, 2013 than the same period in 2012 primarily due to lower sales of test equipment and reduced activity on government contracts in 2013 compared to the prior year.

Our contract backlog at June 30, 2013 was $104,000 compared to $1.0 million at June 30, 2012. The backlog is scheduled for completion during the next twelve months.

Development revenue.

(in thousands)     2013     2012     $ change     % change
                         
Three months ended June 30   $ 880    $   $ 880      -  
                         
                         
                         
(in thousands)     2013     2012     $ change     % change
                         
Six months ended June 30   $ 1,180    $   $ 1,180      -  

We earn development revenue from performance on collaborative research and development agreements with commercial customers researching and developing commercial applications for our technology. Our contributions under the collaborative agreements generally include research services, components, and prototype devices and fixtures. Our development revenue from such agreements in a particular period is dependent upon the values and timing of agreements, and the availability of technical resources to perform the work. We evaluate the performance criteria and terms of our collaborative research and development agreements to determine whether revenue should be recognized under a performance-based method or milestone method.

In March 2013, we entered into a $4.6 million collaborative research and development agreement with a prominent electronics company to incorporate our PicoP® display technology into a display engine that could enable a variety of new products. During the three and six months ended June 30, 2013, $880,000 and $1.2 million of revenue was recognized on this agreement.

14


Based on the terms of this agreement, we recognize development revenue as work progresses on the agreement and as our customer accepts the deliverables using a proportional method based on lesser of the cumulative proportion of total planned costs to be incurred under the agreement versus the cash payments received plus outstanding billings for work accepted by the customer. Since our collaborative agreements generally require some level of technology development, the actual costs required to complete a contract can vary from our estimates. The proportional revenue recognition method we use for collaborative research and development agreements includes adjustments for revisions to estimated total agreement costs. Each period, we evaluate total estimated costs for each agreement and include any significant revisions in the period we become aware of changes in estimated total costs. In the future, revisions in these estimates could significantly impact recognized revenue in any one reporting period.

Our backlog of collaborative research and development agreements at June 30, 2013 was $3.4 million compared to zero at June 30, 2012. The backlog is scheduled for completion during the next twelve months.

Cost of product revenue.

            % of           % of            
            product           product            
(in thousands)     2013     revenue     2012     revenue     $ change     % change
Three months ended June 30   $ 837      91.3    $ (281)     (37.5)   $ 1,118      (397.9)
Six months ended June 30     1,501      70.3      3,894      170.9      (2,393)     (61.5)

Cost of product revenue includes the direct and allocated indirect cost of manufacturing products sold to customers. Direct costs include labor, materials and other costs incurred directly in the manufacture of these products. Indirect costs include labor, manufacturing overhead, and other costs associated with operating our manufacturing capabilities and capacity. Manufacturing overhead includes the costs of procuring, inspecting and storing material, and facility and depreciation costs, and is allocated to cost of product revenue based on the proportion of direct material purchased to support production. In the event that we maintain production capacity in excess of production requirements, cost of product revenue may also include manufacturing overhead associated with the excess capacity.

Cost of product revenue was higher during the three months ended June 30, 2013 than the same period in 2012 because, during the three months ended June 30, 2012, we negotiated a lower price for certain components in inventory that had previously been written down to net realizable value. As a result of this renegotiation, the aggregate purchase price was reduced and we recorded a credit of $1.4 million to cost of product revenue during second quarter of 2012. This change was partially offset by lower costs in 2013 resulting from a change in product mix from sales of lower margin SHOWWX™ products in 2012 to sales of higher margin components to support Pioneer's Cyber Navi production.

Cost of product revenue was lower during the six months ended June 30, 2013 than the same period in 2012 primarily because of the change in product mix from lower margin SHOWWX™ products to sales of higher margin components, decreased inventory write downs and lower manufacturing overhead associated with excess production capacity compared to the prior year. During the six months ended June, 2013 and 2012, cost of product revenue included inventory write downs of $303,000 and $1.1 million, respectively. During the six months ended June 30, 2013, cost of product revenue did not include any manufacturing overhead associated with production capacity in excess of production requirements, compared to $411,000 during the same period in 2012.

The cost of product revenue as a percentage of product revenue can fluctuate significantly from period to period, depending on the product mix and volume, the level of overhead expense and the volume of direct material purchased. It decreased substantially during the six months ended June 30, 2013 than the same period in 2012 due to costs incurred in 2012 associated with aligning our operations to our ingredient brand strategy per above.

Cost of contract revenue.

            % of           % of            
            contract           contract            
(in thousands)     2013     revenue     2012     revenue     $ change     % change
Three months ended June 30   $ 26      35.6    $ 248      45.5    $ (222)     (89.5)
Six months ended June 30     163      45.9      403      54.0      (240)     (59.6)

15


Cost of contract revenue includes both the direct and allocated indirect costs of producing prototype units and evaluation kits and performing on long-term, cost plus fixed fee, and fixed price contracts. Direct costs include labor, materials and other costs incurred directly in producing prototype units and evaluation kits or performing on a contract. Indirect costs include labor and other costs associated with operating our research and development department and building our technical capabilities and capacity. Cost of contract revenue is determined by the level of direct and indirect costs incurred, which can fluctuate substantially from period to period.

Cost of contract revenue was lower during the three and six months ended June 30, 2013 than the same period in 2012 as a result of the decreased sales of test equipment and reduced activity on government contracts.

The cost of revenue as a percentage of revenue can fluctuate significantly from period to period, depending on the contract cost mix and the levels of direct and indirect costs incurred.

Research and development expense.

(in thousands)     2013     2012     $ change     % change
Three months ended June 30   $ 2,339    $ 3,227    $ (888)     (27.5)
Six months ended June 30     4,591      7,167      (2,576)     (35.9)

Research and development expense consists of compensation related costs of employees and contractors engaged in internal research and product development activities, direct material to support development programs, laboratory operations, outsourced development and processing work, and other operating expenses. We include costs for work performed under collaborative research and development agreements in research and development costs in the periods incurred. We allocate our research and development resources based on the business opportunity of the available projects, the skill mix of the resources available and the contractual commitments we have made to customers.

We believe that a substantial level of continuing research and development expense will be required to further develop our PicoP technology and to support our customers to integrate our technology into their products under the ingredient brand business model. Accordingly, we anticipate our level of research and development spending will continue to be substantial. We believe that under the ingredient brand business model, we will have lower research and development spending in the future than had we not implemented the strategy.

The decrease in research and development expense during the three and six months ended June 30, 2013, compared to the same period in 2012, is primarily attributable to decreased payroll costs associated with reductions in staffing levels and lower subcontracted services compared to the prior year.

Sales, marketing, general and administrative expense.

(in thousands)     2013     2012     $ change     % change
Three months ended June 30   $ 2,101    $ 3,064    $ (963)     (31.4)
Six months ended June 30     4,504      6,352      (1,848)     (29.1)

Sales, marketing, general and administrative expense includes compensation and support costs for marketing, sales, management and administrative staff, and for other general and administrative costs, including legal and accounting services, consultants and other operating expenses. We believe that under the ingredient brand business model we will have lower costs in sales, marketing, general and administrative expense in the future than had we not implemented the strategy.

The decrease in sales, marketing, general and administrative expense during the three and six months ended June 30, 2013, compared to the same period in 2012, is primarily due to decreased payroll costs associated with reductions in staffing levels compared to the prior year.

16


Other income (expense).

(in thousands)     2013     2012     $ change     % change
Three months ended June 30   $ (3)   $ (9)   $     (66.7)
Six months ended June 30     (4)     16      (20)     (125.0)

The change in other income (expense) for the six months ended June 30, 2013 compared to the same period in 2012 resulted primarily from prior year sales of excess inventory.

Liquidity and Capital Resources

We have incurred significant losses since inception. We have funded operations to date primarily through the sale of common stock, convertible preferred stock, warrants, the issuance of convertible debt and, to a lesser extent, from contract revenues, collaborative research and development agreements and product sales. At June 30, 2013, we had $6.0 million in cash and cash equivalents and a working capital deficit of $2.6 million.

Based on our current operating plan, we anticipate that we have sufficient cash and cash equivalents to fund our operations through October of 2013. We will require additional cash to fund our operating plan past that time. We plan to obtain additional cash through the issuance of equity or debt securities. There can be no assurance that additional cash will be available or that, if available, it will be available on terms acceptable to us on a timely basis. If adequate funds are not available on a timely basis, we intend to consider limiting our operations substantially. This limitation of operations could include reducing our planned investment in development projects resulting in reductions in staff, operating costs, capital expenditures and investment in research and development.

We received a report from our independent registered public accounting firm regarding the consolidated financial statements for the year ended December 31, 2012 that includes an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. These financial statements are prepared assuming we will continue as a going concern.

Cash used in operating activities totaled $6.3 million during the six months ended June 30, 2013, compared to $13.0 million during the same period in 2012. During the six months ended June 30, 2013, the decrease in net cash used in operating activities was primarily driven by lower personnel costs and increased margins on product sales, as well as savings resulting from steps taken to lower our cash use as we aligned our operations with our ingredient brand strategy.

Net cash used in investing activities totaled $83,000 for the six months ended June 30, 2013 compared to net cash used in investing activities of $38,000 during the six months ended June 30, 2012. During the six months ended June 30, 2013, the change in net cash used in investing activities was primarily driven by prior year activity which did not occur in the current year. Prior year activity included a $350,000 decrease of our restricted cash offset by purchases of property and equipment totaling $400,000.

Net cash provided by financing activities totaled $5.5 million for the six months ended June 30, 2013 compared to $14.7 million during the same period in 2012.

In May 2013, we raised $5.85 million before issuance costs of approximately $362,000 from the sale of 2.6 million shares of common stock and warrants to purchase up to an aggregate of 2.0 million shares of our common stock in a registered direct offering. The warrants have an exercise price of $2.886 per share, a five year term, and are exercisable beginning on the date of issuance. Each warrant to purchase a share of common stock may also be exchanged during its term for a number of shares of common stock (but not more than one share of common stock for each warrant so exchanged) with a value determined by a negotiated formula if, among other things, our common stock is then trading at a price at or lower than the warrant exercise price per share. Subject to limitations in the warrants, we may require the warrants be exercised for cash if the closing bid price of our stock is over $3.61 for 20 consecutive trading days and the average daily dollar volume over that period is equal to or exceeds $300,000.

In June 2012, we raised $10.5 million before issuance costs of approximately $823,000 through an underwritten public offering of 4.2 million shares of our common stock and warrants to purchase 2.1 million shares of our common stock. The warrants have an exercise price of $2.65 per share, a five year term, and are exercisable beginning one year from the date of issuance.

17


In May 2012, we raised $5.0 million before issuance costs of approximately $71,000 from the sale of 3.3 million shares of common stock and warrants to purchase 1.0 million shares of our common stock to a strategic investor. The warrants have an exercise price of $2.12 per share, a three year term, and are exercisable beginning on the date of issuance.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate and Market Liquidity Risks

As of June 30, 2013, all of our cash and cash equivalents have variable interest rates. Therefore, we believe our exposure to market and interest rate risks is not material.

Our investment policy generally directs that the investment managers should select investments to achieve the following goals: principal preservation, adequate liquidity and return. As of June 30, 2013, our cash and cash equivalents are comprised of short-term highly rated money market savings accounts.

The values of cash and cash equivalents by maturity date as of June 30, 2013, are as follows:

(amount in thousands)     Amount     Percent  
Cash and cash equivalents   $ 6,003      100.00  %
Less than one year         -   %
One to two years         -   %
Greater than five years         -   %
    $ 6,003      100.00  %

Foreign Exchange Rate Risk

All of our contract and collaborative research and development agreements payments are currently made in U.S. dollars. However, in the future we may enter into contracts or collaborative research and development agreements in foreign currencies that may subject us to foreign exchange rate risk. We have purchase orders and supply agreements in foreign currencies and may enter into such arrangements from time to time in the future. We believe our exposure to currency fluctuations related to these arrangements is not material. We may enter into foreign currency hedges to offset material exposure to currency fluctuations when we can adequately determine the timing and amounts of the exposure.

ITEM 4. CONTROLS AND PROCEDURES

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934) as of the end of the period covered by this report and, based on this evaluation, our principal executive officer and principal financial officer have concluded that these disclosure controls and procedures are effective. There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Securities Exchange Act of 1934) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II

OTHER INFORMATION

ITEM 1A - RISK FACTORS

Risk Factors Relating to the MicroVision Business

We have a history of operating losses and expect to incur significant losses in the future.

18


We have had substantial losses since our inception. We cannot assure you that we will ever become or remain profitable.

  • As of June 30, 2013, we had an accumulated deficit of $444.6 million.
  • We incurred consolidated net losses of $414.8 million from inception through 2011, $22.7 million in 2012, and a net loss of $7.1 million in the six months ended June 30, 2013.

The likelihood of our success must be considered in light of the expenses, difficulties and delays frequently encountered by companies formed to develop and market new technologies. In particular, our operations to date have focused primarily on research and development of our technology platform and development of demonstration units. We are unable to accurately estimate future revenues and operating expenses based upon historical performance.

We cannot be certain that we will succeed in obtaining additional contracts or collaborative research and development agreements or that we will be able to obtain substantial customer orders for our products. In light of these factors, we expect to continue to incur substantial losses and negative cash flow at least through 2013 and likely thereafter. We cannot be certain that we will achieve positive cash flow at any time in the future.

>We will require additional capital to fund our operations and to implement our business plan. If we do not obtain additional capital, we may be required to curtail our operations substantially. Raising additional capital may dilute the value of current shareholders' shares.

Based on our current operating plan, we anticipate that we have sufficient cash and cash equivalents to fund our operations through October of 2013. We will require additional cash to fund our operating plan past that time. We plan to obtain additional cash through the issuance of equity or debt securities.

We are introducing new technology into an emerging market which creates significant uncertainty about our ability to accurately project revenue, costs and cash flows. Our capital requirements will depend on many factors, including, but not limited to, the rate at which we can, directly or through arrangements with original equipment manufacturers, introduce products incorporating PicoP display technology and the market acceptance and competitive position of such products. If revenues are less than we anticipate, if the mix of revenues varies from anticipated amounts or if expenses exceed the amounts budgeted, we may require additional capital earlier than expected to fund our operations. In addition, our operating plan provides for the development of strategic relationships with systems and equipment manufacturers that may require additional investments by us.

Additional capital may not be available to us, or if available, on terms acceptable to us or on a timely basis. Raising additional capital may involve issuing securities with rights and preferences that are senior to our common stock and may dilute the value of current shareholders' shares. If adequate funds are not available on a timely basis we intend to consider limiting our operations substantially to extend out funds as we pursue other financing opportunities and business relationships. This limitation of operations could include delaying development projects and reductions in staff, operating costs, including research and development, and capital expenditures.

We are dependent on third parties in order to develop, manufacture, sell and market our products.

Our strategy for commercializing our technology and products incorporating PicoP display technology includes entering into cooperative development, manufacturing, sales and marketing arrangements with corporate partners, original equipment manufacturers and other third parties. We cannot be certain that we will be able to negotiate arrangements on acceptable terms, if at all, or that these arrangements will be successful in yielding commercially viable products. If we cannot establish these arrangements, we would require additional capital to undertake such activities on our own and would require extensive manufacturing, sales and marketing expertise that we do not currently possess and that may be difficult to obtain. In addition, we could encounter significant delays in introducing PicoP display technology or find that the development, manufacture or sale of products incorporating the PicoP display engine would not be feasible. To the extent that we enter into cooperative development, sales and marketing or other joint venture arrangements, our revenues will depend upon the performance of third parties. We cannot be certain that any such arrangements will be successful.

19


We cannot be certain that our technology platform or products incorporating PicoP display technology will achieve market acceptance. If products incorporating PicoP display technology do not achieve market acceptance, our revenues may not grow.

Our success will depend in part on customer acceptance of PicoP display technology. PicoP display technology may not be accepted by manufacturers who use display technologies in their products, by systems integrators who incorporate our products into their products or by end users of these products. To be accepted, PicoP display technology must meet the expectations of our potential customers in the consumer, automotive, industrial, and other markets. If our technology fails to achieve market acceptance, we may not be able to continue to develop our technology platform.

Future products based on our PicoP display technology are dependent on advances in technology by other companies.

Our PicoP display technology will continue to rely on technologies, such as light sources, MEMS and optical components that are developed and produced by other companies. The commercial success of certain future products based on our technology will depend in part on advances in these and other technologies by other companies. We may, from time to time, contract with and support companies developing key technologies in order to accelerate the development of them for our or our customers' specific uses. There are no guarantees that such activities will result in useful technologies or components for us.

We are dependent on a small number of customers for our revenue. Our quarterly performance may vary substantially and this variance, as well as general market conditions, may cause our stock price to fluctuate greatly and potentially expose us to litigation.

Since 2010, most of our revenues have been generated from product sales to a limited number of customers and distribution partners. In 2012, 61% of our revenue was generated from sales to one commercial customer. For the six months ended June 30, 2013, two commercial customers accounted for approximately 89% of our total revenue. Our quarterly operating results may vary significantly based on:

  • commercial acceptance of PicoP-based products;
  • changes in evaluations and recommendations by any securities analysts following our stock or our industry generally;
  • announcements by other companies in our industry;
  • changes in business or regulatory conditions;
  • announcements or implementation by our competitors of technological innovations or new products;
  • the status of particular development programs and the timing of performance under specific development agreements;
  • economic and stock market conditions; or
  • other factors unrelated to our company or industry.

In one or more future quarters, our results of operations may fall below the expectations of securities analysts and investors and the trading price of our common stock may decline as a consequence. In addition, following periods of volatility in the market price of a company's securities, shareholders often have instituted securities class action litigation against that company. If we become involved in a class action suit, it could divert the attention of management, and, if adversely determined, could require us to pay substantial damages.

We or our customers may fail to perform under collaborative research and development agreements, contracts and open orders, which could adversely affect our operating results and cash flows. 

Our backlog totaled $3.8 million as of June 30, 2013. We may be unable to meet the performance requirements, including performance specifications or delivery dates, required by such collaborative research and development agreements, contracts or purchase orders.  Further, our customers may be unable or unwilling to perform their obligations thereunder on a timely basis or at all if, among other reasons, our products and technologies do not achieve market acceptance, our customers' products and technologies do not achieve market acceptance or our customers otherwise fail to achieve their operating goals. To the extent we are unable to perform under such collaborative research and development agreements, contracts or purchase orders or to the extent customers are unable or unwilling to perform, our operating results and cash flows could be adversely affected.

20


It may become more difficult to sell our stock in the public market or maintain our listing on the NASDAQ Global Market.

Our common stock is listed for quotation on The NASDAQ Global Market. To keep our listing on this market, we must meet NASDAQ's listing maintenance standards. If we are unable to continue to meet NASDAQ'S listing maintenance standards for any reason, our common stock could be delisted from The NASDAQ Global Market. If our common stock were delisted, we likely would seek to list the common stock on the NASDAQ Capital Market, the American Stock Exchange or on a regional stock exchange. Listing on such other market or exchange could reduce the liquidity of our common stock. If our common stock were not listed on the NASDAQ Capital Market or an exchange, trading of our common stock would be conducted in the over-the-counter market on an electronic bulletin board established for unlisted securities or directly through market makers in our common stock. If our common stock were to trade in the over-the-counter market, an investor would find it more difficult to dispose of, or to obtain accurate quotations for the price of, the common stock. A delisting from The NASDAQ Global Market and failure to obtain listing on such other market or exchange would subject our securities to so-called penny stock rules that impose additional sales practice and market-making requirements on broker-dealers who sell or make a market in such securities. Consequently, removal from The NASDAQ Global Market and failure to obtain listing on another market or exchange could affect the ability or willingness of broker-dealers to sell or make a market in our common stock and the ability of purchasers of our common stock to sell their securities in the secondary market. In addition, when the market price of our common stock is less than $5.00 per share, we become subject to penny stock rules even if our common stock is still listed on The NASDAQ Global Market. While the penny stock rules should not affect the quotation of our common stock on The NASDAQ Global Market, these rules may further limit the market liquidity of our common stock and the ability of investors to sell our common stock in the secondary market. The market price of our stock has traded below $5.00 per share during 2013 and 2012. On August 6, 2013, the closing price of our stock was $2.43.

Our lack of financial and technical resources relative to our competitors may limit our revenues, potential profits, overall market share or value.

Our current products and potential future products will compete with established manufacturers of existing products and companies developing new technologies. Many of our competitors have substantially greater financial, technical and other resources than we have. Because of their greater resources, our competitors may develop products or technologies that are superior to our own. The introduction of superior competing products or technologies could result in reduced revenues, lower margins or loss of market share, any of which could reduce the value of our business.

We may not be able to keep up with rapid technological change and our financial results may suffer.

The information display industry has been characterized by rapidly changing technology, accelerated product obsolescence and continuously evolving industry standards. Our success will depend upon our ability to further develop our technology platform and to cost effectively introduce new products and features in a timely manner to meet evolving customer requirements and compete with competitors' product advances.

We may not succeed in these efforts because of:

  • delays in product development;
  • lack of market acceptance for our products; or
  • lack of funds to invest in product development and marketing.

The occurrence of any of the above factors could result in decreased revenues, market share and value.

21


We could face lawsuits related to our use of PicoP display technology or other technologies. Defending these suits would be costly and time consuming. An adverse outcome in any such matter could limit our ability to commercialize our technology and products, reduce our revenues and increase our operating expenses.

We are aware of several patents held by third parties that relate to certain aspects of light scanning displays and image capture products. These patents could be used as a basis to challenge the validity, limit the scope or limit our ability to obtain additional or broader patent rights of our patents or patents we have licensed. A successful challenge to the validity of our patents or patents we have licensed could limit our ability to commercialize our technology and the PicoP display engine and, consequently, materially reduce our revenues. Moreover, we cannot be certain that patent holders or other third parties will not claim infringement by us with respect to current and future technology. Because U.S. patent applications are held and examined in secrecy, it is also possible that presently pending U.S. applications will eventually be issued with claims that will be infringed by our products or our technology. The defense and prosecution of a patent suit would be costly and time consuming, even if the outcome were ultimately favorable to us. An adverse outcome in the defense of a patent suit could subject us to significant costs, to require others and us to cease selling products that incorporate PicoP display technology, to cease licensing our technology or to require disputed rights to be licensed from third parties. Such licenses, if available, would increase our operating expenses. Moreover, if claims of infringement are asserted against our future co- development partners or customers, those partners or customers may seek indemnification from us for damages or expenses they incur.

If we fail to manage expansion effectively, our revenue and expenses could be adversely affected.

Our ability to successfully offer products and implement our business plan in a rapidly evolving market requires an effective planning and management process. The growth in business and relationships with customers and other third parties has placed, and will continue to place, a significant strain on our management systems and resources. We will need to continue to improve our financial and managerial controls, reporting systems and procedures and will need to continue to train and manage our work force.

Our products may be subject to future health and safety regulations that could increase our development and production costs.

Products incorporating PicoP display technology could become subject to new health and safety regulations that would reduce our ability to commercialize PicoP display technology. Compliance with any such new regulations would likely increase our cost to develop and produce products using PicoP display technology and adversely affect our financial results.

Our operating results may be adversely impacted by worldwide political and economic uncertainties and specific conditions in the markets we address.

In the recent past, general worldwide economic conditions have experienced a downturn due to slower economic activity, concerns about inflation, increased energy costs, decreased consumer confidence, reduced corporate profits and capital spending, and adverse business conditions. Any continuation or worsening of the current global economic and financial conditions could materially adversely affect (i) our ability to raise, or the cost of, needed capital, (ii) demand for our current and future products and (iii) our ability to commercialize products. We cannot predict the timing, strength, or duration of any economic slowdown or subsequent economic recovery, worldwide, or in the display industry.

Because we plan to continue using foreign contract manufacturers, our operating results could be harmed by economic, political, regulatory and other factors in foreign countries.

We currently use foreign manufacturers and plan to continue to use foreign manufacturers to manufacture future products, where appropriate. These international operations are subject to inherent risks, which may adversely affect us, including:

  • political and economic instability;
  • high levels of inflation, historically the case in a number of countries in Asia;
  • burdens and costs of compliance with a variety of foreign laws;
  • foreign taxes;
  • changes in tariff rates or other trade and monetary policies; and
  • changes or volatility in currency exchange rates.

22


Qualifying a new contract manufacturer or foundry for our products could cause us to experience delays that result in lost revenues and damaged customer relationships.

We rely on single suppliers to manufacture our PicoP display engine and our MEMS chips in wafer form. The lead time required to establish a relationship with a new contract manufacturer or foundry is long, and it takes time to adapt a product's design to a particular manufacturer's processes. Accordingly, there is no readily available alternative source of supply for these products and components in high volumes. Changing our source of supply and manufacture could cause significant delays in shipping products which may result in lost revenues and damaged customer relationships.

Our success will depend, in part, on our ability to secure significant third-party manufacturing resources.

Our success depends, in part, on our ability to provide our components and future products in commercial quantities at competitive prices. Accordingly, we will be required to obtain access, through business partners or contract manufacturers, to manufacturing capacity and processes for the commercial production of our expected future products. We cannot be certain that we will successfully obtain access to sufficient manufacturing resources. Future manufacturing limitations of our suppliers could result in a limitation on the number of products incorporating our technology that we are able to produce.

If our licensors and we are unable to obtain effective intellectual property protection for our products and technology, we may be unable to compete with other companies.

Intellectual property protection for our products is important and uncertain. If we do not obtain effective intellectual property protection for our products, processes and technology, we may be subject to increased competition. Our commercial success will depend in part on our ability and the ability of our licensors to maintain the proprietary nature of the PicoP display and other key technologies by securing valid and enforceable patents and effectively maintaining unpatented technology as trade secrets. We try to protect our proprietary technology by seeking to obtain United States and foreign patents in our name, or licenses to third-party patents, related to proprietary technology, inventions, and improvements that may be important to the development of our business. However, our patent position and the patent position of our licensors involve complex legal and factual questions. The standards that the United States Patent and Trademark Office and its foreign counterparts use to grant patents are not always applied predictably or uniformly and can change. Additionally, the scope of patents are subject to interpretation by courts and their validity can be subject to challenges and defenses, including challenges and defenses based on the existence of prior art. Consequently, we cannot be certain as to the extent to which we will be able to obtain patents for our new products and technology or the extent to which the patents that we already own or license from others protect our products and technology. Reduction in scope of protection or invalidation of our licensed or owned patents, or our inability to obtain new patents, may enable other companies to develop products that compete with ours on the basis of the same or similar technology.

We also rely on the law of trade secrets to protect unpatented know-how and technology to maintain our competitive position. We try to protect this know- how and technology by limiting access to the trade secrets to those of our employees, contractors and partners with a need to know such information and by entering into confidentiality agreements with parties that have access to it, such as our employees, consultants and business partners. Any of these parties could breach the agreements and disclose our trade secrets or confidential information, or our competitors might learn of the information in some other way. If any trade secret not protected by a patent were to be disclosed to or independently developed by a competitor, our competitive position could be materially harmed.

We could be exposed to significant product liability claims that could be time-consuming and costly, divert management attention and adversely affect our ability to obtain and maintain insurance coverage.

We may be subject to product liability claims if any of our product applications are alleged to be defective or cause harmful effects. For example, because some of our PicoP displays are designed to scan a low power beam of colored light into the user's eye, the testing, manufacture, marketing and sale of these products involve an inherent risk that product liability claims will be asserted against us. Product liability claims or other claims related to our products, regardless of their outcome, could require us to spend significant time and money in litigation, divert management time and attention, require us to pay significant damages, harm our reputation or hinder acceptance of our products. Any successful product liability claim may prevent us from obtaining adequate product liability insurance in the future on commercially desirable or reasonable terms. An inability to obtain sufficient insurance coverage at an acceptable cost or otherwise to protect against potential product liability claims could prevent or inhibit the commercialization of our products.

23


Our contracts and collaborative research and development agreements have long sales cycles, which make it difficult to plan our expenses and forecast our revenues.

Our contracts and collaborative research and development agreements have lengthy sales cycles that involve numerous steps including determination of a product application, exploring the technical feasibility of a proposed product, evaluating the costs of manufacturing a product and manufacturing or contracting out the manufacturing of the product. Our long sales cycle, which can last several years, makes it difficult to predict the quarter in which contract signing and revenue recognition will occur. Delays in entering into contracts and collaborative research and development agreements could cause significant variability in our revenues and operating results for any particular quarterly period.

Our contracts and collaborative research and development agreements may not lead to products that will be profitable.

Our contracts and collaborative research and development agreements, including without limitation those discussed in this document, are exploratory in nature and are intended to develop new types of products for new applications. These efforts may prove unsuccessful and these relationships may not result in the development of products that will be profitable.

If we lose our rights under our third-party technology licenses, our operations could be adversely affected.

Our business depends in part on technology rights licensed from third parties. We could lose our exclusivity or other rights to use the technology under our licenses if we fail to comply with the terms and performance requirements of the licenses. In addition, certain licensors may terminate a license upon our breach and have the right to consent to sublicense arrangements. If we were to lose our rights under any of these licenses, or if we were unable to obtain required consents to future sublicenses, we could lose a competitive advantage in the market, and may even lose the ability to commercialize certain products completely. Either of these results could substantially decrease our revenues.

Loss of any of our key personnel could have a negative effect on the operation of our business.

Our success depends on our executive officers and other key personnel and on the ability to attract and retain qualified new personnel. Achievement of our business objectives will require substantial additional expertise in the areas of sales and marketing, research and product development and manufacturing. Competition for qualified personnel in these fields is intense, and the inability to attract and retain additional highly skilled personnel, or the loss of key personnel, could reduce our revenues and adversely affect our business.

ITEM 6. Exhibits

31.1

Chief Executive Officer Certification Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Chief Financial Officer Certification Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

Chief Executive Officer Certification pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2

Chief Financial Officer Certification pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS* 

XBRL Instance Document

101.SCH* 

XBRL Taxonomy Extension Schema

101.CAL* 

XBRL Taxonomy Extension Calculation Linkbase

101.DEF* 

XBRL Taxonomy Extension Definition Linkbase

101.LAB* 

XBRL Taxonomy Extension Label Linkbase

101.PRE* 

XBRL Taxonomy Extension Presentation Linkbase

Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability.

24


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

MICROVISION, INC.

Date: August 9, 2013

BY:

/s/ Alexander Y. Tokman

   

Alexander Y. Tokman

   

Chief Executive Officer
(Principal Executive Officer)

Date: August 9, 2013

BY: 

/s/ Stephen P. Holt

   

Stephen P. Holt

   

Chief Financial Officer
(Principal Financial Officer) 

 

 

 

 

25


EXHIBIT INDEX

The following documents are filed herewith.

Exhibit
Number

Description

31.1

Chief Executive Officer Certification Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Chief Financial Officer Certification Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

Chief Executive Officer Certification pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2

Chief Financial Officer Certification pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS* 

XBRL Instance Document

101.SCH* 

XBRL Taxonomy Extension Schema

101.CAL* 

XBRL Taxonomy Extension Calculation Linkbase

101.DEF* 

XBRL Taxonomy Extension Definition Linkbase

101.LAB* 

XBRL Taxonomy Extension Label Linkbase

101.PRE* 

XBRL Taxonomy Extension Presentation Linkbase

Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability.

 

 

 

26


EX-31.1 2 exh31-1.htm CEO 302 CERTFICATE June 30, 2013 10-Q Exhibit 31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO
RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Alexander Y. Tokman, certify that:

1. I have reviewed this quarterly report on Form 10-Q of MicroVision, Inc;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles:

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 9, 2013

/s/ Alexander Y. Tokman


Alexander Y. Tokman
Chief Executive Officer


EX-31.2 3 exh31-2.htm CFO 302 CERTFICATE June 30, 2013 10-Q Exhibit 31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO
RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Stephen P. Holt, certify that:

1. I have reviewed this quarterly report on Form 10-Q of MicroVision, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 9, 2013

/s/ Stephen P. Holt


Stephen P. Holt
Chief Financial Officer


EX-32.1 4 exh32-1.htm CEO 906 CERTFICATE June 30, 2013 10-Q Exhibit 32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as chief executive officer of MicroVision, Inc. (the "Company"), does hereby certify that to the undersigned's knowledge:

1)    the Company's Form 10-Q for the quarter ended June 30, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2)    the information contained in the Company's Form 10-Q for the quarter ended June 30, 2013 fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 9, 2013

/s/ Alexander Y. Tokman


Alexander Y. Tokman
Chief Executive Officer


EX-32.2 5 exh32-2.htm CFO 906 CERTFICATE June 30, 2013 10-Q Exhibit 32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as chief financial officer of MicroVision, Inc. (the "Company"), does hereby certify that to the undersigned's knowledge:

1)    the Company's Form 10-Q for the quarter ended June 30, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2)    the information contained in the Company's Form 10-Q for the quarter ended June 30, 2013 fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 9, 2013

/s/ Stephen P. Holt


Stephen P. Holt
Chief Financial Officer


GRAPHIC 6 logo.jpg LOGO begin 644 logo.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`,@"T`P$1``(1`0,1`?_$`)L``0`"`@,!`0$````` M```````("08'!`4*`P(+`0$``@,!`0$`````````````!@@#!0<"!`$0```& M`@$#`P,#`P,%``````$"`P0%!@<(`!$2"1,4"B$5%B(7&#$C&3(D&D$EE]=8 M$0`"`@$#`@0$`P<%```````!`@`#!!$%!B$2,4$3!U%A<2*!,D)28B-C%#05 MD7*B,PC_V@`,`P$``A$#$0`_`/?QQ$XSQZSCVRSV0=MF+-N7O<.WBZ39L@3J M!>]9=8Y$DB]P@'4P@'4>8KKJ<>HW9#JE*C4LQ"J!\R=`/QF*Z^G&J:_(=:Z% M&I9B%4#XDG0#\9T4?=:;+.DV,5;:S)O50$4F@&%-NV=J*G`!'Z M]`Y\./O>S9=HHQ,O%MN/@J6HS'Z`,3-?C;[LF9:,?$S,6V\^"I;6S'Z!6),R M;FSFUCB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB)JS(EZEH1>. MJ-)C$)W(5C076B6;OO\`L\'&HF!)Q9K,=%9!9.);*F[$D2'(J]7#TR&*4JJJ M44Y)OV7@/7M&QU+D0016IZ*H(:QOM4@!F6)\DW_,P;*] MGV*I2I-:MKZ=2#H;[R""*P>BJ"&M;[5(`9ET3(ZAQU_<%E\T7^V7^:/_ M`'/3]PW:0L:J8OU2AHE1LO%Q[8AOZ%;M6_=_4P"81,,"R?9ZCD-@S.;;CE[A MFGKIJ%K0_"M""B*/@J)KXGJ29`,GV:Q>16#,YQN&9N.<>NFH6I#\*JRIK11\ M$1-?$]23*_I'1"8S)8;\^I4S&U.JX\G9B"@'BT:LY>72Q5Y=0JK)B+9PS"-8 MD43*FH^$5>QP;L(B<2*=E?;O8;-YCN&X7[+?7B;5MU]E53%"S9-U).JKH5[$ MU`!M^[1SH$8JW;7/*_\`/V9S?+]`B:*AO\`<)M13`Q3G*(6.]N-RW?$]NL6S*#Y>1A6VU6:L6M:FJVQ04U_ M,]:=H"D_>J%00S`BR_MKN.\X7MOBME!\S)P+;J;-6+6O35;8H["?S65IV`*Q M^]:RH(9@1*:-DF,Q'L96,=)/8Z2:H/F+M`W#*PU!'U M$YO,\SQQ$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1-*EF:YCE6VW[), MK'5Z3M%B>QT<5VL#I^O7:\NM&5J*@6#,KJ2DE7[!N:4.U:IJK`J].)B`)1[8 M2,W;>-OE\@Y+;7C9.5D,B=Q[F--)*4I4J]SN74&\H@9M;6U'0Z089NV<9?,Y M#R>ZO'RLO)9$#'N;EK*M:9*2=2[Q5 M99VY1]DHHHJ*I;LIJ50P!+OZMEYO=VL8LUC MKZ1)8D=IG[L''MSX[M-6)?G*N'BJ6[*:E4,-398;;+S>[M8Q9K'7TB2Q([3. M1@",7C,14\7)>Q:80E;6)1$1,"5RGI2V-BJ=?U%4(UF2%$H_4@AV_3ITYD]O M<5\7A^%Z@T>Y7O\`PR+7O&OS[;`"/+P\IE]N\:S&X=A&T:/>MF1^&3;9D+K\ M^VT`CR\/*=7AUX6.L.6L?)&`6%0N192%1*4Y4V$-=&ZLN$:GU$Q!(VFV[\Y> MT0[2*E#M#H`C\G#+AC;AN_'4_P"C#S>^L==$KR0;.P?[;!:1IY,!H-.OR\+N M&-N6\<<3^WP\T65#KHE>2IL[!Y=+5M(T\`P&@TZU&?(?\J.2O%)I)6\I8*84 MN3SME[,$)B2A!>HMY.PE;C%:Q:K9;[R>":24.26<03&N(,FR2RXH$?2K=55% MPBFHD:?2?R(GQB_,/M%Y/JGMA0-PGM3F;6=U"-AZHP,1E++N&+A^K,^Y;(G;>Q,9 MPB7J:A>:+$5=T`\>^<_)QES'.!M@MUJ39YJH5^`J-^=1-^_'KPG`1$Q!0U9A MKDM!K3]5LM;?KI.%46XO)4Y&O5),Q4D2=>V7E-\>FC-ACZ=M7MABG$5UDV*, MHVHTE(R5BO2<4Z$"LY9_2J7&62TQ42_'K[=TZ:(H..P_IG-Z9^U$ZW4_RP>/ M3>*?O-9U8V:J>6)?&=/4OU^(SKM_K$?5*U33**AE"I_JXB=+FGSL>([7O(UEQ+E;>;$,+D M&G23N%M^)+8+?CQ1Y]P_F.?PA*8]?2,JTC6MU91T)(Y!J5(MKM@9>IMLHJ2F8( M'+LS#1[.H5!DZH&1K6TCI(K([Q5G"LT\>)13AV)&8*R@VQ\]1.PL&?)^ M$>.(E`B/N(>"57<>BX/&+^HB>A:D^8;QH9#U\R#M76-N\;J:]XMN$;CZ[Y1G M&=PJ$#&7J88M)2+J#%"W5F"E['9'T<^2739QC9XN9(W=V]`-T1(V?\D+PE?_ M`'OC_P#\?9O_`/5_$2WEFEHR? MC):;BW#ES'U5U!09E8:#=.U$Y!VU5;MD156*F02F,B:,V&\VGBIU6R9.X5JUM:[/-#'`%F#U1!XD/T.F40' MB))/4_?73G>:H6*\ZF[#8YS97J>Z19W`U7E%FLU4%72;I9@>V56?:P]JK+63 M18N#M%WS)!!V5NL*)U`24[42!TW\BOPKUZ8E(*1WZQ>=_#2#N,>GB:MEFP1A MG3%<[9<8^<@<>R4)+LQ53'TW+1PNV6+T,FU_>S\O8_AWW7[G]E_'?6Z_3)XYQKD[98*OSUCK]:/&-$7Z]?B??H/:"K]H6.@56!_&')5E4D.AU73D' M1BJG[^^D%7.,C;/?3=#SK&OR<#'ONJI[%#FJON#8I],Z:U>@W<57JSOZI#-K MK1/'Y[E[5[^;L>>8N1E8&-D74T&M0YIK[PV(?3)&M7H,&*IU:Q_5(=N[6PQK MD\\I/EN>+:ED2;AY!L+RZQSZGS,-#S;-BV2;I2U7>31615;DP9MBD*V;D.E) MMR@D8Q5R("-AZN4'+W#_`#?%<3[)1L>RNNU54`64-;VZY**``B`K>@ M"$BP)+(U)N^R7!QGA<>ME.A5KV%3$@]5:I69V!&H[#TUZ23;UNN+ MOO$K'V2X.-P5<>ME.A5LAA420>JM4K,[`CN7L/37I,&BLR,<93\KB_*JS*(= MP[567H\W$QSE&$L=$47<)PK1)H55ZLQG(!-N,>X3,.?15,/1=!NG8T4`,4.T#HF+U$0$`TGM%N&1R#/W_DS@C$R M<]*Z]?Y*,QT/F`+E74=-5(UU!`T?L_N61R+<>0\H8$8>3GI57K_)1F;0^8`N M5-1TU4C4D'3Q=_,-M\WL/O%XR_'S3G2A9^8CUK)[5$YE6[JR[-97KV&Z*+QL MGW"=Y$*XP?&2*(=X)2)N@=%`Z]KG;Y&'+.[C'P(^9#S:1M)@5DGF4-=8-OK3 M#)1AW<,;,^1V^!K[CN9DU7Y?34K-#@[_`&F0?`4X(.G,09B0I3JD!)$JK\A& MH=PU&TBT(Q?D!I.63=GR-Y`N6[F?V^0?SP>2_ M/'DQEL.VUEZQ?J5/WC5#'F':6 MK8V>NN@'Q MW9K<^J:[XM/O2?Q]9%VBCMC;71(2P9LQ_D')N(+-;:?*4FXSK!_8L:.L>56W MLVA&T,I&E$S$3.BF7.NH9$@1\:_7[PWQWC6S/LWOLPTNR)DYWE+)`7<^SB>* M+K8,98TI=10W$2I76#RQ7_$'A6R?XK\#-[5+[(;;;@V*%:GK$6[<2L3K] MD2@8BKTU2JW[-H"LI;LP7R+W4-'F.B>N.TZ:UKP0_&7V M^K[M2/1V.S'@QQ%Y\N,8JB:2D\S;*C!8/;5*M2A#%>.:_B&'OPLHTZ!BEZLG MLN1)!1VX`$2J[`7B01VO^-+JSB6+V2PCK3FG)FT.3-[("O9ZNS:E4[*!FS.Z MZ]PC.5=G55E(QTYQY$1;V/EF\?)(H)J@W43*5T=9%$PC0/9^AZS[M:Q>,?R8 M^(;Q59?ELK6;$V)L<[*X'P'JI=KJLO?+`3'M"R'<+-28J\4/)35S:&Z)9A4H MURP1Z/N'SQ-PX*""R)MO$F0K#L1\E#R];R5%`LX7QV:S;=S.-G*Z9EXU&_8& MP^TU6J\5&I(IK@Z+/OR6"01.!#I+ID65*(F.D!D3&?BUX`\7&2L`[>;6>1)U MJ/D[,A1]'@+Y*9./5\PNW4-ZF0+5:I1)Q.KM5%Q/7U M4TUR='`'1(<>+S,U1`%1([:I$%/])ES=42/ZO*Y)IBTJHBU]T[M4-&&`6$M%-"D,+^ MYLBI/R65K^NVM?M9- M"UM854^Y%1Y/XFRS5,L5EE,U]VW3=E0(23A?5(#N+=)@":R(H_I.+6[8F9M[J+@H#U:CN1AT(T^&O@?P.AU$ZMQ#E^TNC=V;OMH ML_M\EM""Y`!]*_0D"Y1]VI%@U;U%U&]\2S\;/?D?#7KIW=F[[<>S^VR6T(+G M0'TLH^_4BP:MZBUI;`U3;39#,F.ZZEB][04*^SEHIW9',1(I5:/;R3I MHO+2LK;6[B3A))-LE'IBU:LW2RBIN[T@,*@]M9_<':?=OW*YEMVVC:GV],=+ M*VN-;BA`[*;+'R`7J<`(.Q*W8L=>T$L=*M^X^T>\7N=S?;=MKVFS;J\=+*VN M:MQ0BNRFRRS(!>IPH1?3KKL8L=>P$L=+:<4XV@L1T"MX_KOJ*L(!EZ2S]P4I M7DQ*.55'DO-O^T1+[R7DEU5SE+^A,3]A``A2@%M^*<:P.(.;;J MDE*&LC1V$\VJ:Y8283]X!%6IRJNA%10#"(\D4DDPO9?PA^.7;S;VI;MY]PL^ MO&:ZJC44UDUKM:6-"N"U!,`TQU>*0RD48FPF@B)(I^B;TVCYNW30>HN40,F9 M$S;:+Q#Z+;E;18BW#V&QK9+QG#!K>@,\<2II3(]79N:5"3[" ML2C/9Y?;V\1KN)F\B2 MN0+I*1I&+NFPN/3)QE,=S1ZE%F0I5?;1J1D693)MRFZ#W',842(VROQR/$/M M=F6[9]RKK&X;Y-R3,.[)?I:A92RECV*M-ID53.):TOZO5;='5EM8)MT8[)GV'J;3-&5VCU7* MMJJ["ERMGEK$A:R3DNH%8C$6:"*ZYT&Z11],A1,811+@"8XHO[NR-%^Q!65JM*QD0J\C*/'CY8B29#JF*F0"HE;&N_Q\O%7J[M&.WN)]>%FF68 MZQ/;=2&MCO5PM=$QE:)!1=9>>H5+FY5U%1\DV7A$JB4[`&IDDA31 M)W[LZ.Z[^0G"*^N^T-:GK?BEU:J_,:3$1=-G7"#C-$W2KS M`P'>R:W:DS10(!4$B)E1-F7#Q@ZK^8?Z]U[K]??U^O$2=_$ M355EPMCRS2REB5AUH2SJ'!52S522D*Q-+K`'8"\@O#.&J$RJ"7Z`%ZFYZ%Z` M'3H7I$]SX3QS=,L[B])HW0G4W4.]%A/QU-%Y<\E/VQ``IFZEXEV`J].G M3U'L(>*E/H(!_I7*`_T'J`B`Y4XO3H$NS=SLJ'DFNN5>*U M$!+L[=+*A^DY5B:_5JO3L_T<:^>LV0DF5)--(HG$J1")E%551902D*!0%198 MZBRIQ`/J8YC&,/U$1'DE50BA!KH!IU))Z?$G4D_,DD^ EX-101.INS 7 mvis-20130630.xml XBRL INSTANCE DOCUMENT 0000065770 2012-12-31 0000065770 2013-06-30 0000065770 2013-01-01 2013-06-30 0000065770 2012-01-01 2012-06-30 0000065770 mvis:CostOfContractRevenueMember 2013-01-01 2013-06-30 0000065770 mvis:CostOfContractRevenueMember 2012-01-01 2012-06-30 0000065770 mvis:CostOfProductRevenueMember 2013-01-01 2013-06-30 0000065770 mvis:CostOfProductRevenueMember 2012-01-01 2012-06-30 0000065770 us-gaap:ResearchAndDevelopmentExpenseMember 2013-01-01 2013-06-30 0000065770 us-gaap:ResearchAndDevelopmentExpenseMember 2012-01-01 2012-06-30 0000065770 mvis:SalesMarketingGeneralAndAdministrativeExpenseMember 2013-01-01 2013-06-30 0000065770 mvis:SalesMarketingGeneralAndAdministrativeExpenseMember 2012-01-01 2012-06-30 0000065770 us-gaap:EmployeeStockOptionMember 2013-06-30 0000065770 us-gaap:EmployeeStockOptionMember 2013-01-01 2013-06-30 0000065770 mvis:RestrictedStockRightsMember 2013-06-30 0000065770 mvis:RestrictedStockRightsMember 2013-01-01 2013-06-30 0000065770 us-gaap:WarrantMember 2013-01-01 2013-06-30 0000065770 us-gaap:WarrantMember 2012-01-01 2012-06-30 0000065770 us-gaap:StockCompensationPlanMember 2013-01-01 2013-06-30 0000065770 us-gaap:StockCompensationPlanMember 2012-01-01 2012-06-30 0000065770 us-gaap:RestrictedStockMember 2013-01-01 2013-06-30 0000065770 us-gaap:RestrictedStockMember 2012-01-01 2012-06-30 0000065770 2012-06-30 0000065770 2011-12-31 0000065770 2013-08-06 0000065770 2013-04-01 2013-06-30 0000065770 2012-04-01 2012-06-30 0000065770 us-gaap:WarrantMember 2013-04-01 2013-06-30 0000065770 us-gaap:WarrantMember 2012-04-01 2012-06-30 0000065770 us-gaap:StockCompensationPlanMember 2013-04-01 2013-06-30 0000065770 us-gaap:StockCompensationPlanMember 2012-04-01 2012-06-30 0000065770 us-gaap:RestrictedStockMember 2013-04-01 2013-06-30 0000065770 us-gaap:RestrictedStockMember 2012-04-01 2012-06-30 0000065770 mvis:CostOfContractRevenueMember 2013-04-01 2013-06-30 0000065770 mvis:CostOfContractRevenueMember 2012-04-01 2012-06-30 0000065770 mvis:CostOfProductRevenueMember 2013-04-01 2013-06-30 0000065770 mvis:CostOfProductRevenueMember 2012-04-01 2012-06-30 0000065770 us-gaap:ResearchAndDevelopmentExpenseMember 2013-04-01 2013-06-30 0000065770 us-gaap:ResearchAndDevelopmentExpenseMember 2012-04-01 2012-06-30 0000065770 mvis:SalesMarketingGeneralAndAdministrativeExpenseMember 2013-04-01 2013-06-30 0000065770 mvis:SalesMarketingGeneralAndAdministrativeExpenseMember 2012-04-01 2012-06-30 0000065770 2013-05-01 2013-05-31 0000065770 2013-05-31 0000065770 us-gaap:CustomerConcentrationRiskMember 2013-04-01 2013-06-30 0000065770 us-gaap:CustomerConcentrationRiskMember 2013-01-01 2013-06-30 0000065770 mvis:AccountsReceivableConcentrationRiskMember 2013-01-01 2013-06-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure mvis:Percent 3035000 2106000 1115000 1088000 4007000 3253000 442560000 444795000 12938000 10597000 9695000 7452000 386000 12000 48000 43000 20000 0 6850000 6003000 14764000 13075000 -847000 1689000 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>6. COMMITMENTS AND CONTINGENCIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>Litigation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We are subject to various claims and pending or threatened lawsuits in the normal course of business. We are not currently party to any legal proceedings that management believes are reasonably possible to have a material adverse effect on our consolidated financial position, results of operations or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>Adverse purchase commitments</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We have periodically entered into noncancelable purchase contracts in order to ensure the availability of materials to support production of products based on our PicoP display technology. We periodically assess the need to provide for impairment on these purchase contracts and record a loss on purchase commitments when required. As of June 30, 2013 and December 31, 2012 we had approximately $500,000 and $634,000, respectively, accrued for adverse purchase commitments related to these purchase contracts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 25000 28000 -7090000 -14739000 -3436000 -4941000 163000 403000 26000 248000 355000 746000 73000 545000 1664000 4297000 863000 -33000 486000 880000 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>2. NET LOSS PER SHARE</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Basic net loss per share is calculated using the weighted-average number of common shares outstanding during the reporting periods. Diluted net loss per share is calculated using the weighted-average number of common shares outstanding and taking into account the dilutive effect of all potentially dilutive securities, including common stock equivalents and convertible securities outstanding. Potentially dilutive common stock equivalents primarily consist of warrants, employee stock options and nonvested equity shares. Diluted net loss per share for the three and six months ended June 30, 2013 and 2012 is equal to basic net loss per share because the effect of all potential common stock outstanding during the periods, including options, warrants and nonvested equity shares is anti-dilutive. The components of basic and diluted net loss per share were as follows (in thousands, except loss per share data):</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Three Months Ended</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Six Months Ended</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Numerator:</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Net loss available for common shareholders - basic and diluted</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(3,436)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(4,971)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(7,090)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(14,774)</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Denominator:</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Weighted-average common shares outstanding - basic and diluted &#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">26,493&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">19,167&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">25,870&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">18,097&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Net loss per share - basic and diluted &#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(0.13)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(0.26)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(0.27)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(0.82)</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We excluded the following convertible securities from diluted net loss per share, as the effect of including them would have been anti-dilutive:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Three Months Ended</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Six Months Ended</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Publicly Traded Warrants Exercisable</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">753,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">753,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">753,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">753,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Options and Private Warrants Exercisable</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">7,612,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5,302,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">7,612,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5,302,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Nonvested Equity Shares</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">80,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">80,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Total</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,580,000&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,135,000&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,580,000&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,135,000&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 2007000 -1272000 1007000 1328000 -0.27 -0.82 -0.13 -0.26 -1046000 -2976000 -27000 95000 -771000 -726000 765000 31000 -150000 -2294000 0 -58000 8000 17000 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>4. INVENTORY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Inventory consists of the following:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>&#160;&#160;&#160; June 30, &#160;&#160;&#160;</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Raw materials</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">11,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">361,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Finished goods</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">33,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">136,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">44,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">497,000&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The inventory at June 30, 2013 and December 31, 2012 consisted of components supplied under our &#34;Image by PicoP<sup>&#174;</sup>&#34; ingredient brand business model, and finished goods primarily composed of our accessory pico projectors. Inventory is stated at the lower of cost or market. Management periodically assesses the need to provide for obsolescence of inventory and adjusts the carrying value of inventory to its net realizable value when required. In addition, we reduce the value of our inventory to our estimated scrap value when management determines that it is not probable that the inventory will be consumed through normal production during the next twelve months. During the six months ended June 30, 2013, we recorded inventory write-downs of $303,000. In 2012, we recorded inventory write-downs of $1,094,000. At June 30, 2013 and December 31, 2012, we have aggregate write-downs recorded of $10,279,000 and $9,916,000, respectively, offsetting inventory on hand deemed to be obsolete or scrap inventory.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 497000 44000 303000 1094000 7884000 10395000 12938000 10597000 7864000 10065000 5532000 14739000 -83000 -38000 -6296000 -13012000 -7090000 -14774000 -3436000 -4971000 9093000 13518000 4440000 6290000 -7086000 -14790000 -3433000 -4962000 1221000 305000 22000 18000 0 -88000 4000 -16000 3000 9000 86000 400000 0 0 1205000 1191000 12000 12000 4591000 7167000 2339000 3227000 -437531000 -444621000 3671000 3025000 1870000 1295000 67000 17000 4504000 6352000 2101000 3064000 481000 854000 5054000 202000 25870000 18097000 26493000 19167000 2000 1000 0 1000 79000 92000 2000 1000 1580000 1501000 98000 863000 2136000 2279000 917000 750000 1501000 3894000 837000 -281000 4000 12000 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>5. SHARE-BASED COMPENSATION </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We use the straight-line attribution method to allocate the fair value of share-based compensation awards over the requisite service period for each award. The following table shows the amount of stock-based compensation expense included in the consolidated statements of operations:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Three Months Ended</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Six Months Ended</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Cost of contract revenue</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">4,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">4,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">10,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Cost of product revenue</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Research and development expense</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(72,000)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">87,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">88,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">224,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Sales, marketing, general and administrative expense</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">168,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">390,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">388,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">600<font style="font-size: 10pt">,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Total share-based employee compensation expense</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">96,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">481,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">481,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">854,000&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><u>&#160;Options Activity and Positions</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The following table summarizes shares, weighted average exercise price, weighted average remaining contractual term and aggregate intrinsic value of options outstanding and options exercisable as of June 30, 2013:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Remaining</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Contractual</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Aggregate</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Term</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Intrinsic</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">Options</font></td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Shares</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>(years)</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Value</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Outstanding as of June 30, 2013</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,255,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">12.63&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6.9&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">376,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Exercisable as of June 30, 2013</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">770,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">18.80&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5.6&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">97,000&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">As of June 30, 2013, our unamortized share-based employee compensation was $941,000 which we plan to amortize over the next 1.9 years and our unamortized nonvested equity share-based employee compensation was $366,000 which we plan to amortize over the next 0.9 years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>1. MANAGEMENT'S STATEMENT AND PRINCIPLES OF CONSOLIDATION&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><u>Management's Statement</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The Consolidated Balance Sheet as of June 30, 2013, the Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended June 30, 2013 and 2012, and Consolidated Statements of Cash Flows for the six months ended June 30, 2013 and 2012 have been prepared by MicroVision, Inc. (&#34;we&#34; or &#34;us&#34;) and have not been audited. In the opinion of management, all adjustments necessary to state fairly the financial position at June 30, 2013 and the results of operations, comprehensive loss and cash flows for all periods presented have been made and consist of normal recurring adjustments. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the rules of the Securities and Exchange Commission (the &#34;SEC&#34;). The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. You should read these condensed consolidated financial statements in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012. The results of operations for the three and six months ended June 30, 2013 are not necessarily indicative of the operating results that may be attained for the entire fiscal year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We have incurred significant losses since inception. We have funded operations to date primarily through the sale of common stock, convertible preferred stock, warrants, the issuance of convertible debt and, to a lesser extent, from contract revenues, collaborative research and development agreements and product sales. At June 30, 2013, we had $6.0 million in cash and cash equivalents and a working capital deficit of $2.6 million.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Based on our current operating plan, we anticipate that we have sufficient cash and cash equivalents to fund our operations through October of 2013. We will require additional cash to fund our operating plan past that time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We plan to obtain additional cash through the issuance of equity or debt securities. There can be no assurance that additional cash will be available or that, if available, it will be available on terms acceptable to us on a timely basis. If adequate funds are not available on a timely basis, we intend to consider limiting our operations substantially to extend our funds as we pursue other financing opportunities and business relationships. This limitation of operations could include delaying development projects and reductions in staff and operating costs, including research and development, and capital expenditures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We are introducing new technology into an emerging market which creates significant uncertainty about our ability to accurately project revenue, costs and cash flows. Our capital requirements will depend on many factors, including, but not limited to, the rate at which we can, directly or through arrangements with OEMs, introduce products incorporating the PicoP display engine and image capture technologies and the market acceptance and competitive position of such products. If revenues are less than anticipated, if the mix of revenues vary from anticipated amounts or if expenses exceed the amounts budgeted, we may require additional capital earlier than expected to further the development of our technologies, for expenses associated with product development, and to respond to competitive pressures or to meet unanticipated development difficulties. In addition, our operating plan provides for the development of strategic relationships with systems and equipment manufacturers that may require additional investments by us.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In May 2013, we raised $5.85 million before issuance costs of approximately $362,000 from the sale of 2.6 million shares of common stock and warrants to purchase up to an aggregate of 2.0 million shares of our common stock in a registered direct offering. The warrants have an exercise price of $2.886 per share, a five year term, and are exercisable beginning on the date of issuance. Each warrant to purchase a share of common stock may also be exchanged during its term for a number of shares of common stock (but not more than one share of common stock for each warrant so exchanged) with a value determined by a negotiated formula if, among other things, our common stock is then trading at a price at or lower than the warrant exercise price per share. Subject to limitations in the warrants, we may require the warrants be exercised for cash if the closing bid price of our stock is over $3.61 for 20 consecutive trading days and the average daily dollar volume over that period is equal to or exceeds $300,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We have received a report from our independent registered public accounting firm regarding the consolidated financial statements for the year ended December 31, 2012 that includes an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. These consolidated financial statements are prepared assuming the Company will continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><u>Principles of Consolidation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Our condensed consolidated financial statements include the accounts of MicroVision, Inc. and MicroVision Innovations Singapore Pte. Ltd. (&#34;MicroVision Singapore&#34;), a wholly owned foreign subsidiary. MicroVision Singapore was incorporated in April 2011 and is engaged in operational support functions for MicroVision, Inc. There were no material intercompany accounts and transactions during the three and six months ended June 30, 2013.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 899000 301000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Principles of Consolidation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Our condensed consolidated financial statements include the accounts of MicroVision, Inc. and MicroVision Innovations Singapore Pte. Ltd. (&#34;MicroVision Singapore&#34;), a wholly owned foreign subsidiary. MicroVision Singapore was incorporated in April 2011 and is engaged in operational support functions for MicroVision, Inc. There were no material intercompany accounts and transactions during the three and six months ended June 30, 2013.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Net Loss Per Share</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Basic net loss per share is calculated using the weighted-average number of common shares outstanding during the reporting periods. Diluted net loss per share is calculated using the weighted-average number of common shares outstanding and taking into account the dilutive effect of all potentially dilutive securities, including common stock equivalents and convertible securities outstanding. Potentially dilutive common stock equivalents primarily consist of warrants, employee stock options and nonvested equity shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">We use the straight-line attribution method to allocate the fair value of share-based compensation awards over the requisite service period for each award.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>8. NEW ACCOUNTING PRONOUNCEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In July 2012, the Financial Accounting Standards Board (&#34;FASB&#34;) issued guidance that will allow an entity to first assess qualitative factors to determine whether it is necessary to perform a quantitative impairment test for indefinite-lived intangible assets. Under this guidance, an entity would not be required to calculate the fair value of an indefinite-lived intangible asset unless the entity determines, based on qualitative assessment, that it is not more likely than not, the indefinite-lived intangible asset is impaired. This guidance is effective for impairment tests performed for fiscal years beginning after September 15, 2012, with early adoption permitted. We do not expect the implementation of this guidance will have a material impact on our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In February 2013, the FASB issued guidance that requires disclosure of amounts reclassified out of accumulated other comprehensive income in its entirety, by component, on the face of the statement of operations or in the notes thereto. Amounts that are not required to be reclassified in their entirety to net income must be cross-referenced to other disclosures that provide additional detail. This standard is effective prospectively for annual and interim reporting periods beginning after December 15, 2012. We do not expect the implementation of this guidance will have a material impact on our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The components of basic and diluted net loss per share were as follows (in thousands, except loss per share data):</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Three Months Ended</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Six Months Ended</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Numerator:</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Net loss available for common shareholders - basic and diluted</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(3,436)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(4,971)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(7,090)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(14,774)</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Denominator:</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Weighted-average common shares outstanding - basic and diluted &#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">26,493&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">19,167&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">25,870&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">18,097&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Net loss per share - basic and diluted &#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(0.13)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(0.26)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(0.27)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(0.82)</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Inventory consists of the following:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>&#160;&#160;&#160; June 30, &#160;&#160;&#160;</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Raw materials</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">11,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">361,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Finished goods</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">33,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">136,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">44,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">497,000&#160;</font></td></tr> </table> <p style="margin: 0">&#160;</p> <p style="margin: 0">&#160;</p> <p style="margin: 0">&#160;</p> <p style="margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The following table shows the amount of stock-based compensation expense included in the consolidated statements of operations:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Three Months Ended</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Six Months Ended</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Cost of contract revenue</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">4,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">4,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">10,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Cost of product revenue</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Research and development expense</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(72,000)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">87,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">88,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">224,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Sales, marketing, general and administrative expense</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">168,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">390,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">388,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">600<font style="font-size: 10pt">,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Total share-based employee compensation expense</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">96,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">481,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">481,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">854,000&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The following table summarizes shares, weighted average exercise price, weighted average remaining contractual term and aggregate intrinsic value of options outstanding and options exercisable as of June 30, 2013:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Remaining</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Contractual</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Aggregate</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Term</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Intrinsic</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">Options</font></td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Shares</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>(years)</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Value</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Outstanding as of June 30, 2013</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,255,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">12.63&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6.9&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">376,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Exercisable as of June 30, 2013</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">770,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">18.80&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5.6&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">97,000&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 8580000 6135000 753000 753000 7612000 5302000 215000 80000 8580000 6135000 753000 753000 7612000 5302000 215000 80000 361000 11000 136000 33000 481000 854000 4000 10000 1000 20000 88000 224000 388000 600000 96000 481000 0 4000 0 0 -72000 87000 168000 390000 1255000 12.63 376000 770000 18.80 97000 941000 366000 0 3000 0 -2000 75000 66000 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>3. KEY ACCOUNTING POLICY - REVENUE RECOGNITION</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We evaluate the performance criteria and terms of our collaborative research and development agreements to determine whether revenue should be recognized under a performance-based method or milestone method. Significant items included in our evaluation are the following:</p> <ul style="list-style-type: disc"> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">the nature of our obligation under the agreement,</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether provisions leading to variable revenues exist</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether any payments are required to be repaid,</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether the deliverables should be treated as one unit of accounting or separated into multiple units,</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether substantive milestones exist,</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether milestone payments are commensurate with either our level of effort or the increase in value of the customer's rights, and</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether a licensing agreement exists.</font></li> </ul> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><font style="font: 10pt Times New Roman, Times, Serif">In March 2013, we entered into and began work under a $4.6 million collaborative research and development agreement with a customer researching and developing commercial applications for our technology. Our contributions under the collaborative agreement include research services, components, and prototype devices and fixtures. Development revenues to be realized are subject to successful completion of the deliverables as defined in the collaborative research and development agreement.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">Based on the terms of this agreement, we recognize development revenue as work progresses on the agreement and as our customer accepts the deliverables using a proportional method based on the lesser of the cumulative proportion of total planned costs to be incurred under the agreement or the cash payments received plus outstanding billings for work accepted by the customer. Since our collaborative agreements generally require some level of technology development, the actual costs required to complete a contract can vary from our estimates. The proportional revenue recognition method we use for collaborative research and development agreements includes adjustments for revisions to estimated total agreement costs. Each period, we evaluate total estimated costs for each agreement and include any significant revisions in the period we become aware of changes in estimated total costs. The costs for work performed under collaborative research and development agreements are expensed in the periods incurred and included in the Statement of Operations in research and development expense.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">For the three and six months ended June 30, 2013, two commercial customers accounted for approximately 93% and 89% of our total revenue. The accounts receivable balance from these customers was approximately 98% of our net accounts receivable balance at June 30, 2013.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 436000 435000 -1000 -350000 609000 28000 1180000 0 880000 0 -581000 0 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We have incurred significant losses since inception. We have funded operations to date primarily through the sale of common stock, convertible preferred stock, warrants, the issuance of convertible debt and, to a lesser extent, from contract revenues, collaborative research and development agreements and product sales. At June 30, 2013, we had $6.0 million in cash and cash equivalents and a working capital deficit of $2.6 million.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Based on our current operating plan, we anticipate that we have sufficient cash and cash equivalents to fund our operations through October of 2013. We will require additional cash to fund our operating plan past that time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We plan to obtain additional cash through the issuance of equity or debt securities. There can be no assurance that additional cash will be available or that, if available, it will be available on terms acceptable to us on a timely basis. If adequate funds are not available on a timely basis, we intend to consider limiting our operations substantially to extend our funds as we pursue other financing opportunities and business relationships. This limitation of operations could include delaying development projects and reductions in staff and operating costs, including research and development, and capital expenditures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We are introducing new technology into an emerging market which creates significant uncertainty about our ability to accurately project revenue, costs and cash flows. Our capital requirements will depend on many factors, including, but not limited to, the rate at which we can, directly or through arrangements with OEMs, introduce products incorporating the PicoP display engine and image capture technologies and the market acceptance and competitive position of such products. If revenues are less than anticipated, if the mix of revenues vary from anticipated amounts or if expenses exceed the amounts budgeted, we may require additional capital earlier than expected to further the development of our technologies, for expenses associated with product development, and to respond to competitive pressures or to meet unanticipated development difficulties. In addition, our operating plan provides for the development of strategic relationships with systems and equipment manufacturers that may require additional investments by us.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In May 2013, we raised $5.85 million before issuance costs of approximately $362,000 from the sale of 2.6 million shares of common stock and warrants to purchase up to an aggregate of 2.0 million shares of our common stock in a registered direct offering. The warrants have an exercise price of $2.886 per share, a five year term, and are exercisable beginning on the date of issuance. Each warrant to purchase a share of common stock may also be exchanged during its term for a number of shares of common stock (but not more than one share of common stock for each warrant so exchanged) with a value determined by a negotiated formula if, among other things, our common stock is then trading at a price at or lower than the warrant exercise price per share. Subject to limitations in the warrants, we may require the warrants be exercised for cash if the closing bid price of our stock is over $3.61 for 20 consecutive trading days and the average daily dollar volume over that period is equal to or exceeds $300,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We have received a report from our independent registered public accounting firm regarding the consolidated financial statements for the year ended December 31, 2012 that includes an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. These consolidated financial statements are prepared assuming the Company will continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We evaluate the performance criteria and terms of our collaborative research and development agreements to determine whether revenue should be recognized under a performance-based method or milestone method. Significant items included in our evaluation are the following:</p> <ul style="list-style-type: disc"> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">the nature of our obligation under the agreement,</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether provisions leading to variable revenues exist</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether any payments are required to be repaid,</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether the deliverables should be treated as one unit of accounting or separated into multiple units,</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether substantive milestones exist,</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether milestone payments are commensurate with either our level of effort or the increase in value of the customer's rights, and</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether a licensing agreement exists.</font></li> </ul> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><font style="font: 10pt Times New Roman, Times, Serif">In March 2013, we entered into and began work under a $4.6 million collaborative research and development agreement with a customer researching and developing commercial applications for our technology. Our contributions under the collaborative agreement include research services, components, and prototype devices and fixtures. Development revenues to be realized are subject to successful completion of the deliverables as defined in the collaborative research and development agreement.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">Based on the terms of this agreement, we recognize development revenue as work progresses on the agreement and as our customer accepts the deliverables using a proportional method based on the lesser of the cumulative proportion of total planned costs to be incurred under the agreement or the cash payments received plus outstanding billings for work accepted by the customer. Since our collaborative agreements generally require some level of technology development, the actual costs required to complete a contract can vary from our estimates. The proportional revenue recognition method we use for collaborative research and development agreements includes adjustments for revisions to estimated total agreement costs. Each period, we evaluate total estimated costs for each agreement and include any significant revisions in the period we become aware of changes in estimated total costs. The costs for work performed under collaborative research and development agreements are expensed in the periods incurred and included in the Statement of Operations in research and development expense.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> March 2013 4600000 634000 500000 Microvision Inc 0000065770 10-Q 2013-06-30 false --12-31 No No Yes Smaller Reporting Company 27939000 Q2 2013 9916000 10279000 332000 347000 0.001 0.001 25000000 25000000 0 0 0.001 0.001 100000000 100000000 25237000 27925000 25237000 27925000 P1Y10M24D P0Y10M24D 0 32000 0 11000 5607000 14805000 P5Y7M6D P6Y10M24D 0 32000 0 32000 0.93 0.89 0.98 0 3755000 0 330000 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>7. COMMON STOCK AND WARRANTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In May 2013, we raised $5.85 million before issuance costs of approximately $362,000 from the sale of 2.6 million shares of common stock and warrants to purchase up to an aggregate of 2.0 million shares of our common stock in a registered direct offering. The warrants have an exercise price of $2.886 per share, a five year term, and are exercisable beginning on the date of issuance. Each warrant to purchase a share of common stock may also be exchanged during its term for a number of shares of common stock (but not more than one share of common stock for each warrant so exchanged) with a value determined by a negotiated formula if, among other things, our common stock is then trading at a price at or lower than the warrant exercise price per share. Subject to limitations in the warrants, we may require the warrants be exercised for cash if the closing bid price of our stock is over $3.61 for 20 consecutive trading days and the average daily dollar volume over that period is equal to or exceeds $300,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Based on the terms of the agreement, we have determined that the warrant instruments should be classified as a liability given that the warrants could result in the issuance of a variable number of common shares based on a conditional exercise provision that is outside of our control at any point when the share price of our common stock is equal to or less than the stated exercise price of $2.886 per share. At the date of issuance, and as of June 30, 2013, our common stock was trading at a value less than the stated exercise price, as such upon expiration of the 45 day lock up period, the holders may elect to exchange the warrants for a variable number of shares of common stock as determined by a negotiated formula included in the warrant agreement. However, the agreement contains a limit that restricts the number of shares that may be issued under this exchange provision, such that we will not issue any more common shares than could be issued on a one-for-one basis upon exercise of the warrants. As of June 30, 2013, based upon the terms of the agreement and the quoted market price of our common stock, if the exchange feature were to be fully exercised, we would be required to issue approximately 1,490,000 shares of common stock, equal to an estimated fair market value of $3,755,000, which we believe is the best indication of the fair value of the warrant obligation as of June 30, 2013. Changes in the market value of our common stock will increase or decrease the number of shares to be issued under this exchange feature; however the aggregate fair market value of shares to be issued under this provision will not change significantly due to the negotiated and fixed exchange formula in the agreement. Due to the limiting provisions on the exchange agreement, the maximum number of shares of common stock that we could be required to issue is 1,976,352.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">At each balance sheet date, we will evaluate the fair value of the warrants and any change in value will be recorded as a non-operating gain or loss on the statement of operations. We will re-assess the appropriate valuation model for determining the estimated fair value of the warrant instruments, which may include a binomial valuation model to take into consideration the other features of the warrants. Determination of the fair market value of the warrant instruments includes consideration of Level 3 inputs. Level 3 inputs are unobservable inputs for which there is little or no market data, which requires us to develop our own assumptions, which are significant to the measurement of the fair values.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Management's Statement</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The Consolidated Balance Sheet as of June 30, 2013, the Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended June 30, 2013 and 2012, and Consolidated Statements of Cash Flows for the six months ended June 30, 2013 and 2012 have been prepared by MicroVision, Inc. (&#34;we&#34; or &#34;us&#34;) and have not been audited. In the opinion of management, all adjustments necessary to state fairly the financial position at June 30, 2013 and the results of operations, comprehensive loss and cash flows for all periods presented have been made and consist of normal recurring adjustments. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the rules of the Securities and Exchange Commission (the &#34;SEC&#34;). The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. You should read these condensed consolidated financial statements in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012. The results of operations for the three and six months ended June 30, 2013 are not necessarily indicative of the operating results that may be attained for the entire fiscal year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We excluded the following convertible securities from diluted net loss per share, as the effect of including them would have been anti-dilutive:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Three Months Ended</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Six Months Ended</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Publicly Traded Warrants Exercisable</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">753,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">753,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">753,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">753,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Options and Private Warrants Exercisable</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">7,612,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5,302,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">7,612,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5,302,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Nonvested Equity Shares</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">80,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">80,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Total</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,580,000&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,135,000&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,580,000&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,135,000&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 2600000 5850000 362000 2000000 2.886 2013-05-31 P5Y0M0D <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Based on the terms of the agreement, we have determined that the warrant instruments should be classified as a liability given that the warrants could result in the issuance of a variable number of common shares based on a conditional exercise provision that is outside of our control at any point when the share price of our common stock is equal to or less than the stated exercise price of $2.886 per share. At the date of issuance, and as of June 30, 2013, our common stock was trading at a value less than the stated exercise price, as such upon expiration of the 45 day lock up period, the holders may elect to exchange the warrants for a variable number of shares of common stock as determined by a negotiated formula included in the warrant agreement. However, the agreement contains a limit that restricts the number of shares that may be issued under this exchange provision, such that we will not issue any more common shares than could be issued on a one-for-one basis upon exercise of the warrants. As of June 30, 2013, based upon the terms of the agreement and the quoted market price of our common stock, if the exchange feature were to be fully exercised, we would be required to issue approximately 1,490,000 shares of common stock, equal to an estimated fair market value of $3,755,000, which we believe is the best indication of the fair value of the warrant obligation as of June 30, 2013. Changes in the market value of our common stock will increase or decrease the number of shares to be issued under this exchange feature; however the aggregate fair market value of shares to be issued under this provision will not change significantly due to the negotiated and fixed exchange formula in the agreement. Due to the limiting provisions on the exchange agreement, the maximum number of shares of common stock that we could be required to issue is 1,976,352.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 3755000 0 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">At each balance sheet date, we will evaluate the fair value of the warrants and any change in value will be recorded as a non-operating gain or loss on the statement of operations. We will re-assess the appropriate valuation model for determining the estimated fair value of the warrant instruments, which may include a binomial valuation model to take into consideration the other features of the warrants. Determination of the fair market value of the warrant instruments includes consideration of Level 3 inputs. Level 3 inputs are unobservable inputs for which there is little or no market data, which requires us to develop our own assumptions, which are significant to the measurement of the fair values.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> EX-101.SCH 8 mvis-20130630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 0002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 0005 - Statement - Consolidated Statements of Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 0006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0007 - Disclosure - MANAGEMENT'S STATEMENT AND PRINCIPLES OF CONSOLIDATION - Note 1 link:presentationLink link:calculationLink link:definitionLink 0008 - Disclosure - NET LOSS PER SHARE - Note 2 link:presentationLink link:calculationLink link:definitionLink 0009 - Disclosure - KEY ACCOUNTING POLICY - REVENUE RECOGNITION - Note 3 link:presentationLink link:calculationLink link:definitionLink 0010 - Disclosure - INVENTORY - Note 4 link:presentationLink link:calculationLink link:definitionLink 0011 - Disclosure - SHARE-BASED COMPENSATION - Note 5 link:presentationLink link:calculationLink link:definitionLink 0012 - Disclosure - COMMITMENTS AND CONTINGENCIES - Note 6 link:presentationLink link:calculationLink link:definitionLink 0013 - Disclosure - COMMON STOCK AND WARRANTS - Note 7 link:presentationLink link:calculationLink link:definitionLink 0014 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS - Note 8 link:presentationLink link:calculationLink link:definitionLink 0015 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 0016 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 0017 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 0018 - Disclosure - Share-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 0019 - Disclosure - Management's Statement (Financing Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0020 - Disclosure - Net Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 0021 - Disclosure - Net Loss Per Share (Convertible Securities and Options Excluded) (Details) link:presentationLink link:calculationLink link:definitionLink 0022 - Disclosure - Collaborative Research and Development Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 0023 - Disclosure - Concentration of Customers (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0024 - Disclosure - Inventory Components (Details) link:presentationLink link:calculationLink link:definitionLink 0025 - Disclosure - Inventory (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0026 - Disclosure - Stock-Based Compensation (Schedule Of Stock-Based Compensation Expense By Statement Of Operations) (Details) link:presentationLink link:calculationLink link:definitionLink 0027 - Disclosure - Shared-Based Compensation (Options Activity and Position) (Details) link:presentationLink link:calculationLink link:definitionLink 0028 - Disclosure - Share-Based Compensation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0029 - Disclosure - Commitments and Contingencies (Adverse Purchase Commitments Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0030 - Disclosure - Common Stock and Warrants (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 mvis-20130630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 mvis-20130630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 mvis-20130630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cost of contract revenue Income Statement Location [Axis] Cost of product revenue Research and development expense Sales, marketing, general and administrative expense Employee Stock Options Award Type [Axis] Restricted Stock Rights Publicly Traded Warrants Exercisable Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis] Options and Private Warrants Exercisable Nonvested Equity Shares Customer Revenue Concentration Concentration Risk Benchmark [Axis] Accounts Receivable Concentration Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] Assets Current assets Cash and cash equivalents Accounts receivable, net of allowance of $347 and $332 Costs and estimated earnings in excess of billings on uncompleted contracts Inventory Other current assets Total current assets Property and equipment, net Restricted cash Intangible assets Other assets Total assets Liabilities and Shareholders Equity Current liabilities Accounts payable Accrued liabilities Deferred revenue Billings in excess of costs and estimated earnings on uncompleted contracts Warrant liability Current portion of capital lease obligations Current portion of long-term debt Total current liabilities Capital lease obligations, net of current portion Deferred rent, net of current portion Total liabilities Commitments and contingencies (Note 7) Stockholders equity Preferred stock, par value $.001; 25,000 shares authorized; 0 and 0 shares issued and outstanding Common stock, par value $.001; 100,000 shares authorized; 27,925 and 25,237 shares issued and outstanding Additional paid-in capital Accumulated deficit Total shareholders' equity Total liabilities and shareholders' equity Allowance for doubtful accounts receivable, current Stockholders equity Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Product revenue Contract revenue Development revenue Total revenue Cost of product revenue Cost of contract revenue Total cost of revenue Gross margin Research and development expense Sales, marketing, general and administrative expense Gain on disposal of fixed assets Total operating expenses Loss from operations Other income (expense) Net loss Net loss per share - basic and diluted Weighted-average shares outstanding - basic and diluted Statement of Comprehensive Income [Abstract] Net loss Other comprehensive gain (loss): Unrealized gain (loss) on investment securities, available-for-sale Less: reclassification adjustment for losses realized in net loss Comprehensive loss Statement of Cash Flows [Abstract] Cash flows from operating activities Adjustments to reconcile net loss to net cash used in operations: Depreciation Amortization of intangible assets Gain on disposal of property and equipment Realizeld loss on sale of short-term investments Non-cash stock-based compensation expense Inventory write-downs Non-cash deferred rent Change in: Accounts receivable, net Costs and estimated earnings in excess of billings on uncompleted contracts Inventory Other current assets Other assets Accounts payable Accrued liabilities Deferred revenue Billings in excess of costs and estimated earnings on uncompleted contracts Net cash used in operating activities Cash flows from investing activities Sales of investment securities Decrease in restricted cash Proceeds on sale of property and equipment Purchases of property and equipment Net cash used in investing activities Cash flows from financing activities Principal payments under capital leases and long-term debt Net proceeds from issuance of common stock and warrants Net cash provided by (used in) financing activities Net increase (decrease) in cash and cash equivalents Cash and cash equivalents, at beginning of period Cash and cash equivalents, at end of period Supplemental disclosure of cash flow information Cash paid for interest Supplemental schedule of non-cash investing and financing activities Other non-cash additions to property and equipment Warrant liability Organization Consolidation Abstract Management's Statement and Principles of Consolidation - Note 1 Earnings Per Share [Abstract] Net Loss Per Share - Note 2 Risks and Uncertainties [Abstract] KEY ACCOUNTING POLICY - REVENUE RECOGNITION - Note 3 Inventory Disclosure Inventory - Note 4 Disclosure Of Compensation Related Costs Share-Based Compensation - Note 5 Commitments And Contingencies Disclosure Footnote Commitments and Contingencies - Note 6 Common Stock And Warrants - Note 7 COMMON STOCK AND WARRANTS - Note 7 Notes to Financial Statements NEW ACCOUNTING PRONOUNCEMENTS - Note 8 Management's Statement Going Concern Principles of Consolidation Net Loss Per Share Revenue recognition Share-based Compensation Fair Value Measurement, Warrants Net Loss Per Share Tables Net Loss Per Share (Tables) Anti-dilutive securities Inventory Tables Inventory (Tables) Share-Based Compensation Tables Stock-based employee compensation expense Options activity and positions Managements Statement Financing Narrative Details Number of shares of common stock issued Cash received from stock sale, before issuance costs Stock issuance costs Common shares underlying warrants Warrant exercise price, per share Date from which warrants are exercisable Warrant term, in years Warrant terms and provisions Net Loss Per Share Details Numerator: Net loss available for common shareholders - basic and diluted Denominator: Statement [Table] Statement [Line Items] Antidilutive Securities [Axis] Anti-dilutive shares Collaborative Research And Development Agreement Details Date of collaborative research and development agreement Amount of collaborative research and development agreement Concentration Risk, Percentage Inventory Components Details Raw materials Finished goods Inventory, net Inventory Narrative Details Inventory allowance Stock-based employee compensation expense Shared-Based Compensation Options Activity And Position Details Outstanding shares Weighted-average exercise price of options outstanding Weighted-average remaining contractual term (in years) of options outstanding Aggregate intrinsic value of options outstanding Exercisable shares Weighted-average exercise price of options exercisable Weighted-average remaining contractual term (in years) of options exercisable Aggregate intrinsic value of options exercisable Unrecognized compensation cost related to share-based compensation Weighted-average service period, years Commitments And Contingencies Adverse Purchase Commitments Narrative Details Accrued liability for loss on commitments to purchase materials to support production of PicoP based products Common Stock And Warrants Narrative Details Amount of collaborative research and development agreement Income statement expense catergory containing stock-based compensation expense. Income statement expense catergory containing stock-based compensation expense. Date of collaborative research and development agreement Disclosure of compensation related costs, abstract Inventory Disclosure Disclosure of loss per share calculation heading, abstract Disclosure of loss per share calculation heading, abstract Organization consolidation abstract An arrangement whereby an employee is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Although there are variations, normally, after vesting, when an option is exercised, the employee-holder pays the strike value in cash to the issuing employer-entity and receives equity shares. The equity shares can be sold into the market for cash at the current market price without restriction. Options may be used to attract, retain and incentivize employees, in addition to their regular salary and other benefits. Income statement expense catergory containing stock-based compensation expense. Assets, Current Assets [Default Label] Liabilities, Current Liabilities Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Stockholders' Equity Attributable to Parent [Abstract] Revenues Cost of Goods Sold Contract Revenue Cost Cost of Revenue Gross Profit Research and Development Expense Selling, General and Administrative Expense Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Operating Expenses Operating Income (Loss) Other Nonoperating Expense Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Increase (Decrease) in Accounts Receivable Increase (Decrease) in Unbilled Receivables Increase (Decrease) in Inventories Increase (Decrease) in Other Current Assets Increase (Decrease) in Other Noncurrent Assets Increase (Decrease) in Accounts Payable, Trade Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Deferred Revenue Increase (Decrease) in Billing in Excess of Cost of Earnings Net Cash Provided by (Used in) Operating Activities Increase (Decrease) in Restricted Cash Payments to Acquire Other Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Long-term Debt, Long-term Capital Lease Obligations, and Capital Securities Net Cash Provided by (Used in) Financing Activities, Continuing Operations Cash and Cash Equivalents, Period Increase (Decrease) Liabilities Assumed Allocated Share-based Compensation Expense EX-101.PRE 12 mvis-20130630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 13 R8.xml IDEA: NET LOSS PER SHARE - Note 2 2.4.0.80008 - Disclosure - NET LOSS PER SHARE - Note 2truefalsefalse1false falsefalseFrom2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_EarningsPerShareAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_EarningsPerShareTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>2. NET LOSS PER SHARE</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Basic net loss per share is calculated using the weighted-average number of common shares outstanding during the reporting periods. Diluted net loss per share is calculated using the weighted-average number of common shares outstanding and taking into account the dilutive effect of all potentially dilutive securities, including common stock equivalents and convertible securities outstanding. Potentially dilutive common stock equivalents primarily consist of warrants, employee stock options and nonvested equity shares. Diluted net loss per share for the three and six months ended June 30, 2013 and 2012 is equal to basic net loss per share because the effect of all potential common stock outstanding during the periods, including options, warrants and nonvested equity shares is anti-dilutive. The components of basic and diluted net loss per share were as follows (in thousands, except loss per share data):</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Three Months Ended</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Six Months Ended</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Numerator:</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Net loss available for common shareholders - basic and diluted</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(3,436)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(4,971)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(7,090)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(14,774)</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Denominator:</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Weighted-average common shares outstanding - basic and diluted &#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">26,493&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">19,167&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">25,870&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">18,097&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Net loss per share - basic and diluted &#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(0.13)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(0.26)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(0.27)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(0.82)</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We excluded the following convertible securities from diluted net loss per share, as the effect of including them would have been anti-dilutive:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Three Months Ended</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Six Months Ended</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Publicly Traded Warrants Exercisable</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">753,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">753,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">753,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">753,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Options and Private Warrants Exercisable</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">7,612,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5,302,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">7,612,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5,302,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Nonvested Equity Shares</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">80,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">80,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Total</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,580,000&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,135,000&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,580,000&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,135,000&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for earnings per share.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 55 -Paragraph 52 -URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false0falseNET LOSS PER SHARE - Note 2UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/EarningsPerShare12 XML 14 R6.xml IDEA: Consolidated Statements of Cash Flows 2.4.0.80006 - Statement - Consolidated Statements of Cash FlowstruefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$From2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2012-01-01to2012-06-30http://www.sec.gov/CIK0000065770duration2012-01-01T00:00:002012-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_StatementOfCashFlowsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-7090000-7090USD$falsetruefalse2truefalsefalse-14774000-14774USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 false23true 2us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse04false 3us-gaap_Depreciationus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse486000486falsefalsefalse2truefalsefalse880000880falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false25false 3us-gaap_AmortizationOfIntangibleAssetsus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse7900079falsefalsefalse2truefalsefalse9200092falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 false26false 3us-gaap_GainLossOnDispositionOfAssetsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedTerseLabel1truefalsefalse-2000-2falsefalsefalse2truefalsefalse-1000-1falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 false27false 3us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairmentsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse3200032falsefalsefalsexbrli:monetaryItemTypemonetaryThis item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 7 -Article 5 false28false 3us-gaap_ShareBasedCompensationus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse481000481falsefalsefalse2truefalsefalse854000854falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false29false 3us-gaap_InventoryWriteDownus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse303000303falsefalsefalse2truefalsefalse10940001094falsefalsefalsexbrli:monetaryItemTypemonetaryCharge to cost of goods sold that represents the reduction of the carrying amount of inventory, generally attributable to obsolescence or market conditions.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=28360613&loc=d3e4542-108314 false210false 3us-gaap_OtherNoncashExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse-88000-88falsefalsefalsexbrli:monetaryItemTypemonetaryOther expenses or losses included in net income that result in no cash outflows or inflows in the period and are not separately disclosed.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false211true 2us-gaap_IncreaseDecreaseInOperatingCapitalAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse012false 3us-gaap_IncreaseDecreaseInAccountsReceivableus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse2700027falsefalsefalse2truefalsefalse-95000-95falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false213false 3us-gaap_IncreaseDecreaseInUnbilledReceivablesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse00falsefalsefalse2truefalsefalse5800058falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period of the amount of revenue for work performed for which billing has not occurred, net of uncollectible accounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false214false 3us-gaap_IncreaseDecreaseInInventoriesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse150000150falsefalsefalse2truefalsefalse22940002294falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false215false 3us-gaap_IncreaseDecreaseInOtherCurrentAssetsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse899000899falsefalsefalse2truefalsefalse301000301falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in other current operating assets not separately disclosed in the statement of cash flows.No definition available.false216false 3us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse40004falsefalsefalse2truefalsefalse1200012falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in other noncurrent operating assets not separately disclosed in the statement of cash flows.No definition available.false217false 3us-gaap_IncreaseDecreaseInAccountsPayableTradeus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-1046000-1046falsefalsefalse2truefalsefalse-2976000-2976falsefalsefalsexbrli:monetaryItemTypemonetaryChange in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false218false 3us-gaap_IncreaseDecreaseInAccruedLiabilitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-771000-771falsefalsefalse2truefalsefalse-726000-726falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false219false 3us-gaap_IncreaseDecreaseInDeferredRevenueus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-581000-581falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false220false 3us-gaap_IncreaseDecreaseInBillingInExcessOfCostOfEarningsus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse765000765falsefalsefalse2truefalsefalse3100031falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the liability reflecting cash payments received before the related costs have been incurred.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false221false 3us-gaap_NetCashProvidedByUsedInOperatingActivitiesus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-6296000-6296falsefalsefalse2truefalsefalse-13012000-13012falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585 true222true 2us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse023false 3us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse1100011falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26853-111562 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585 false224false 3us-gaap_IncreaseDecreaseInRestrictedCashus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse10001falsefalsefalse2truefalsefalse350000350falsefalsefalsexbrli:monetaryItemTypemonetaryThe net cash inflow or outflow for the increase (decrease) associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as investing activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585 false225false 3us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipmentus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse20002falsefalsefalse2truefalsefalse10001falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585 false226false 3us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipmentus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-86000-86falsefalsefalse2truefalsefalse-400000-400falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow for acquisition of or capital improvements of property, plant and equipment, used to produce goods or deliver services, and not otherwise defined in the taxonomy.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585 false227false 3us-gaap_NetCashProvidedByUsedInInvestingActivitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-83000-83falsefalsefalse2truefalsefalse-38000-38falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585 true228true 2us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse029false 3us-gaap_RepaymentsOfLongTermDebtAndCapitalSecuritiesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-75000-75falsefalsefalse2truefalsefalse-66000-66falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow associated with security instruments that either represent a creditor or an ownership relationship with the holder of the investment security with a maturity of beyond one year or normal operating cycle, if longer. Includes repayments of (a) debt, (b) capital lease obligations, (c) mandatory redeemable capital securities, and (d) any combination of (a), (b), or (c).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585 false230false 3us-gaap_ProceedsFromIssuanceOfCommonStockus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse56070005607falsefalsefalse2truefalsefalse1480500014805falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash inflow from the additional capital contribution to the entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585 false231false 3us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse55320005532falsefalsefalse2truefalsefalse1473900014739falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585 true232false 2us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-847000-847falsefalsefalse2truefalsefalse16890001689falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 230 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450594&loc=d3e33268-110906 true233false 2us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1truefalsefalse68500006850falsefalsefalse2truefalsefalse1307500013075falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585 false234false 2us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse60030006003falsefalsefalse2truefalsefalse1476400014764falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585 false235true 2us-gaap_SupplementalCashFlowInformationAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse036false 3us-gaap_InterestPaidus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse80008falsefalsefalse2truefalsefalse1700017falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of cash paid for interest during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585 false237true 2us-gaap_NoncashInvestingAndFinancingItemsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse038false 3us-gaap_CapitalExpendituresIncurredButNotYetPaidus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse386000386falsefalsefalse2truefalsefalse1200012falsefalsefalsexbrli:monetaryItemTypemonetaryFuture cash outflow to pay for purchases of fixed assets that have occurred.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586 false239false 3us-gaap_LiabilitiesAssumed1us-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse37550003755USD$falsetruefalse2truefalsefalse00USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe fair value of liabilities assumed in noncash investing or financing activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586 false2falseConsolidated Statements of Cash Flows (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/StatementOfCashFlowsIndirect239 XML 15 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Inventory (Tables)
6 Months Ended
Jun. 30, 2013
Inventory Tables  
Inventory (Tables)

Inventory consists of the following:

          June 30,         December 31,
      2013     2012
Raw materials   $ 11,000    $ 361,000 
Finished goods     33,000      136,000 
    $ 44,000    $ 497,000 

 

 

 

XML 16 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Income Statement [Abstract]        
Product revenue $ 917 $ 750 $ 2,136 $ 2,279
Contract revenue 73 545 355 746
Development revenue 880 0 1,180 0
Total revenue 1,870 1,295 3,671 3,025
Cost of product revenue 837 (281) 1,501 3,894
Cost of contract revenue 26 248 163 403
Total cost of revenue 863 (33) 1,664 4,297
Gross margin 1,007 1,328 2,007 (1,272)
Research and development expense 2,339 3,227 4,591 7,167
Sales, marketing, general and administrative expense 2,101 3,064 4,504 6,352
Gain on disposal of fixed assets 0 (1) (2) (1)
Total operating expenses 4,440 6,290 9,093 13,518
Loss from operations (3,433) (4,962) (7,086) (14,790)
Other income (expense) (3) (9) (4) 16
Net loss $ (3,436) $ (4,971) $ (7,090) $ (14,774)
Net loss per share - basic and diluted $ (0.13) $ (0.26) $ (0.27) $ (0.82)
Weighted-average shares outstanding - basic and diluted 26,493 19,167 25,870 18,097
XML 17 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
INVENTORY - Note 4
6 Months Ended
Jun. 30, 2013
Inventory Disclosure  
Inventory - Note 4

4. INVENTORY

Inventory consists of the following:

          June 30,         December 31,
      2013     2012
Raw materials   $ 11,000    $ 361,000 
Finished goods     33,000      136,000 
    $ 44,000    $ 497,000 

 

The inventory at June 30, 2013 and December 31, 2012 consisted of components supplied under our "Image by PicoP®" ingredient brand business model, and finished goods primarily composed of our accessory pico projectors. Inventory is stated at the lower of cost or market. Management periodically assesses the need to provide for obsolescence of inventory and adjusts the carrying value of inventory to its net realizable value when required. In addition, we reduce the value of our inventory to our estimated scrap value when management determines that it is not probable that the inventory will be consumed through normal production during the next twelve months. During the six months ended June 30, 2013, we recorded inventory write-downs of $303,000. In 2012, we recorded inventory write-downs of $1,094,000. At June 30, 2013 and December 31, 2012, we have aggregate write-downs recorded of $10,279,000 and $9,916,000, respectively, offsetting inventory on hand deemed to be obsolete or scrap inventory.

 

 

XML 18 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 19 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Inventory Components (Details) (USD $)
Jun. 30, 2013
Dec. 31, 2012
Inventory Components Details    
Raw materials $ 11,000 $ 361,000
Finished goods 33,000 136,000
Inventory, net $ 44,000 $ 497,000
XML 20 R29.xml IDEA: Commitments and Contingencies (Adverse Purchase Commitments Narrative) (Details) 2.4.0.80029 - Disclosure - Commitments and Contingencies (Adverse Purchase Commitments Narrative) (Details)truefalsefalse1false USDfalsefalse$AsOf2013-06-30http://www.sec.gov/CIK0000065770instant2013-06-30T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$AsOf2012-12-31http://www.sec.gov/CIK0000065770instant2012-12-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1mvis_CommitmentsAndContingenciesAdversePurchaseCommitmentsNarrativeDetailsAbstractmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_OtherLiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse500000500000USD$falsetruefalse2truefalsefalse634000634000USD$falsetruefalsexbrli:monetaryItemTypemonetaryAggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet. Includes costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6904-107765 false2falseCommitments and Contingencies (Adverse Purchase Commitments Narrative) (Details) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/CommitmentsAndContingenciesAdversePurchaseCommitmentsNarrativeDetails22 XML 21 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2013
Share-Based Compensation Tables  
Stock-based employee compensation expense

The following table shows the amount of stock-based compensation expense included in the consolidated statements of operations:

      Three Months Ended     Six Months Ended
      June 30,     June 30,
      2013     2012     2013     2012
Cost of contract revenue   $   $ 4,000    $ 4,000    $ 10,000 
Cost of product revenue             1,000      20,000 
Research and development expense     (72,000)     87,000      88,000      224,000 
Sales, marketing, general and administrative expense     168,000      390,000      388,000      600,000 
Total share-based employee compensation expense   $ 96,000    $ 481,000    $ 481,000    $ 854,000 

 

 

 

Options activity and positions

The following table summarizes shares, weighted average exercise price, weighted average remaining contractual term and aggregate intrinsic value of options outstanding and options exercisable as of June 30, 2013:

              Weighted      
              Average      
          Weighted   Remaining      
          Average   Contractual     Aggregate
          Exercise   Term     Intrinsic
Options   Shares     Price   (years)     Value
Outstanding as of June 30, 2013   1,255,000    $ 12.63    6.9    $ 376,000 
                     
Exercisable as of June 30, 2013   770,000    $ 18.80    5.6    $ 97,000 

 

 

 

XML 22 R25.xml IDEA: Inventory (Narrative) (Details) 2.4.0.80025 - Disclosure - Inventory (Narrative) (Details)truefalsefalse1false USDfalsefalse$From2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2012-01-01to2012-06-30http://www.sec.gov/CIK0000065770duration2012-01-01T00:00:002012-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$AsOf2012-12-31http://www.sec.gov/CIK0000065770instant2012-12-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1mvis_InventoryNarrativeDetailsAbstractmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_InventoryWriteDownus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse303000303000USD$falsetruefalse2truefalsefalse10940001094000USD$falsetruefalse3falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryCharge to cost of goods sold that represents the reduction of the carrying amount of inventory, generally attributable to obsolescence or market conditions.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=28360613&loc=d3e4542-108314 false23false 2us-gaap_InventoryValuationReservesus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1027900010279000USD$falsetruefalse2falsefalsefalse00falsefalsefalse3truefalsefalse99160009916000USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of valuation reserve for inventory.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 6 -Subparagraph a -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 35 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 4 -Subparagraph (SX 210.12-09) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.BB) -URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 09 -Article 12 false2falseInventory (Narrative) (Details) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/InventoryNarrativeDetails33 XML 23 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Shared-Based Compensation (Options Activity and Position) (Details) (USD $)
6 Months Ended
Jun. 30, 2013
Shared-Based Compensation Options Activity And Position Details  
Outstanding shares 1,255,000
Weighted-average exercise price of options outstanding $ 12.63
Weighted-average remaining contractual term (in years) of options outstanding 6 years 10 months 24 days
Aggregate intrinsic value of options outstanding $ 376,000
Exercisable shares 770,000
Weighted-average exercise price of options exercisable $ 18.80
Weighted-average remaining contractual term (in years) of options exercisable 5 years 7 months 6 days
Aggregate intrinsic value of options exercisable $ 97,000
XML 24 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Schedule Of Stock-Based Compensation Expense By Statement Of Operations) (Details) (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Stock-based employee compensation expense $ 96,000 $ 481,000 $ 481,000 $ 854,000
Cost of contract revenue
       
Stock-based employee compensation expense 0 4,000 4,000 10,000
Cost of product revenue
       
Stock-based employee compensation expense 0 0 1,000 20,000
Research and development expense
       
Stock-based employee compensation expense (72,000) 87,000 88,000 224,000
Sales, marketing, general and administrative expense
       
Stock-based employee compensation expense $ 168,000 $ 390,000 $ 388,000 $ 600,000
XML 25 R19.xml IDEA: Management's Statement (Financing Narrative) (Details) 2.4.0.80019 - Disclosure - Management's Statement (Financing Narrative) (Details)truefalseShare data in Millions, except Per Share data, unless otherwise specifiedfalse1false USDfalsefalse$From2013-05-01to2013-05-31http://www.sec.gov/CIK0000065770duration2013-05-01T00:00:002013-05-31T00:00:00sharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170perShareItemTypeDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$1true 1mvis_ManagementsStatementFinancingNarrativeDetailsAbstractmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_StockIssuedDuringPeriodSharesNewIssuesus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse26000002.6falsefalsefalsexbrli:sharesItemTypesharesNumber of new stock issued during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30 -Article 5 false13false 2us-gaap_StockIssuedDuringPeriodValueNewIssuesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse58500005850000USD$falsetruefalsexbrli:monetaryItemTypemonetaryEquity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 false24false 2us-gaap_PaymentsOfStockIssuanceCostsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse362000362000USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe cash outflow for cost incurred directly with the issuance of an equity security.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585 false25false 2us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse20000002.0falsefalsefalsexbrli:sharesItemTypesharesNumber of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(2)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph i -Subparagraph 2 -Article 4 false16false 2us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2.8862.886USD$falsetruefalseus-types:perUnitItemTypedecimalExercise price per share or per unit of warrants or rights outstanding.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(4)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph i -Subparagraph 4 -Article 4 false37false 2us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisableus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse002013-05-31falsefalsetruexbrli:dateItemTypedateDate the warrants or rights are exercisable, in CCYY-MM-DD format.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(3)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph i -Subparagraph 3 -Article 4 false08false 2mvis_WarrantTermInYearsmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse005 years 0 months 0 daysfalsefalsefalseus-types:durationStringItemTypenormalizedstringNo authoritative reference available.No definition available.false09false 2us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployeesus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Based on the terms of the agreement, we have determined that the warrant instruments should be classified as a liability given that the warrants could result in the issuance of a variable number of common shares based on a conditional exercise provision that is outside of our control at any point when the share price of our common stock is equal to or less than the stated exercise price of $2.886 per share. At the date of issuance, and as of June 30, 2013, our common stock was trading at a value less than the stated exercise price, as such upon expiration of the 45 day lock up period, the holders may elect to exchange the warrants for a variable number of shares of common stock as determined by a negotiated formula included in the warrant agreement. However, the agreement contains a limit that restricts the number of shares that may be issued under this exchange provision, such that we will not issue any more common shares than could be issued on a one-for-one basis upon exercise of the warrants. As of June 30, 2013, based upon the terms of the agreement and the quoted market price of our common stock, if the exchange feature were to be fully exercised, we would be required to issue approximately 1,490,000 shares of common stock, equal to an estimated fair market value of $3,755,000, which we believe is the best indication of the fair value of the warrant obligation as of June 30, 2013. Changes in the market value of our common stock will increase or decrease the number of shares to be issued under this exchange feature; however the aggregate fair market value of shares to be issued under this provision will not change significantly due to the negotiated and fixed exchange formula in the agreement. Due to the limiting provisions on the exchange agreement, the maximum number of shares of common stock that we could be required to issue is 1,976,352.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>falsefalsefalsexbrli:stringItemTypestringDescription of the purpose of issuing warrants to nonemployees.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666 false0falseManagement's Statement (Financing Narrative) (Details) (USD $)NoRoundingHundredThousandsNoRoundingUnKnowntruefalsefalseSheethttp://microvision.com/role/ManagementsStatementFinancingNarrativeDetails19 XML 26 R9.xml IDEA: KEY ACCOUNTING POLICY - REVENUE RECOGNITION - Note 3 2.4.0.80009 - Disclosure - KEY ACCOUNTING POLICY - REVENUE RECOGNITION - Note 3truefalsefalse1false falsefalseFrom2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_RisksAndUncertaintiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_ConcentrationRiskDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>3. KEY ACCOUNTING POLICY - REVENUE RECOGNITION</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We evaluate the performance criteria and terms of our collaborative research and development agreements to determine whether revenue should be recognized under a performance-based method or milestone method. Significant items included in our evaluation are the following:</p> <ul style="list-style-type: disc"> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">the nature of our obligation under the agreement,</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether provisions leading to variable revenues exist</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether any payments are required to be repaid,</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether the deliverables should be treated as one unit of accounting or separated into multiple units,</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether substantive milestones exist,</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether milestone payments are commensurate with either our level of effort or the increase in value of the customer's rights, and</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether a licensing agreement exists.</font></li> </ul> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><font style="font: 10pt Times New Roman, Times, Serif">In March 2013, we entered into and began work under a $4.6 million collaborative research and development agreement with a customer researching and developing commercial applications for our technology. Our contributions under the collaborative agreement include research services, components, and prototype devices and fixtures. Development revenues to be realized are subject to successful completion of the deliverables as defined in the collaborative research and development agreement.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">Based on the terms of this agreement, we recognize development revenue as work progresses on the agreement and as our customer accepts the deliverables using a proportional method based on the lesser of the cumulative proportion of total planned costs to be incurred under the agreement or the cash payments received plus outstanding billings for work accepted by the customer. Since our collaborative agreements generally require some level of technology development, the actual costs required to complete a contract can vary from our estimates. The proportional revenue recognition method we use for collaborative research and development agreements includes adjustments for revisions to estimated total agreement costs. Each period, we evaluate total estimated costs for each agreement and include any significant revisions in the period we become aware of changes in estimated total costs. The costs for work performed under collaborative research and development agreements are expensed in the periods incurred and included in the Statement of Operations in research and development expense.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">For the three and six months ended June 30, 2013, two commercial customers accounted for approximately 93% and 89% of our total revenue. The accounts receivable balance from these customers was approximately 98% of our net accounts receivable balance at June 30, 2013.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6327-108592 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13531-108611 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 21 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6442-108592 false0falseKEY ACCOUNTING POLICY - REVENUE RECOGNITION - Note 3UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/KeyAccountingPolicy-RevenueRecognition-Note312 XML 27 R12.xml IDEA: COMMITMENTS AND CONTINGENCIES - Note 6 2.4.0.80012 - Disclosure - COMMITMENTS AND CONTINGENCIES - Note 6truefalsefalse1false falsefalseFrom2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:001true 1mvis_CommitmentsAndContingenciesDisclosureAbstractExtendedmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_CommitmentsAndContingenciesDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>6. COMMITMENTS AND CONTINGENCIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>Litigation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We are subject to various claims and pending or threatened lawsuits in the normal course of business. We are not currently party to any legal proceedings that management believes are reasonably possible to have a material adverse effect on our consolidated financial position, results of operations or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>Adverse purchase commitments</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We have periodically entered into noncancelable purchase contracts in order to ensure the availability of materials to support production of products based on our PicoP display technology. We periodically assess the need to provide for impairment on these purchase contracts and record a loss on purchase commitments when required. As of June 30, 2013 and December 31, 2012 we had approximately $500,000 and $634,000, respectively, accrued for adverse purchase commitments related to these purchase contracts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for commitments and contingencies.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.25) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 460 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 440 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308 false0falseCOMMITMENTS AND CONTINGENCIES - Note 6UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/CommitmentAndContingencies12 XML 28 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Inventory (Narrative) (Details) (USD $)
6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Dec. 31, 2012
Inventory Narrative Details      
Inventory write-downs $ 303,000 $ 1,094,000  
Inventory allowance $ 10,279,000   $ 9,916,000
ZIP 29 0001136261-13-000356-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001136261-13-000356-xbrl.zip M4$L#!!0````(`)V&"4-`L6?L;$T``%1J`P`1`!P`;79I'%Q<`)=X?/C'T\!%0Q)PRKR/)WI-.T'$LYE#O=['D^\/U?.'B^OK M$_2/3__]7PC^?/B?:A5]H<1USM`ELZO77I>]1S=X0,[0K\0C`18L>(]^PVXH MG[!_?;[_"K]&\L^06:L[J%I-(>PWXCDL^'Y_/1/6%\(_.ST=C48UCPWQB`4_ M>3&*;R=)J2<68;>7%>^*,4T0\BK/8S]688NYAV5>/(B M`0R\"9A+>&(>]28AD\<\+QPDXW)$<"K&/CF%1%5(10)JS_*]G&DY`V"0CY/1 MJ3<)Z`9#.L\PH';`X`$T9VA\`Y5<:YC:R;1Y2),ZX\IP[TD7*6L\ZZLZDH*J MTPRU)^Z<3%Y+S1]/.!WX+IC6Z514U%QLY@GR)!!U/IZ<\]LN"#"J\!<`3A+. MDA)/4#&>/9T]IXY\TZ4D0`H966)M:ET7U_]W\DFV5JU1;S:U#Z?QS'-UIXGZ M)MI\8)PY"2A4XQ&?Y@68J9B\B<4<'DF3`FR'I"\! M&TQ-7=,%.UC"@)1`R'[KT[PX4TGS=\^R0?>ZD&F1Y^F;0GDV%G@V#I]G(P_/ MQ@YX3K#G/RX8%[?="T@<8%O+4ZF--*>@.RT*IGKQP`\^2[ MU*8BPHH<"BFC<>JD_SV[AJ'J@,AA%Y%2OC(;"TAP_D3YR2?9W9RM*?R'TT0] MBQA/DT&^L99:6M`^6M`!^J"[@#GA&S6@I+*7'BB;!RKM9X_LYZ#\SSWA!`=V M_QP4`H,N\R4=5T\^5,=;,*1IHA0\E$XIK5,JC>HPC.J@/-4#=@G_AH.?1%"O M%\7476#VW!E0CW(8A`HZ)&_'R%07F(.4THVE=6.EQ1V!Q>V?CUL.0_]Q-?!= M-B9`.K-_WOJ2[N.PI?,1#IS'L4^6.\65Y=VUF;Q^1+VL^]>J^SWOE&(N`L:1 M(J"V((XB[I[V^H(?I:&H+F9-<=^@CR@K_[4J?\^=Q!J;^8&#`(SS2*P$Y#K4 M#>6X\H'884`%)?SJR79#ASB2A0LV\$.A1JJWW2L<>#`RY7.CC@'P>)PM8 M[IF6&"L-+>T4J32TPS6T_9L9K8O^R,Y`T@^5IOB_<_&QC)5W879K^"N]7>J` M4&F$1VF$!^4)8P/DTOQ2FU\BU*(SQ.(SPH3UC&I(XG)G50WJ\T MO.,QO(/R>.66XSW<6FXSVRGP/T0*7][)']')3_*?<7 M'\;^XH-R2J51'891'92G*K<0'\$6XH-R8Z7%'8'%[;./JR_XN/KAK4*+M^QZ MGI9=7UB\MJV=OP?([?+BM?K65OBMZ7`G/N&/BY`+<`K!!?-LXJD&SKQ[RH\D M4O^L6)_'GXEG]P?@XY:'=&F@%E'&F2U`6EE\1C,*-X2>W+[,?U)@F>OE]B(06MOQ/\W(4L0_/AQ]S5 M=D<"V4I7JE"->Y(HO9+9&H6)5[C#8^42PB``.6C2*N[E=1JQRS"0%*->2(-% M#K'I`+O\XTG5//ED:F8=/-^'T_7R\Z.8[JI8B\+0M<8&*.8>\H:(31G1=3V9 MD20MFR)*Q8ZNM5J;(`I"XGREN$-=M1QE4X(L36O&X22KV`A+*FI,HV[FQ.(X M5':CV+W#U+GV+K!/!78OV&#`/+4R)S]!EE&7YKP(ZT5MQ>!+19IE6UM)Z%9HV1Q3.G=B%H_IAD4D;T"5H:6!-5=4"+)4A&V& MBLLOD_*_JW^'T/F[D(B?BPL5CP#YLQL?,*Z[Y^X75[SW M$1=CEWP\Z4*F,Z1KOD"/=$`XNB$C=,\&V*M$#RKH`N*0K?S_YI2?>2]$=^4.CABYNOWV[?OQV=?/X@,YO+G_YBVZ^O[B]>;R^ M^?7JYN+ZZD$F/NU,LYWZZB>9*OIG!RB_PJ@X\LFOAN4'03@@B(>=/XDMD&!H MB,$V0A@4NY@..,*>@]3HQ.LI+"Q`H@_F(HA''.3B$0\I#*&I!X\)\E@`Q@BF M$`9@T:R+.B&G'N&\AB::/`9=6]3[N&/DXT",I5;LC9%+>I#7#YA-B-3'0206 M@-K#/?7M&76(2\F0<(5$2I-V"_.*CA3%.*AA,6P)@7,U6*B"=ARX4#LK!?!(%1N$WR`G- M26'HNFS$:Z]E/^>38OEA8/Q"Y0`B`H-:,!.H'0_& M'_(Z7U?&%A250;'`(8&L3N))3Z,,#`\Q=:/9]UC6R[2*N4S'0]]G M@9`F)-=_4EG/W>EO',DKAYUIY=]1F]TAAW+?Q6,%0A"[[S&7]<;*6)?P8YCV MT??`DQ=/3702-8`J/`! MXA.5#$$)WD%G7(&N0>5YUS`M^8LR<1^:!!U"FDK4K*(8ARH77F-@D-55+0>X M6%7BG;<,//#?_T5O:#MWZ:^F>*9NH<_/U&\G]?J3J,QFPWTC-OR+R1:YZ$"&@G%-)O/3(YC9*& MSEP7DEPK#\=%,8/0IM;6XJ4H$N4KD)!Y+%N%>8[9/C(6DHZ$6L^":9F-(R,A MZ;RF]218;4O?+0E+6]CDMI)"&K;>B$47GNO)"25S\[+B@8["H&2V<2-NX`62 MDLW0C'@(-#T4/DE33'"['N\\EY7D`9'90II6N9W]RP^!G['S.#^DL"/9-- M5;2@D,JW8E^Z%A5D59ZYYM7B@)3*XT=6[&=LT*BAFZM']/7VX0'=7=VCAW^> MWU^]6KCD,^;41AX144#`EZL))7>(0*`P*#?1%A#=W-]AE7I%Q!'T5'\`$V,KF<;8*)^5$P4>+Q)!XNR9?RQ'A"V=HZZ;)@9@TR M'DN4)$Z?$"`4?8Z(YT#.Y^$B%2&"&@55V)6QF\XJ`^P0&X<\"KNMJ(Q9S&K& M]0J#FYC98A5-&*C,.%K'A40,:6AU6A(S3X4[56RZ.RF-E.2L)F\$ M8WZ$.9#HRO@M^IN*7K.00SY954\V\9]E"S,5(UZU$.5-1TD5/Q2BGE13;$LZ^2H!B`OG>QQ/K M)$F:K8+0L[Y`5L)BA50Y_0^):F6YOWA4S>M;U*RN9+.*=18R]^R7-T?/`_B< MC.2H'X/2GK-76$=]$ZE&G``W+I""]%H=/(GZE/4>%5&ETU[C:.Q\[V@K6T`6 M";NI/CE$*L3B%P'DY"FGB)T191RF:RCM:4^)2F-/V_:9:7'/=BF=':#IEQ)* M":\G(5,3%LQ?-[19V[+3-.-I7&"RI,B-EO(L1JWZS`7WQU'U>5@A8]-?`7;9 M?^;LS#**3D'-NZRE2^HFC)HA^PF'A4#M)FC^9E8LL_'WDO'=,6Y5VDV]9'R' MC#HZ[V0_1>@RO+79;[%KNB M-YHEI45::;W2:FHEI45::0LF]VFLM)QR[L]0O"QW6>ZW4.Y]&JW>/%^J>:RC MTA1L[%F\5*OI9AF@WBGA1OG5:\>$-TO"=TIXR\CT`>94+;-?>G1L!SK\('+_ M@;H26.VLI-#V]Y]7Y)6R[:RA:PEVNORT7J*8DJ-SV4 M]G0`FQZV&:&[@SD?M=TQ>@RPG*'\F.[=OGHB@4VYFIX=[`QZ\_:8@L)FW91' M+QY#$+/DJ^3K#?&U9[[X=N$(D;N`#K$@I3_.4?^5AFZ4+28#8_6*J96,E3:V M+S:6R2]O^Q/V[/RBJ^C\(G40&G\3M9UMXI1Q69I>?X/M9YN,MK22T-)$]YK1 MU":ZFY'YOM?$?BPH*\M=EOLME'N?1IV/3&#W[78WA:U(:E7J&PZ+]J+M;96C M1D4W-QOH'#]'I1T5:T<)OG:'2P'=R2>[&-#YA[OXTKA=K!-\M06*KZ=XIFY^ M&OW*$^?C1]/_&C#.[P+6I<5[H3J"O\%YJBRY!"\%4;F<7.8+-J,/WE>%D-PI_8G+7@@P>QSY9 M!'M]\P6J2:XGGV/-"&@+Y5EO:&G*TS+VJ3SK;3=->71SG\JSOCVDLK=&D>59 MNASXVCN/;FG@=WBLKM*2*T"*N>U.UV(W#:537ASD["[8:#>W"_F>V(0.HP7V M17!L-%/"G2LN"FQF=MOU[6"5]YI^I='ML?+&CV*N:FSJ+Z.-:2X*;7:[;1HI MS#8SVL]TU9--.+_M1A`^9*U;%R*:V]( M/,&"PBQ6[Q)E[EV*(7(LP06EA2+-36F^] M0&@JN-'=FG>8.H7P%\-*N&KF]^N[IY MO+W__86`QBXF]3M1-ZN]>WF0:QX>:TE'O).;SH+T6#Q_/YR MA6!QQAE=:#Z)YD`/'%T\/[D5'/'0]UT*C\&FY*WT83"9SYO6^^N!/!"],T9W MU&9WLE20>J'X32LJ_M)3R`<(>P%Q*"A`G6"*J1-RZA'.T8`YQ*VH79G=I6'! MT@WQ@)!':"4F;,M0ORRS#U@@(?N3V,`!KZ%YQ(I"<026901B9,C*92-9IJ[2 M;S-YXWP@6?U)1`U]PQX4;R!!1I>O2\<-JC'G1/Y5$CPB3QE3"H?4B2Y`8QWH M;@B'&9)-HI/"9O4!1<+.GZ&,FLG<-@Z",9"A]`^Q&\;2@V`*2>5Y9`&!]O(? M%4"+$H[ZQ(.G_PXI4"E+B60,37Z6KJ`1@3=.:$=7S\\$2Z*6A,,#I9IP00>* M&&X'V%_4,)BSX!"8``UD'8%88)`*R:C'A"Q]1T%3S\62#8ZHZZ*.^JS)PX$Z MDPT<5*\/&8,!=I5^R`]H)?;%*^\]\!)(C(@[)&`3\JBH&KJ]`*>G+3\:+@F5ZE0:L8S;94H02^:U?:NAJ(5"`=]\'$Z9"X MXPHD[G(BA.1FCA?H[*MC7PD91&;:B31'%@J*P5JC&I]EJNW8896K\%[ZY+'R M\X@\['?Q<\@YO^VJSS'PU]37?XZ!?C3V/68N-*O"5)^>K/@'QA3Z?LAF<0FM MHI"/7]#*DR',U.0#DOU3F/;L:^M+2%:M8LA2Y!-C]Y.[0R2[@O*76C;;96H4B4541T%(25(^UP@V@781!(#OI_-;1 M6&D=$]GYM*==$]M8:2LKU(/GN,"\?Q>-O)S/X^\P'KSVOE`/>_+CXKGL'",! M"4OW"G$I];JYO(QX,TS;+V%V7V4US?;NBWBMS@!8DE;,2IR6F:8P">J+!9Y] M/4G,B14.?%)%Q3/>,-J---`3`!0+/<V@*0S&9AJL:#Y%4)/9GS2,S&!$GP3GG!.Q\2Q`-XQE=_9<=C[M*6?H]?S*;YAG;UAZ MPUBE?BX\-X)T\Z!63@3R-0Q,)GZEZ,76"2IRHLCN+%H)E*2#PF+>MA!6K$0T M<56;0,KA3QM;!Y79K9J[X"F;XY,C[C#^)-/_4*S0AA"R7(;)-J`%9@$0+2)>#]HIC8;^KS5%XOOXCJ MN=BPZ+9LB2M?EZ6T]-Z*%S3-?F==[)(':IQM@ M6_!;:5Z]``_RA\QCL_]TVHK#F(Z_8C!R@@.[#W1?DB%QF2*\T'ZS'JOFM2HW MQI?9837U1G.'^#+WIX89B\-NG;]LG:MI&!OQ)S#UB#/=H_G=P[X/?B"@:E5" MWO9;MW>E:_IK4V2Q;=2L/H&?+&JZG5ZG> ML4#F.!P;'*J0[1Q/+=7K&MQU(7@V5TI4YZN9NR@D#^( M7.A&G/,A-)$>N0GE:L?;;G1B_VTHN,">5*$.2!M35NSSIN"95Q'J\)\\$ MI_"RK&\^Z\NBM[384J#_;^_:GQHWDO^_HMK:J]M4&0?;8""YI,H!-DX(5]."]=:RZ\0X.,-3M^]L(.9%U"Y=G_$&?Y-H2HF MT?V6S;E,T[O\S^3-@QDUWC.W/-RAQ)^FT MQ/(9UZ>O/!1:>PWZ;GUO*(1%`(#WIB/ZH^TF_M.TEIA]PX2OJ=IK$`Z1X]0. MZ:X`/L8EA&/A#LM5(G\+[!]'YCQ.7MT)!V]? M<(.".+VEJQE$%6$)CYO&_;][=Y<'O_3N+R^,\_[U[>7-?>_AJG]C9*"7;,+F92V*<% YL;?G$@P)O[/& M=^@D0_0P6[^/68B=N/*.[`DG`90+SW9\^''W(&VU5:+>'B2^$ M<"GON[6]EF;,""EXMSSL$,U20#V]&SBO'MEH#*@GA66.= M;A#KM):G6I[>,';N.>%JC>B(C&7(OT]8/RY[+[:^YE2E./5F4/AWPJWV*[6WZC66P7B@ M^CV6NJVHMWTI^SZ=M''?OZO9M)1-IT7!N6MV$;M.:W:5L;WMHF>(4L9WRYU- MJ-ZG(5'%;7?<,,;\HDBB@2??%+TK:[S5=AW=]ZA:6^THKY/\WV>NN52@U1ZK!4JUP]Q&953B)MU!I7 M:]RK'.*MN)7R*K.)2=KVIZOA<@!>UYK^A M(:G9V'ZP7>U2!3@%36@V8[16VK;UBR=Z"=O+^9O*$IN M>"6+'EN-]O%Q?1V[#[UY4]LPO,@W(M?DS@$(WAG7ZG.A7&Z]_A.8 M[8]G1U1+BW(QG!A/PI@YIFL@KJD<+48I=6$GX61_9E#>@JOQ,A.[GOLH`JP! M%-3#IPPEG6ZW%"6'BI)F[A;LI,YS>97I6YQ83Q^7][2I_<_&>?_F MOO_[U04A)6=$8+`'6X1#4]'RM>F:8T(+_F=@W"OD8*)F.T7-6S.^%0,CWF+5 M]WD2[?D7$VSM4!CW$R'"1#A/A,1^)LQ^[SZ%$MW7*-'D'-`6^&("Y@!?#F-+ M(,*SQD%"0N+%#P7V-V/J$>BL0-#9M&O#CQ`-B"S7D*,NG/_<#";&9P>AL-5$ M+P^//[2-B0DD#H1P#2!Y!K;*,@;/QK4]]+T_[0"6U"`RKMQAT_C$JM.*@;>]F>VB&X0E3+4F-1!9W#"M MOZ*`N\V`U\-N'J;_C$Z1\+F))L0<=YX9?MQV81MMTS%4WR7##'.6S)CC0>1D MT;T;Y)?C37-PT_`;0V3M2+,626.(Q!\W`"CS1R8,EX;+,G" MMXX6;KLWM4/\TBSR@\@$NX>$P!81ER/\(JP<_T%-9F%;!//T\MMP8KIC5*GI MU`Y0RHQ/^#DM//>7Y[$@,?H[1CP'@KDJ21A(Y0U(>4$Q3`JH+-B?1\F6$7@Z M)7:Y#&H8@PB?!Q%C0\53VNA&BV$>.!9.8)*+<-U4N,@5.G[O%-FW+7Y$[Y)@2MS:E%$1%X@NX!RA6 M!)SO"]BQ)"(^AK8]U\47*W=B!A&H`8-^!J$#*WSPFS8P(^`.?`2W15J8"U!3 M[+EG=%JD.*EO1$1*YU8PBCX;$V40;-(""_A(&`U2VN0,L#U*U<,)6(.I M^4PT#*BI`37TUA0`6V!WDVO*CZVWYYF^"-8RF[MA("O&KCV"I<%9$:V18`Y" MV#>D3PD*^IJ&^N(H(H8EV`O[BE*#0CIE7@&CO6C,TA&8CF#PSREPW*"F"6@% M7BAT@,[D-4DD-0"39I,`U^6X5>`=3BV-@0_KNX)0Q$/^%_#L2$V MP#W-2$T0#;`N(+3)4\(WR":P(,B)`TJ!8$@!)G;`E'!(E?8^0_*YRN%;\/5GG")I9<"L_"6&TAJ`(8R& M_%4;[:4Y&LF'F4I^AWC@;\@AE=GP%^"[-:2VL5$A"`D0`0PV]B#SN-OX%A6M M**[$A?%",9RXGN.-T<>B&7=E(DO@"&.)FR2S5MC2"0.*I->"@(3C6GST._`@ MS,)=-@>V@TJ"(PY!/^!K(`F2T\H9-)B7F0B\:?0C/V6+I8UA1T`Z8(D9R1.& MX>ZS,0(/X_G)3>&`#T6;)`-L:.BQ,T-2\-B@\W!#Y*<%XP]#YYD5,-9]\H-C M/37$7/W+:YJ(V2B44T)Q@;A[YDDIP:EN[:%WBP$F&)MGB#[&U&H)Z`9//<:) M9R@)\18H:?9FJH`U.`C(+O2E`4".2^8\9F`N?K`,.G-`K'6>"K"7YU^">4HHJ ML+\>Q,8X%FV>BB#F-!1F`IV<>?QCBL7P>SX=H&AXQA1/(9&;94O2H%@V.ER( M2I9'K"GWO$:QI'"@GAZ)&5RBR8WN8-GZ\H.`Y@'B?@T9?:.>F"3AT#:3I&,XW;8QZ/AXW3X]U'#<0P!^. M;K0S9O,!/#)GP,5OH%9D9CYVN@07R0*<#(,3D9Q\_)\-CDD:5/B+^PT^"LZQ M<%B+9D9L'^/'_33J8/3WM*N:8/''BVE"T3"?P,#H1\N`/*XPH"V(C)Q$6@7(KADL] MVW4'N?DM^*1L]]3S!9L$SQ79V?G#?/Y7?>04V8$74_$=:XHIP1`$QU[()@+3,I%C@EUKH!%#)DG;@_UF&SD[2F=K>?[W3:Z#A&A*[A7\"(2! M3U.&+8PW.+NO>B>;QGTT("\)O(_#FD"UL8N/9FFKJD-5+4&#&,."S\#D8Z7! MQYP'DCNPK5BR<(%Z970=];'3[+;HR^U#BOL@V"6SJ)9KF<_::;%F2'0,R\2S MJ(6'/=]X])QHJF^X@"^R`2!,@_&H0Y&X+YT(7I8=4FG"_JZ^U'D;-%1@FHDT ME](D9%.04;;+48CR1@G-GD4#!^QU(H4TLD'\T6+XEHH.7D[Y*(>P+/O"[)3Q MK?(#Z`#!M9@0%$'09<)^^.9L@K]%9X8$)")T0LT)\V,W/+[;$!!@O&X:8T^" MG4#$YY*Y"A8M8RX9Y8LX28FGHJEB`Z;1,8;3#;47S;>OVY_;./N'2?CDE=T6 MKX"6$]2ASQWP&HA"-)9-6E+P%,.@&`-4Y\5OXI>L]2BMT#UMBSM`N MWX9@JWX/K>2-0?);^I-QCI#+TGF9T3<)X@D;0M&P+/II$[#J5] MXRB;\Y@],%X.:D*+(VM,*8[-L4QRJG,@@O7NJ M6*C]>>W/JZH)NU2VV`(OLZ99RWMI^IC2"&Z%3X5X>S6^-R+D8B"@QB!RWL;6 M[.JZ$\[-KN#+\#@I@G9@:#K#B$HN#0R"QG'"0X(V':C40YQ@4MD:F6=*/%=- M*#4?["D?RS4_3>/"=B*5O?Y.7NC'7T]2V#1N<^9;.*JLF%+5 M"(GRJ#AUI>ND^=L*#95+5O)JK'>>DZZ/)@4L:]80QV70R4+IOCJF@"]&,7H4 MMPZX5QYKM\;YBP#;P2$37JL@.PX1'27-A7AQ*-[(!!X;X@)^%6$/R1[0=8\1W@ M[3?>--!U"A;2<<^8+DH&I<4K(L/$D7`*'LJ&`X3M MTZ5K")Z+E!HO!^#D!BH/]N613B^PQK'-STDQ?=`T_G`MOEP*]&(:">J?L'*% MZ.#*ZK@Z%1/S*@3),4VF^_+T1N3*@@"AYM-LP&I957:68!F?]8B3?&_.-P\A M1D3ZLLZQ_Q94@@A$P"]E_>"+U,`0S$4L&W](V2A($8>NPV$TE2$\WZRFR_$Q%S#%_]"-,5?K MAL\-O*?%#WHNB9T7UUN#$NMZ8,V]3`$8*2,_JTL60S>-GJ24*_-D(5Q2QTCE M$JO@86Q?4Z;JX?"4(&F?1@'IZM"'4\,!E=8*8!N-QTM.UIOS52C7?R0K,D`5 M3=N1FA!(XYC2!/Q6,..?G6>M%R97=%/F!),;]G3^=#.G$/I.4>G#O,`;!82= M"XNQ^P5N6M),]? M?JNFC1OE;P>4`Z$ZTDP6(EWRP_E,,Y`-3@+C$QDH+PK@NWC&_H9E@]GT!;Z? M^:YN';)+E-:2(\`R@?GN3Q^./N2-MC+$**6NKSEE?8DIZ\QQ8Y>8E-5CS[W] MK2QSG/*(-;4\[Q!443T.>C-R7CFVU1I0/2A1C4ZUKL2_=UAW58ZX%\+UIK9;'W+K M$>H17O,A]TNVKGYQ-7W.(==X"]#UZZ8[-Q9QMKN-H[-*]FUZM2QMG35:W9.: MI9N4TN/&Z4DEFW"\6I:V3N%P7T1*ZR-G=4+Q>MWUNM_#NJL4K=[,/QI]JU%I M`6Y4+%]ZV&QUZ@3U3AG>KF^]=LSPDYKA.V7X:;O4!]OU?L57H^O^*# ME\7O9J[<1^$BJJ-$HGI'#V7TTA6BA.X[P^]?@+OULY8J)9#+E7,6,+3XF4%F MOIR?XJ8@RS]'M`ZT)+^VHM9-,#*))EN`'2LD=MZQI-?EV55CU);*L[>92[@S MG_0[ZJ`.ZE]6T`(SM5IUV_,ML+73+B\%=VJ"$-;G6YUM*KJ^[!_\[G=5-/1T5O1KM?'^K.3U?5P6<)O97B7 MO7]1?SPOX;4\4[4$&48B@]XS4&(^;F"/<1D)C.9.#+VQ"YMEW1*^T3GVA'H? M*;&'9/++X"17,$$HF+@-F^&-B`P"6LW#JY2]TE+-@>?:TP2I1N0QNE:=<:MP M'J(&DJF!9*K#[JUL6.4046JVK<2V6@,JF3"M,\L;S"S7\E3+TQN^JZ M<$/?C)M\USF*C637#^JLSX8Y6N?2:JZ^%JZV#K=Q";`[IS#S/2MZ"SYA_;CL MO=CZFE.5XM2;J7G8";?:K]3>WHE`F#[VD\*'1F!L'6]&/3%DEK_>]A?PJ]JX M[Z_X]<1.V'1:]"JT9A>QZ[1F5QG;VRYZABAE?+=<1W9O.GA/.37]OP6V16D8 M8^$*7S;C,:TIUIF%/G<,>T_6>*O%4=WWJ%I;K=\[*QKYU!PMR-%W:?Y7Y6@7 M.%6`J:_003QX(;8\2[2-U4V0\^IQ7J^4%.!%M4K[SHI6V-:LWWA5Y>F;R4O4 MO*]Y7_Q(>+S&&:>&#WB+$^OIL'(OF^Z8RH`_N4Y_LBM^8R_ MZF'O>F[E'OPI@E!8/=>ZI+ZQPGKP\%?]&*'S'4$6Y-9G1U/X)&Q,(-%+&\:3 M1#'/&83SVQ1@; MA-OP5]M%]"G=(9P[7*>!4_%+\O=$B"3`Y";=^"W]KA[WI:[\WA=20CW$WO`2 M%`XQS?9ZR]A*#5'J#%VK7#W$9E6NQ^ZNUKA:XU[E$&_%O919QYT*3:NXD%IK M:ZU]+QZJS#+.XU-D%9>RZTU5Q^<"O*@U_PT-449(+F6.IHKZ4F8=#\*?5G$- M.V;#E4J454CG7[I'+[Q*F9]=8W.K_+:0/4GW@MLQ^@MM6UK5M3TD[<7\S<4)3>\DK6PK4;[^+B^I=\&9]O- M;B6[V*V^I&[SK(H+>M5BTCG9"OSB6^UZ5FGBWNNZ*TU<1=9=L=#F3DS;PTJ)3':ITV3RO)U=67=-SL5G%!KUI,M@5G^U;*,=_?Q'JZO`+4 M7=>%9BM4>VYH4^-,^U'8^$6+#8U M(M?F#W&)YE4HI@_/,_'!L,30GII.\-.'JYO/'WX^/3X%)3J,&;81,G>V]G9B M[>VR:^^V.L>O>.TY^_Z?+R;*5(N_6:36J>H*S) MD%?M7D$HCMYQ:''TCD.+[+Z_3X^:(P3ODQ%Y$E&'%OD"4H<6^?+RWD.+.4%Y M!:&%;H)T9SY=JRZ>J?7U@OZ(U@3_Z[02U/]Q?Y$D^?##SYUN*T5Q[N`K4S`? MH,Q3T%J'`-5H\5?LL[@J#UJ=;CX)J=%7IZ$(%SJ=%4B0;[-!5G,3:9>R"5/I M!-4\>4>GZ5TJ-O/FZ%V>5)JG]_3X:*_TYAWC\+5\?Z0JXN\8M'C.P.3POFJ< M7WDEK<.*;LHM(TF76TD5]Z3T0MK5VQ(%-]MSK8L8;%8.4F!)IZ>5VYQUE]1N M5\^<$3;EM4*F_)5Q*6&!O10J9?$U=BJX;YM>(\89>][')7K/NOO>DB7Y MGNI%*7DGK%5]9;78_DJ#E\4;4MI15G(_7M,J%J0?UO*+!R?MJAFH]<.7D\JI MS*;=8*N[=U<_GR'<=#ASM@E7OVZ%3*(4YB9"FHOE)U[(:G9"H%95A2""[WQW$>NRL0Y`L(G3_X=X]8;+_PJPAA,=`DG_J,GQ=L8)KF` M\ST[2A\$MT9Z)7B4N;.Z0^D.BH0HW>Y^N-0/)\+'+_EB`M^#N.K*'7I3\8?K M"]/!;_S;<]"L_VK:[N]>$/3=^/:LY]L!_.D"_NF.&8?V1L!9Z,'\MO9-QT$G M=43:%IW[Y$>IFQ3D1_IBZBVRI%16['V(2/&T&_+CH+T7&;D3,_9G8`Y_]]PQ M(LYLK,OVG:2ZMQQM:O0_NYYR(HA$_V_LX. M_KZP@Z'C!9&_+@2W!M9.@$GL^+4*@55TFL9OEU^-WOEY_X^;AZN;7XW;_N]7 MYU^-`^/N\L_+FS\NX;_G_5]OKAZN^C<9D(M]O*[9R71?A"$0[1OQOT'%#0CA M1YX/@V',#Z*"M1J$^(UXX8SWC;#@$1Z7',<<>+)1F;^HGZ0Y]@7%K($1>O`7 M',=VA?$T$6A25*-?(YAXD6,9`QQ*!TB1:\%'S"15W!*'")G"")YE>+XQM1V( M7SP8EG_7-.YM&&)D#TT@`58Q#0S;Y0H=^('HE\O&3CH0$]'B-03[0LSRR%'; MX-A!>$`_'X1PU/G!L$!A/LQ_P['G%.%'8Q'(2O8M7I%]IB\C]:X9@K8:7G$12((/Z8WI#'_DL^Q][4`)0XSWWL$9X&8\XXP";$%Q.;1!#'$EX1( ME)28P!#?8`^JN`C3?3:4*2;A\L5_(]N78@OK(2F?F;95R3U`*;&$8^-1&I@> M2-TD:H#R$#P^]1<(#-0X=%`H=.9PB)5MN&.@D0$LSZ>/V2XL>!HYH3US^--! M)5<=1`/,/)$UT_9$"EDE"8Z-7DK6("J#?X#C1DQ*I.S)#B>&L.D[:!D5)FCGZG%JJ`0N$6B"]L&WPH"$. MZ;J4TPM")3(@G)&OW'XLRS'MTO0.S6`2&W%@B8!90%B=*-UY9X!*ZXY9>X@Q MO%#X[.`Y9:LQ`,80?BY0)U(2,;GL/>P\JQC%".#[L8^(]3.Y00U>!W<2XA6K M$`>7+G5`H)V0U26P1G0K_K,Q@H,CGR,P"`]".,^&J'K8`RFU)4H(I(@0N^4V M@>!$@2`VE#^&2)/!AQG3^@M8QG_`X6!2&7[".A1UEMSC>.-HS4WCTH2I9I30 M8/.KCU+T^?C[S".<0.!7]$!,@VLIHBAT#!)GEY@>:2YX-IQL(#`!8YA/)D?] MPPE>#]`'LX1+0E M':=2ZD#%V/`-W$!PJ+[WC38:]/>L\P]BT^G9/]09D#=?ZA%M/Y/`HRA+0]A1 M`].A,S]J)U(KRZQP\(Z4O@\DE^!\"\'_O7+38VTDI7Z0??VU?,Y-T%@Z=7Y`+%V#R@LQ M$NC69)WFRH+8/3Q+T9$9=X5I"^U1^[3,K'3[0]5T\@,W8@6,I!PR6JW,Z\J\ MF5:EIK10;(F.TG>1I]ME2KF+P))TS.O1,I%=V<0B2E/X MNPT6W;+#YXU=Q6W\ZFAB/L:GW-2Y!>C%TWJ`IU`*._`'*O5I&NJ+HXB"7R\. M^?&&"(]/,]_&WK<.'FI]+QI/*(@.0/+HH`.A,9P%`RR,P12/2["K&'/.?,E2 M]<D$N6\;';/-39.C@24:X`!Z`?1.ST.1%"ISILJ$:Y M*+[UI8S3D+/T']MQ\J^YX_!0)X8X5\,QD=Q]=TP9%%HV)N&']DSEK\,)'"&> MI,P$T0C70M'40D[`#J)L\3U80KJD+/6'H3?@Q`X=2%`@GX`E.@6"[8=E$@+' M5K>VGQ[E98:?2]$63+,"J%-8$&0$PT"IVBT&6:TT$?8,ML\P`0DF!<0-X?GF-BSH$D$/6"&E"@Q57HQ0[EWG<;6Q8CE845^+">(EDI;P`(4+`\N((8QSI;XB*GB8V+&Y( MUYA!RFM%(-T^ZA"H!)CU**1=-@>V@TJ"(PZ'=+$&DB`YK9Q!0V;6M$$:.=Y3 M0)<:*5LL;0SGS4@'+#$C>7*!/O?9&(&'\?SDIC1`9$(2;9(,RNIQ!A9)P00+ MK^B)M+5A6##^,'2>60%CW3?C`N*`[W'ZE]%)O,P_*H^D!O@9)V_"[S7>6>4+4I,82\WV%U`S3=VS*]0.!0L+8LE/R$Q?L M6J^2535)_C4X8:RH`OOK#6W*ZM+FJ0AB3D-A)M#)F>?J9+QF,5ZBH,*2:'C& M5`@4^BQ;D@;%LM'AXO4]^H2KV+LTP7?LVC0!AZZ!-!W#^::- M4<_'X^;IL8[C!@+X(^-BY8S9?&`A12K3^K'3;2,`M\[,ZC`X$T$@R4@PP>:J88T0"KPU%"TYP=(4'IH"N56"% M5+UJV,A)((DS\(;+;X=0M/.WX).RW5./JLR`"UBRD9F=/TPTZ$LB17;@Q51\ MI^[?N4)#E]/1!2!0(\9>R"8";W4BQP2[UD`CADR2M@=O$!LY.TK7I):QJCI4U1(TT%LO M+S_(QTJ#CZ=COA^U8LG"!>J5>7#.`U5J=EOTY?8AQ7T0[))95,NUS&?MM%@S M^#41_`'/HA8>]GSCT7.BJ>`AR13)*SF8!N-1AR)Q7SJ1`&8]I/X5>XB12.WT M=3+J*\:B;$F0/;;+L8?R00E]GD4#!ZQTHJAK9(/0HYWP+143(`^QN1P+'(>\ M)E9(RDN]V`V0)O-=UP700SK3:=%1M\U,3-_*DM\$AV(B7I:!I61CWYQ-\+?H MPI"`1%P..Q/AZ3TO8L-#NRUK"4QC[''4BW&>2T8J6+0,:1#T4E!?9UBU1W>9 M8&&FB@U8%H^1&T5SR^;;WV57W:3@A83:_*T.!8]W<>W!+8C(\+EJ&;BZ>+LN MWJY,_65=O+U_\NOB[;IXNR[>KHNWZ^+MNGB[+MZNB[?KXNVZ>/O5%F^_[11% ME7(C+^8[5()D"B+]PP5L/"*')D0M'R*QEU"ZA86*/\=QT+^^7W'\%'G<8V%S M!"XN\3K^\/.1`@!>>>K<4K[?;4YBVB(X7Z/6&0&*.T?SU83SPZ]!11&(J^/# MG)K&Q518PO[A$LYSX?,=):7Q%N#&G!:N'OSYVAZJ;(1QY0[_]?VB$>=G/*=Z M=><*[.FWW\1SX2EIA=WCDY/#Y&R9T9+377@0E\"?$2NM\"RMPX/_X_&37\\; MEI%6+D'HT*L5'3_^.3U+:K3D=#WXJX6?^.R8X\+3C$`P!,^0&B`YLI2)SW8P M-)VOH$)EUW+`ZL'3+!IM7@"^",?YS?6>W'LX4\,)Q+H*@BB#$+ALVALO*0`+ M1IN?]D_/`=MA8H,0!^^Y5YLN,TJ.>#,?[N@R"")2=.-1\=F^BB`EWKFCS<]* MU)SCY3_>Z!2=[![L!WS/T,.KRY8D":FA<]9+MYP$HT;P9TF,R076[!3F+]$Q MZ>2LPT7\Q2;-TU662M:QS_"[XOOQ?^VTGLZ-M'@Z5()RD[&/7C+2PHXZ?ZJ$ M/3I#_U&LW-GG[*RUH+7/W!3K$5.HT=$A;/Z*U"!Z\!/>BGSV_`N\P!Q%3D\^ MI+O3[^C6]>+X+#O+X*YG.?M2S:6X\?# M1:1F)UV?Q-+8O]L@D4*%S7#P!;IXIO5H*LVRE6A*N-;=JG.!B3=$Z_J*O!ZM M6U'AUN%A5D&63+DF=>7Q[S=+W085MWW<[IPL)^Q%1=FXYD+8TS[>"%$O1./; M8%=.++XJ>=M@W!+RM@;GK,X+?B(#V"IX+%@"Z/WS;>MKZ_"Z?72Q`TCJW#6\ M#@XN@_O^^?:P8CR,,7ZOXG)[[H`+,DN9O8>)Z3Z(*3XA\9^OX,AN^WS;L&$X M[S5(V?*JRH-RIP]J&US9K>]1+3)2AL^W^Z.>>B,'.XV_V3"HFH&N@5*H57F0ZB)U=U'J#A3[^>G+=3=CG/1!;C%_90/8/O#1.^.U;Q]2S M<_>4.R0Y$9)("@N2U2[.P^ZZY]? M@>7X@K79EO?D]D>Q`=EUPXO-4+M_WJSK9]\Z?[;1">.M\*8T&,Y>96<.2@V" M=?P%V*Y%KFJN[:,$Y_-<.-P`_F`N]-C_^NK04XTXGG?8L0Q"%71//@0@LN"0HF1LO%!4% MK-*M8$Z:QGG_^KI_8]P_],]_,WHW%\:7WMU=[^;A?F^-7VK@@!HXH`8.J($# M]@X?XC,ZP_43?E`0PL3HZ`E-MAV@]"/.$D:OQ)6D3$_1,277^K% M_AC8ZLX-HZ"O0$\B)U1"H+15/6PV]5/3A'8I464ETT]$Z'HU)B*&J&650 M`G["85LBMF4(EN20@.-#4<_&9U5:_"=*05/2E%67Y&['4$;T9;JF76CND@K2 M"W--5T._2C!IWS*H@G/D(+9W2FO90!0@JX$S$%!3-/,(L,'V%6J9YL;1,2J' M02$`^`[UW`+_),,&4E_A2%U7!BN]^VPR7EAI M!FA1;#"3%0PBH4R@7Z#ODA22AT@+.FW=4.D;3\-Z@K(/CN0`.'"`#H6`\=06 MROV5^J[X#\*6)TNL3/3-Q:9"@X#]-_(4OI3$85NH(QK)2S-C)/A]_!-"$O+[ MK%&$#Y^T;2>3]!3#$,0/FB2?DL$14=%J')V1@5T@18U83\WDJYR1:?L*2DZ_ MM?W8:<`A`T=KQ&AL`^'8`A%261H&,`9BKLB$@#);!%Z`8Z8>[BI!3$`!Y"@T M!++QPZ$8:BT>:E[?47S4$%6Y.S^"2I.J2`E0P6$N MP_38ZF7Z_/BQ,=8R+R=,/+)"]QJ13!#ML8;+MZ%DMA2=6NG3,LK8BQ?Q,!H+ M,H%H(*5<#Y9PALQX$*YH^K)M4GH\S,JJPA=@>87UMQIG)]U&Y[B]ZP@`7`L% MDJJ%0S!!G#CT-`UM@=1K.6WI%XJP1*8%.R4YI]^H*PA0?"3H6RH8<#WW((:5 M&R.B*060@=Z#(/'P+(&/R=L8@[D>F/CHE'6/U!\,#LICC!TR]2SAD'=1[D)A M^F34/54/X"021Y0U M*YBWR!>28(T3JO<@@;;X$MGZ.66&`/C&[_2(M`.?F$4X7_K?=*2*7&^`IQEIAEY),1;*D\MP2WQI MH[Y!#[D3;RVEYD[!C$6^%@X5C\>;N``0<+?O[M[?^\+"B:)LAND7#$_ZHYX& M*.%WB7M!8THN,,(?KDW7Y/OF&''7A_-1BY3."%^N)7AZ>@?PH6S<0PHV!\N#<12\Q_^2C#)%QY0Z; MQB<6B,[1CT]"_X@.0O\C"O2/W]$<-#Q&@32%&5EX=T:8M.0P9^"]V7=-M5K" M:B$42.($N`(!/Q#+`.$_0A7!H(-P&(8A!C+4B,39'E;Z4,,)B2`=AS!R2;QI M%+JD<:'Y1`NDR8?VG,?$%_/4W2MFY-2T%%(R#!:04W,130T#'$S*T[D]7A\< M"!C!&APRH:XQ_1@+>UX(S!.$=<9&-Y!#.<_Z'"RCEWPT1[VKF,0=8LQ&\DZ9 MQ1B+0L-:)$"E(/*"T6:(X!&O#3,PC#J`>#(0<8<$/.EC(B-4T3!Q.7+B$"A1 M\H7+NE3Q.)8.0>B,R_V$G]/"'T\'S`A[E,-..,TQ_N+966V)+;PI4 M#LVF\=6+5)8-SG,DHHQO*1?Y,F"G3=OR5^02;CQO;4HIYF`Q@8LH5@$'?'A^ MR6#U]5P7C]'\A!-#^,\@=&"%#W[3!F9$CPB7HH3RQDE]TU"&L:TL;Q1ENP!E M$&S2`CZ97*:C`VRGGUK3KL]O-:1%\\"7+=BC3'QL=KL`5%@:9Z)LCOIGHCRY-'T^/@7I>4ZFKSR^4N&"U M3(%E&LD>.''WC]C>$0?@6]CFD1Q9\K:-S]9B-.(KO+AE`?Y^*M-QL<%'@+X# MQ=*%,)W<^&,H'">8F=C;`5_:TK]G"/0N_UV:34^V%4[PHX?_2"!]XGR^&HP8 M`4I[8#IPLOS!&'AAZ$U_!-\P_'OL@Q19!T//\?P?\`P:BG@8E"`:RE)#X8:K M86AG\O0CM*HZ`BP3F._^].'H0]YH6$DB_.+=*=7%^P,9YVLVRI=HE#/7[2DT MH'?'GGOP6"690S_ZM3R7W[`!IAS]`^8)\,8!IABMYO$,+\XA1OK1V,26JICC MS2AW3I^A_JS38Z>'M8, MK46TTAPM+**[B=[WN/:R[2E$G`0:^7W?3;K;1WV!O:6?Q M+$4<3N-XS;"H$KJW51YU&ZW.>H'.V^=1+4>;E:,<6_L]%9^E?O7F2B6K5*.Y M^6K+7(0:AJ*^("`.1KCE!`JLA_ZT"/7T.%&C>5P4A1J;@K554[!R9!0DGF#< MUZ`]ISO7Z7$A>M,SSV&)RBZ8_9'^.M;4GQ-`S0:H['33\&O+YIN#[$+(B?Y( M7F7T?<)]NJ''NDGLM7/L-V3]\JRN/.0'%S6(*2<4K'[`*%3O+"P%R@ILIH@Q(9=*#U?\!%H=HC$]5117A]>R,:"\P,5VOX[ZCGVV?-1.4"-'[P;SQ42/;PX+5MT M"S7<3`TWLQ;L=NX6;4LR@YU3[@9K1N,.2,PAO8 M)=P,:T4*CV_7<#-R(U*0,RF!85.T\3"!1M[K[IVZUVI+\^9?GA8L>,>,.)5].3M^V3A`F%K4=,O]R M`$<<\DMNE2@K^<$'KRRW_^^0\$_S[_J]%`5PYV[0O4HU9C0&;T M9S0T%_@"76."F>E1]C/Z9KHK\1OZV^7X!K[ZW5V@]MOW-FHT%)A]P\2F[&X\ MB)@]>-[RHME\>GIZ2^BC^439G_RM1=783>B*63CB=?MM,$$?_GW6:[?@O[/6 M:?OM\PSD[ID>_%5\;[;.FZU/T];9Q?N/%V?GBKUXIK?B42^MY_-6J]V"?S[Y M9]^G,1T>VJ_I6S>/&NU3IN_W=Y,K`>\,!L.$8!8 M^"2D$ES2Z$X_??K4E'\-FR9:/M\S-^RCW0S%B3C#7YV<]C%)N'/!I7@WU#(] M.9X*NT&9+<2W1MBL(7[5.#UKM$_?/G/[)#2^M""C+A[C&1(_881$O2XL/*K3>>@DNPIW%T@6;-/<75`P>+'HS9E<.`1,[ICNBW!&==5V3F*03%YP-CC(Y.!``_8O8\@NX](AA#F+(KS%OB>3C19H831[`CXJDSVI_ M,(&^XG7'LN@*(B>9C\`XUKHQQH^8K("'1>=$!J7&D'JX723L/KP.ILB`0$>0 MUZR+I$PT/)@(PJG!H^5P&F,7!I'=I=SC$X]:?\;_6"1B:4:'5&'A>,%T"NXB MD(3,T\&%?E9,>5`A*9'&@+Z^FXR9X*MR7'U4$;.(]F""#O%3S"$8)?#1\B.+ M[/&\2%IE!H>;-%:+A=&B`-?Q9.(WMQ.Z#]O1O*H^`Y M->_=8IESB0X?KM2$RFA^.-B%JHU+2.KM>'Q1$TZ)^&"BWIK$G/L^$$W4P=1- MYD/AT![D5#WLF8Y;*/I>S*H:GXHRYU-5)1R$]$?,/`4]]L,>0$YK,>H#N>Y"\N'0I)[4YPW)T*"KX M`I8'5`LF"^*Q(+_MKK@'ZPS&RSI)63Z'#Y(BK%`BO%11Y&+*PPM9UJR%A`=< M"4*ZDPS0HFQEKUP,TW-Z@_ZS^(@OU_'EZQ+[`T$5BE?I_+`3H9V4)HA$'0MP ML9?F0=\!. M*E[X[*.;.I<\X2W3M5:NA/T&OF]1X&31=Z<=>%X;X&OQ8/OG) M5D21?%?!V)#J,`M19F/VY>2TU0I[@@QP:R@EGZX$+9I<+)MEK#:",MO*)E/,5N(J9.9EL<--F)TSLP%SP9.E5X-PG;-$):SAG9@;I8G M.,?7MENI`?.N9F#2--/._/(QH>+4F]96#8KW-4.1K:5V@/A2%N4_^N0%61/+ M41@;HB,L];WUR#7]!0'D+K)HEAN,\JETF?@S@%%163NV@ZN$9!@GM M8$]<-D")AO6G//P8`JV:CE4]6?["B#IJ*^=IAUS:7CF>X--CDV[EUG M[C_"+_2U(CHUW#[H@)N:";1#3F[&$ONN[HLC8UI;-80^ZH!0MJK:H1+326DA MH5GZG0'`$25R&=ZLLMY6(-4J!R\7SXY@,;[)3XG7A9^.IP);/I56Z7EA7IZM MMW9@R4U*#]0%^W%11A5[@H)"W(@R:5_/8\[]RA-+]2D5*HE'K%2FM@/B889Y MWIQU(/ZU/BD)@)6Z%&QM26U<_^1P6)@3SU4R#:3=>(]MS2O:I)1H6?^T42F, M6:;1#L..;5*D5[YB#:OM]4WKZ,W6[Q^>K7=^#LW M:T2RO\N3?7/]`Z(SM#ER5.,6_.!A2N[6V;!%GS7Z M^KTF$Z+$P_PR%M$NH*7?%U.(8P%9_:%"%3XE_;5#[=ITB+C4R"`]AR^#X__& MK.C<6`%9_7F_*FI*^FL<]OUBD=!`(?#'&VL4%Y,Z[(*4,EMKFEBH*Y4]0K4; M;;`H5AEG.\WJ'V&IF%_BQ^2AJMUX\>N\?? MTV."EG$XQ2!WA&'3=?["]J_4E0=OH^PR=D,H@YA!YCWX"A;#S*%V:,B".%Y) MC_7/`Z\SLJK&[&@&J=!MC*W@AC?_]2H=^[\K+N\#O`)T.D9W<$79=]`=V_0) MED,;2^P_5`_5;_UKRWH'[&'QTVPOA](K/*+$Z4.)Q`FX(;LLR@I"=%19C`]#&'%ZP M?C&>1UI]WX@M;F7T$R\>W;8D$[?I@TFF>+&DS&3KP6)I.FSKY5QY:._!M/[; M``XX%O8VJG:.+Z^;3]PVG_-0.Z-]_9<&O!C>?%-HAUQTW:I<1?5@%96-6EK; M^B\1>#%BV2;0#JWP,8$E;BY4?2:RU5@-KW.=\S_')#D MW>%Y#J="K0;I)YTA+6,F_=*DI/1WY-YQ77&>/[IEO`S*J>3*-8.CPCG'4L<` M=#AWY):R"L@4@=6Z&J1DF6,`U*]&^S=O%*U;U:@5X=6ZGE3&3D^5_4H)R=&9^E"HVGGT;!4D@]GI[1C@;`,R_7R/N"79:3MQH@2`V`_X^GG M_AF6"-XX';>$_[[RE7C6O[F]JFQ*H\RWUH/2RP!=8Q:^8U7NRYM2/Q^)1_L!YRMQ"9U8GRC\0P!RL%&Z$#/6&VB\Z\1#I%AV4^H@;J.=QR*5\Q M#%]N.\/.=?^V/YS^.$&3:6(U& M8/KN[_#[RO:M6 MMOANTC%VQ=$O4=GE,@=(W6H:R7ZZ*[L<-(W+SJ3?@T%_.^H/)UMC_GWEJBP< MN>]9A$,9J.88_!HGO?GT;%=VD/=V,!4>/)$N#$XKAD\?_!B\.%#@0_4*!-D7 M:!"^]DT._(])%=II*H"Q)U.C^U7J\+TS'G>$0H'X'ZL5?XB?8G[,*(&/EA]. MI0[G21W>)8/0]RWG'1M#^-SM^\`$>IQ7?)>TF'?9VIA-'(@]XHPHC*CM``5C M*OR95.I]PB]\AN(<98PEVO!$(3/T)OQ4\7W9,..+PP+A]##=WB$7J?(A@0_V MY+49""B1)$5O?.**!8YB:):HB?DYHG@E":4U&HDM^EGR)N;?&#V*,W@E\6]- M8LY];XW2H"@!'(I8)&[1ZXGW-K@IZB2FX0V_'WGLE/&;B">*F/Z$W@1\7W?4 M9RESEIB5TX9]+2+#M/:(F2<.[<6N5R"VL92IN'_>1[S1,$.SQ)R=IEFL$[3I M!9G$1D$_*.SHU:#K4A<6\=0?,.EW!7;F#,M!EJE] MMC!S$H\%"Y3NBGMT@1DO],.S9%809R6/\H?,T)O7]\`H*(L(1XF(-IFJ))*# M343?4,<$U^"T4^X=[]NM=#B<-3:?;B$P,UCZYNZ!26U>?TTLS>Q9A[#25-6N MM!E)>R4NKGW`MKP;70&9G?;U5^C*0).JK&;%I(T^A1$XD?['$M'7#[AR-9G, M2B<6&'PEGHQG-`A.P%VNXU?R126_3.43"X88^YVL-A0!&;/L5H$8Z'(=RR&- M^!MZ7L^2(CFRDY8*4J*@1KH6U<7@)'ZFE1)KE3CO'3.%&5?(7R8G80^OJWQ2 M]V)O*+',>7WGV%2,^&[)J&-#"LSQ:`7Y(,@::UFL;`&_^3]02P,$%`````@` MG88)0S];$.IR"P``DG,``!4`'`!M=FES+3(P,3,P-C,P7V1E9BYX;6Q55`D` M`ZE6!5*I5@52=7@+``$$)0X```0Y`0``[5UM<]JX%OY^9^Y_T&7GSF8_$-Z: M-LTVN^,0TLLT`09HN_W$*+8`3VPK(YDD[*^_1_(+!MO8IK9QM^F'%HS.T?/H M'+V<(\G]\.>+::`GPKA.KJA*Z827]?=E_X$O?UO^[K3A+_:S5;G]&4.N*^Q#;^*[XWF>:/Y M?MIL7YR]NVB?IZS%QO:*^[4T7\Z;S4X3_CCB'PS=>K@0?]UC3A`8PN(7+UR_ MK`6X/7=.*5LTVLUFJ_'7W>U$71(3UW5+&$0E-4]*:(F2:[U__[XA?_6*ADJ^ MW#/#JZ/3\.#XFN%7S?8%@H7/&LZ/P:+Z'M4!T%R_X)+)+56Q+5TO$1&*+2&^ MU;UB=?&HWFK7.ZW3%Z[5/#O)QF;4(&,R1^)?<":_5E-7&7W2A5>"#YD-\7L# MS+DRB64KEM:S;-U>"]LR4^(%#E+ADI'Y9$4 MDR4A-A]A!@"6Q-95;"0!3I8LHH7[,#J:)$-C;@L4`6D(O%F7FH^,+(G%]2>2 M&622BB)@=S%?WACTF?B0+;"E_RU[;)=:G!JZ)K]`EQXQ MP@&&_!KH+3X^GL0D%^6Y4>UA9L%\ST>$39;0CY+0QY7/#=`GLE94E:Y@Y+06 M(V@<=5T?DR=BK4"'2A>6')3J`VJ33A+80W3E1J1O046P!%HGH0P5S`V"Z-30 MHZ4[C8D!3J1U*;?YQ*;J0_#')(B9%>5)P=1M=SJ%[B(L"8M4G23VLV3)7$%2 M2S8&U/45,X:AKTJ_>I<&9I)L;D`'Y#G0(1BUX*/JC"RRQO,DM*D5Y#=IK$P3 ML_5P/M&AO\YAB@>#;G=J,*GW;^(T;3HBZ8C"7$PY#Z/!1V)KW7E1CI1'M,`Z' M*<]Q0C$,?$\=8X]A38B9NH3JKV'Q8M!'.:DM&)'>D9+@=ZC,D19,%I;-W/5M M=\5MB#,8S]I)LNK)?Y`4PPJU1"]-"3E9,G^069LU43#'2!"6.^$!6F2XM)5! M8'J.+M![$1_)U3H8OCX2QQ'2FJ*4RO.="+4P&GIV,5C#6`JY`R>Q#7HZ5%!SX',(MO99]X&%. M\_!'%0["B,DH>XEMD4H^D^B6H(*IJWM2UW13Y,=$E.M6%&P@7XMNV0THVG#+ M-"(5%(_;KZRN41/K&4&'I4M`+&NJF\2\)RPCW&W1XK%BP\B&4`H4C\NBMI(5 MFB=3JD^2.5X9]L%.Z8EO8X;'NI/4NX6O6[C)BTTL;;.)(11^_QX0/!9JFLUF M"]61)Q'\B"T-.>)H2[Y`X!EWP4^03?B6%)YZI!^8H1^'*G#)2/O;O>8/KK!$VF MRE1^1LK@&HW&_4&W/[KM3=#P!G6'@\GPMG^M3/O#`0B*3"]J%+]+XU/O&U*ZW>'GP;0_^(A& MT/#=;_!\W/O2&WSNP;_=X<=!/VB*3J'\POM3'OA6-3C\W:@WF&SY^UG13))VJWSH[5WH`/>N/Q6==R)[ M+_17X3L]Z,+0@5W\;PO'G[B-Y3/H1#&`IIY,A]U/DL)793Q6!!\7_;M"T:?? MUO(IO`D//U^W^NUX.(#/W9YC%I?&>;$3WF&[6SZGLU"?!164@_ZP[3*?36CRW>C[E0=6@R>^3N0K_0V=N'I+]?@X+NW07!SE M\L=`?.!>FD\L-%-'$0M4@C:UR.C;K0=Y%04-YS:"UPP&5;>X&^*(*F61V0Z9 MI9AC?B]3%2M>7V#\V)`'AHEA<^^)3'76FRWW3.HO[N.9[US0X*0/'WWF!KXG MAJQ[YA:.*MNH`'39PU/`=LOM0MXXG<(\\&ZJ)V4^SA>!L$&!B`U1)E&V&6MU=Q@`31NP'6UCE:@O.A[/+702G/UG\BL?)*_;+L! M+8]ZK.-5T,7$!8AK=],@FY\$)7,U=G@W(\;291@QC=N$VS!L^W;S'VK\62N" M65[V]S8.#IPZJN<@LK7B?*1S7!]Q\P!W[K9T-\>UVIAPF^FJ331)(,E>D<5GYS^4 MI>(YQ-GHO(IKH-03@F**3%IA"VI'_:SU[CA.D#K0RI%FB@'X0R,BZ5%D;OSP MH[=^%B2<]`]J19Y:F?$(*$:^YI*2/YG/YOH,PYL"055RW]53ADXBTW`52(F\ M9G->LSE%6&FK+XQU_G"UOB*6NC0Q>]B?DDF6K'9>)2WSJBVYP[@]U$GQ<;+D M<9(CJ2V19,#HAJALL(!:GE9U$C3`4ME)U4[)!:L4D1(CCQ`"]( M*\-P&I":G54\M$T$7[V`-<5E13]J"YV#VIQ?V4B7%'LF7V#T88>..@6.W91^ MQ*.<&XD^]]#AJ(#ZG3,\'@0TG,>7&K]-4A_#=)_@B#=N2*Q MH>J^X&Y_?+Y7J-JA>0J^58O*8R`G!70)8L>)Q],T?RJ#53P.+\)F58[`<[9K M,9%W3.@FKE\,Y^("`\.J[5Z#V1NL[9$X4ORH`3;/6D1)2F3O>P>1B!\,C9Z840RHGFG-. M+R;4WG-0(Y7\K)W_NB/GDQ@9>%0O<_7]+S7RLR2ABUE!W3MI$N^*B:=?GL+P M:B@MBY3Q_4<^TPQWNEZ/7;QF='ZFC([RC)DVA5H2KKUL%ZMVUB:24]7R--&S MCR(.6[OW/:_6FS(CO):GZ`2S#3T8Y`ULI;F14$QM1[K"$FE>6@+?BJ:/?GQ7 MJG*RZECN5N7S)#WST:!K0N2.F;,V3(KJ8T6.E`,K=(2@Z:F7E#O;N78PUA=+ MF^^-[O=('.M421DV2T,]=AXX[I+"]S/"GG3Q>KFHUAJ(]PAPH":;A$^IC8W@ M[R+A.*#V-V*[[W;Z>Q.B[>G5>5=9^5,OQ3*OYIJU,,XCPG2JW5`6>)_8GN-2 MY>+X>5TQOCEB1\`CWD'*\_W1?NHH]`*=@+1,@FW5A$[Z$WK5CJ/(.2$E:7NZ]ATFV9V MHRS)/L78*H4D=V]'QT4'BT25L,TB:TB67N;7'Q+@.P$0+%4!:<^'GNY2)O@` M>)!(`(G$W_[K<1V3>YKE+$W^_N+URY,7A"9A&K%D]?<77VZ.9S>G%Q?>D;'ETEZ'SRDV>_YRS"U*^XFW68AKWO"__'F MY/7;EX]+COLL*/A?X;]?G?SEU.//[X2?ZU$!Y*/BRRNOO'V506G+IG_E1GD M6TAR]BX7\#ZE85`(/HU^AF@EX+^.*[%C^.GX]9OCMZ]?/N;1BZKQ10MF:4RO MZ9*(:KXKGC:@_RJA*][9$7SH1_C0ZS_#A_ZM M_/E3L*#Q"P*2G(/:>OW8*:M4>N4:[!7-6!J=)[NA[FM[@L_'3E8\HP)M?>=5 MN$V+(-X)?%O3.>Q+NEN+-WKN6YI/)72WEFYI=F''\.,G_F\=X/2QX',0C2KH M4);!P(E/";M;EEV7GH:=Q M;$NIOLS2M0V*LB72<=G?XD5=NFPY#D!3C8Y81G,QVT_JN'9=+)NT!+B.N0(X M3S0Y_G+SXC]!@Z1+$I8Z))-*?WO5%+X+1Z>6/<8^NZ0&J55(I4-^!:W_]UR6&0W1599&6VL[I)9V;(9,D'M62"7JG2EV M^'0V:"-5<)F@:YI3WHIWLR0ZX[CB=`-$/G_:= M>-.Q]DE8:9(@B4C4Z!(JE0]DJFZ"F.:?@^QW6K!D)3_S#7@`1M-ID'=I,$=AM\VD5M@[#6T1]OE6R1.A0*1&CH-1 MLX<@BV[Y5PQK@9Z,2^8HX;79TA%`PQ`5JCXKA`P!H<,Z\7Q"+C(6%C02]+MF MJ[LBU\^`1G%G,YT%Z'I&,\AZ)X0E0(4356J4-D/JX#`9/P=9%B2%<>+IR;@T M&4IX;9/1$?#.$!.J/BVNMHN8A?$3N`LNU`T-MQDK&,W/'\-XRX%_X!UVFJXWVT)L8LR7YT&6<$S2SN$0T$TK#*AZ_/I,DWN MN3@W=.?_W++B29HS)`[LZ38OTC7-3J'K$K'1DR;7+#<3:53+):4LJ]`FUX@* M&IK9X1RP$6GP;,?5G#+/LA(=ZHWHX.&> M'=#AP5M+C8`>J=4.N[DS"\-TR^?H:QI2/FOS&=K.J$U5=K;Q,[E"]3:0M:9W MMNT$=[#"*/5)4\!^;9Z&<6=IN(7SO%D2G?.%2?$$H;#96D8P+'(1_**JKYV> M,YY-J49-,1LE'.R:@+1/K$J5KSNY]R:424M[GU-I3L.7J_3^5429G$7YO_0G M3_[3;Q+%-5V)8[FD@+CK7JWU8BXH-082&*23\4Z8$6"#TRQ)B496A,'[H\6I ML'CQ11+1QW_0)VWE!G)NB:&!V65&3P@1-=3(--PHA8F0)ES]*F'T"=(10,4&% M3$L)*61!J87?+TA!"11HW, M1)9:@P@5CPPIC>$UW:09Q"#+2^3ZY9=&W/$:U@BZMY15RB)BCQ&@ED1_A`W7 M4J.\^4_*DCRR2;#YE,^CJS33[X#TI-QR1PFQ2YF.""*FJ'!I=CZ$**ED/9J7 M=+U.$W%.+T_>Y]M")/?@M-6/"*.28U-C48&>P3%H("*3!4S=KIK0E`'!1V5` M!6EI^]Q^D3Z]7/%_X+^I9C*#K.MM&"W<_E;,0!`%D\;0:;=DRJ57N3,C5/RS M!A:"=IQI2?IAS`"JFB^U&$*V]+&-<44LT_?.E.=$FI9WX.?+#RP)DI#Q$9#F MS'#^/$W5;>RI?66Z0:CC>MZYMP/8P4W-.N%!NB2U,JFTR:^5/I(PZ%F>TR(? MH6%?R.GE`B7`SGV`C@0:$BEA#3:AA1`F*I1+0RM&#&3=$T,#=\B/GB`RFJC1 MZ?:C`T2L.0URR+D`_P>!T_=!S!'FL^(TR+(G[N.+'(.:NEOJ.@T6G5*=3L2H MC2(:UDU!.V`A5Q+7+D+X%]JHXR#D,$SQDA;ER-&-0:.*4Z-F`;YCVPSR:,AF M`5(;*YK5.DV$*>M$U,0;K*Q(?$D%XD]WR`IMD3'ZV:!NN* MN$VR-P37S:K7_!T-OQ2@AGGS2A$<')@7=S3KN*B:JJD$7?)!#[3-BJ$4&FYH MH0TNOH(@"1$N!6QXXI$BH^SP1XRBE5UYO-DTQ!`IFE$2@\^<&YH53W"I6USP MX&L&D6)//[.855S2Q@9\FT4F>336Q@+D()5+J2)=G$I>>.4X6-;<]E:O;B]Y M7QMMTY0"_-S&MZV8^HK^F#8:=DZ&;,A&!9L4./AYD10<(^.K"VG-^5"3R54@ M.62:1@]\6:!U'&U4W?K?]I7I^N7C>FAX.`'LT(^O5%'-Q"TO<]0<:F0]>?5F M(Z<41,,C$SJU>X^),Q*XT3'UX7%&#@;MU5TR9FJEVIRRU45C;28"[E.RI2Y&?6$?!X9JP*JCPJXD&@X9 MX6F/!S=2&@UYLBV-AJ-!7V6=O&,*F6'W6*06QD0D(T(%ET`>GRTZHTO*@4=E M?CA-=0=2+JFC@=@F3$\$#4W4N`:QQ:44KI>)WI<'R!?)N3A4AH??\I$8EQ$= MEZRQ@M_FD%$!#:-L4/;Y5>ET`P1"4R@![J"!*@4O7WG(%P#TU[CL5#PDXC>" M5^3E5\JCH:4%R#XK2Y5Z2D2RX#L--@PV6VB0T_DB9BN1WFW$R1I3N_7BKQLS M@VX)J+&KHT=W%GH(YCWSD=ZH$AIC98MT>)%",]O5H>YAU[KA(&6S;"9EPJMO0N$KX$ MH?G8F?2^/^+\';*]-]#@Z;*]?0'-N#E(M8:9*)J/B'AM+-MX5UGI>PB$IOOA M2DFWL?]:J-V0_X$8&J[IL0T#_"N?,)<)NS9!1NY!@?SAYJ_U5BZ@`8+1:?Q(M85Z02.C&JAX:\UU$$H2:W(Z[?V2!)M-EFXR!D?,FM884W)[$\JF`MW;3R8--)2S@JF(7-JN MM[$(#XCHDH4,R6G'?OS;@SK/7^-*Z7`K)%R[4WNMDWIC*V\%M?\1U>IH+'I_ M?$=/HX;IOL7(9JE2!Q='+=&.;JL*7Q4O&V=5KJ4/:7:6;A?%[90"T'@;NZ`>.!]U%JYEFI&H+(4$JL1=Y;$2#DI/OM*&Y1+; MM&MK2"ZJW=-LD>9TVG3_;>QL7@79/!/Y@".Q#7)%,W&7SFJC3J_L;_]SK$+Z M+5&=)AJ+.`FN_<8I1EK*9QAF]7::58L,E?S14% MVHEWSJ90KE+P3;$Z$CH>6\:M3P1#J;&=4@CI%DEG-IEUQ()])!M8RSJ%;:*[GT\Z=& M%"^IC#.GDE!(I\VQ=_;L5+S2:N2")NH7]B:`M&(9NHB'"[BF3.L7D4:VV;32 M;M,:&B%W,QDJ1='0RHQOF*\0I$GS?!6VAZIN@ICF9;(&R+V8ZW,'JT6=;M4: MP'8V:15R:`AD`*?(#1QMPP)7EHSZZ09S`I6AF-L930VR.XMU9=`P1`-L.%M) M,5ST$(DVVQS7&Q2UJ/-$J!JP@SRH/3DT=#&`&UY/NZ=Q*C*,XV)-B5S_?$_U M9[=A<5U0W0`X^3=LH&0Y81V;/CJ0/WT,!5>5^M,3P\48'4<>=$*5/(OD_ MYJ]V9-P;&*.GVA+`->.HH&FR@9040<6,CUF:YWR9M60Z<]*1<,D*!;0V)UI_ MQL6((;`^'X0$60?9BB')A7!-<\K;#-Y$:;G(YX\;FN0Z@S&BX_@EFW'XO<=K M]`K89B$;L(J7:H2.B`..6JL>*M5PT.Z&BM#ZCS2A61#S^LVB-4L8;!`6[)Z: M^6>K[#9!VI0*=9.FV6ABH^8DU(-X2UBR'X$=_)U"MH8CLI+E"-(&G9)P\?9C MP))/W(;/DS.6;])!WYEJ3@AM._B@YF=`5!'@8YU\+ ML(,9F>M`!MQ(:'`&E*4*2 M]>J2%J-&J"?CDCU*>&W*=`1PF1P5M#XUN`R)^9]QD*&!^X'W@DSPMN7TGM>& M\(IF[X.`&!1C.^9`Y6]'*[7M!LOAR$W8E*:UIM8AE.WZ_8I7J=!RVF%("& MQ[N@'CQY499Q',A"%$&5>&E=1^W-EW),BVRYI^>O8/>>)I;B] M_+Q3%;LWHB<5@8;>N^$>7IJN(CO3)>FHDS+VTR[B$X]O]P9-#ZEQX7;MQ!I$ M1:/[@,60MN%#*F*UQ$L<,L])]#_;7.3NY369+V^#1^X>L#3B>AEDL#^C\O]' MS(R+#SM?SSIIR,'*^*!?13.ZG%55O4P/.[9R!1O0W\$P_OX=[H'\)>%UC.$6 MV_]-8_!?FOWV5DME+.=_.N/_F:QD(U5--K$WGO\Y#(-V7XUF,U2?^RWT`W1/ M%>P/RZ;8]FB$4R&6W%,Y[DE>?^"(!)6A.%ZFV7$>8'DO6-=NT$37-(R#/&=+ M%HJE>&/28*T^FY]><*OW,Z\AC=*'A"]VZOKN.'[W]5$,HWB_#6@SEO?S1?0C M>J_5')RST#Q_!WG#.L63H"Y?9!J#P4XAO5AI`K@!2%`YUHIFJRJ^QRRH>_^* MXVN\AVBBWLW??7X"UT'"82JGN&3<:>.X?+N$]O#&4?4W)J/JTJT#&$1@TT=+*" M.3!.+27P@%FM9A'(_O7<.'!T1-L-U+REF?DRC!UFFZL'\$0/S8HG$1("FI-F0?9TL=X$+!-2H^VV0XE^[LWL M7'4UQR<7A\9*/;\.PYN+8@GH`FZ^^*C([[AQ.RYHMFZ=R"!9\HB@ ML/XLFN@)D[B M*SU<]PQA3"6\["=Q[G&6/N@8I1)T&^VL`]H-:.Y+H6&1%MHPH6$I2!Y`\A@. MHY#8H.JV"!#<[L9.1]+'91T%5-4]G988&L;HL6F-3E1EO\?S:E$_=*FU(U(^ M3SJ>7M6Z`,?W+R96K'?UPE(;#1\G0Q[L+W,_;46Y:X5DAVI8H>%;8M9MH5+U M2T=]9UN8]*Z\VG(NE_GPI\WZ?EYL`UJTR6HY?:EI6 MTTS5D4+P4]>N`GTJOZ^V?CH;0J%IZPCW)I%]Y+JF9:<4@/-.@HKP]MJX;G=- MQJU*-*(*:D9X`T%35QFCM(?K-<:"$%#9HJ(6E#:4@N;8$WJ5R;2I/T4=#XAU`*Y/IRY!O1;(*',0= M>EK7'&K&0N[\P/"S=M#Z:GZ=9G4ES#YR5P?_"902[W`Q)\7!-\AJ!>$SX"#@ M<)Q=E9'V5[PBQ2R)SJM@>^N1:BC!K]TTH<\QW M+ZZ"I_*.XRSDR#(JCC4F5@0VX[L;_`&U.;*[()<^`69. MVSOPSUX!8%V:/6])]E7L,NAQC^XRX%V(:>KZ@25!$NYAE\%8$`(J6U34@M*& M4M"X&CM#']ME6%8EH"/W-=V4$]%\^2E-5KLAFZEIU1"8W1MD:H\B$VU MLI-[N:6V/)`#?7D!5!#T(H2OPJ MW.MI==&ZW)NR6+)X(M^5_O?WB'T4:`HQ;>5WL!Z^#V*8B]1)V34-.JT(I]E, M=ZA<)U7I!'U<)-\!N8K2K!0EWT6E\/>PGA1,!\,O_H4V'_"4&T==VQD?YUGV MQ$?=3T&L#A*S4G3\G,E&=-)-$63%]![605$2"@BSHBB407R-VO@2> M;[-GWWKHV?/$N+:8!GQ:OU+^!ZL>=9CU9;O9Q"+=;!!7&6HODF6:K64*\Y'L MP;;:3O/"3*M2)U&,G2J:]<4TO(,#]Y8V).\*XS3?9G*)46WR\.FF+@X'8ZO< MW%W^DJ6T36,6==S16131OO6: MI.F"*3M4!9@S0/DZA[`[FH/K('[:YBRA M>7Y&\S!C&]$6251>=Q;O!\4LY,/MECX6[V/]4=N!O^DTV:&+YNND33SD![T/ M/)>U[`_9ST$2K(2?_,><-&\-@3M1GHF74?C=X7Q,N-M"R6L*$RQ.A@.X]JWZ-QLR[0=XGJXQF52N, MEE=CY@Q.R2![>XM8I:EZ@X-6URS_/>>6^@OOR:P(6&(13#FBXS3,S`9^)Z[, MI("&9C8H!VG]04=,E!TM=(;L%'H5KN'#Q`V@S^JM_3&;9J?J]D%4^\IT7SD= MUT/#Q@E@^Z3\Q_DO9'9Z.O]R>7MQ^9%#U^4_GEU_.^?^?SC]> M7MQ>S"\KP_CV0.O^.H%C@UZUX%2*.5O1&T#6RW>%C'>JC`#3Y_AO1'%8)T4= MQJR26<7+(Q&65L@D[YU2$T#JZ57:E/\XD$UI((FPV?J1DVL:0Y"XR&JL&BEV M>LZLSI1JU&;(1LD[B:8B'5RX;L(.YK#GT'K'IM0F0AV'\;*I:/.:3WT-)V';U+!;LKZBDE>&?VLV";6!T,6%T: MXC\?T!"7U\5X#S:F1M:Q$QZ2.Z'BGV42@*F+QJ5RH"GM9 M*5>D^@&'?10`[](XHED.8?'%$Z"S-XT3])V&BD^M5B=8W%;9.TEW13Q@Z_SS MY_DEN;F=G_Z#S"[/R,^SZ^O9Y>W-WMBJ,8%0>'Z;E@&A05R?6^M.4JRUG!E` M^RK4]F])AK&3X-K%A.&@Y"?&'96(NRKV MSJ99Q6V8^3CX;KRY7AX-U2Q`]@GV,86+-N*8.T-RC;`3WFAGX,PJCJ,B1L'W MHB&T\FAX90%2D\5)%;&*@V7]<#8[HHUJ^0PPM*#;B`H:QMGA'`\YQ,&U\IFB M:QJFJX39FS4+/;>)[2RKT\#WX+JG\GN?X]-K+/ MN%L20=6X<])DASY_#.-M1"-(T`M.R%9>MAVVCOTXV-^'_`R1?3>4>O3LZRL( M!]:>JS9X[9H7?UR5O\<'TL9N]8Q[(5I1][=[1CP/C9QW,EF`TU_%P.EDU/A. M(?]14DST*L;4_=A(NTJI+9]9USL%=P2LI^6^'`*-?1(V<]'?D!@W5G9ZSBS7 ME&K49LQ&R3NAIB*UOO^`T]Z=KS=Q^D3YS)_=LY"J]\MFL<`BYO]R)_A?-)+I MP<4UD0G+KGU_S]/"[##-IEFZ[?=CWH>8JQH.AB;$DY9;N+3\(KQ.THQ1"BD0 M9\B0QO&/+ZP0NQMRG\--\6 M>1$D$7?G)[HY[@'Y&>:^&EYM!URC06@H/#7!()&@+*W*Q2O3FV[27"8^/9#K MV(2]Y7706YUS^!*V^&&)?4:+@,5&7W+'@IPYE\^J:.UM[E2*=\H_&[H^6+*= M/Z\NC=3%D;(\)),?S-7P!AF-SK89!(C*=TY@<.>7]$'\2??ZEJVR\[L[UA4: M7-P9U?3.W)W@#G;HM^L%S2`Z+A?R@_?CF"@8-4?%`>R.%.WK(F"HNCH6!.TJ M8N>G$JWR78F,AI3;RTB^="AI"6_9'Y$%7:89;1X_#/&D`KFJ7R"MZP\051EI M[%1\/%%O`J]ZCUXECX:'%B"5"UB4]#J-@YS7I`PTF6?7;'572&/.ZU(7M? M5EGY\T>:A2RG5QF#)W:?,QY&B_(^""PK.\K\D7)PT]T.O.X1#%IJDPVH'\&; M?)+X>#F>%V=\M0GQ`S_?L?"N7^&R/6"W94(S3BG4-^^G-\#8"+`O$?58F%R- M018^KBZ][P$G$,9K$(MK&N1I\B'-P->'K>;T,DVJ@ZA)<_Y82;Y- MGV551V=\^?I\["9.R]Q=XH7X_(#'"KV8<8OS@S$-7_'[8R<"9G'O;++' M:!'7O*?-?`UGVA#Y.HYF;7^<\ MO$C"=$T!MM[8@R:1DY)@NX MIB`,>20O*C@8D6JV1+ MT`L[!D"5#*FE\+&D#\W`%!`E0M9(EP,V^S-O"[U_4A

V3*_CO@YWY[@\W] M<%%9U?6L^G96HT-^!2TD-NF9[3);0XZYP[1Y5;9+R[?7YMCC8),%H[&O^ZS- MR*5&<0)YL'3J,2\RE3%ZUS2GO#GOX-XSO:=QNA$!KJN,B@G"8N_F6<4Y3+_^ M[$JWTK+O7)9W+N^I`L.3\U:)I"I2)'1O%4KJ4@^\FP3'.?`$C7TU5O#O`KPQ@=Y M6_+>F3D!Y'#J;ZD0T#DBC=:ADW*`QYTF$/5JX:K::+E/U3%:A6'6#JV*=R)- MPZE/FM!HXKI%5".\#AX^<_(-EE*4-6(.1I.[Q& M?$F56VKMOSO><"[2(HA-V\U*;%H;?T02>JBE5(-DPBUF"R7WWH'U[>11#>^# M^>7-40]MX(X3A_@ M*AP.3I4):FBDSE)Q+I/+Z(XK+)6=GC1-JE#G*,E*$]T![!34WK(+:2;1,B?) MK$Q),DNBJS(AB<5D.D'9V:0ZN4+UY&JMZ=T([@17F7(N4N6_C[-`U&R2(:N3V%!Z` M;I3]3.&6"XUF?&(-5K1SO_7PK6_^^EK5#D. MI$[O4C8<[*7E?)LV'T(T[@<);65.IMFVN$LSR*7Y!7(H"#]6-IAX%:G3--?0 MTJUF+!NVUYK7=!TPB*8Z31/AN&R#&.YSOC'U*P9TSNT&ADIK[(I_:+CL#IKV M&+5+654`7W[6)8@KI>2[ZIKT]_C-U7X,_05O`9;D+!0)O@X_L?2_]Y6Z(NIF M.Y#ST?T8KF%_P!H.`H16JXRN(,J-5>+D7KSF]BV/U5:ZCX,NW!7?^9K&IK:9 M]CDF!Q_Y9L:BKF;],=B2^Z86[JUZ>5BX6W_]*QV1KA?NEI_^%D?O81?N>TP> M=D'B?T'NI*G'%]\'A8'+3GBI^_X7U=^R*>DN9QQ8 MC,$'OU+#H&FX`XW_WM>^Q6&NKN).*VMT`];J5:S+-+F7C]I``^6W$/79_COD M$[],BU]HT;R9I>F6`W[/Y7`]>+.U1^O!/H9FL!ZZAOVQ^B7):I%N_!3DN^?S M<`P16J1(Y?J\C+AJ"W[CHU>^5_$AS+YCED2P9*"+PQH$D*VG8CCR>D5;_`[ MWB8MR2F7&_;\`8>).P[0,*U4'GLLW?MP.EB55`]EE)HB`+3S%5)^AE3?(6UQ MI+9U"M;R#1>":5[:"2X2PG5_N[.>M*URJFULO_?7D ME9S@;#I2)8JQ'PTXO\%N]),!#E6W[XS?12:X@_4[RT/N[&XS4?6&C-=R'W/P MAJFU$K*^M4<\Z,U:M7SMN1FPU6:O>.GTB`2E2^:C'^M;YPW<0;#-(\+L6"NGWWD$U\<;F,Y2NYH`.'`?L?'HX>K$29@'EW=;RN!7-MI> MNX_[2D7&0DA/`0ZN?"Q3LQ(PR.+JJ'&@P]SK)&@B11):2XHV2Y+?B`/2+Y=O$_-"Q``DZJ8.4`GF,*NYO@3`I< M$!G"1RU)1-`XC'(9%5X5)K[#O\Z]3))O:,B63&Q'BE=Z@YS[H4N6\%]*\=H5 M?4EF<7&7;E=W\#NW%F`Q[H.,!>4GDS1;!W'\Q$M9\C5.!?$(*IQ`;678BJAK M&HR"9XRL4?H$:_TS+PA0,*@_P.:@]_8_*1PDHY.ZXJQEND M;#_^H7]NX3?9`B_)+7RL_1,O,2$+_B'^88BTD46O@^QW6L@WLN"+O*W@YU#N M&E=_EJ&X#PP:I6@W_\LZB\4Z>(+2M[GLUJ`00_&("\/*3T!E(KLINV?_:MHA M%X^#!E$DLUY(5`RZ>,7-,[?6`?_G4ZOO%S3AO5;D7M:)-T%,\\^B37A_?.10 MLB#FRZ-9M(:$=X5<[)2I:#2C?XTC'*[LQ3<9R(I[D- MX/I-WQ+US><6E)$6Q]G4-FWLJ6F%KUH^\GDN/"`^S\1;6.)=I9E89W#GA"VV M!403BY>?Q:V!-([E96`*#HZJ5_93,J(.W7.%E%GWRN+_2.0'CDC]"5)^@[0_ M`BY@]S.D^H[_HJ.`:1!MOQ2P%-SRG-;D93]AC-`U:H] M$42-JT,V#.S)192'D"0@ZJVU.W$.@$O=X@,Q5*VN1Z=XFT;(DE*8@+17JI=` M]$0O!5`UN`J7CN2EG*=&_IC!64N6+IF2V:T_(VI@%:I^\PH9(H6\37VJR`I# MRFZC`J+VM\,YG#E;P2'M1R[/QY-R']*GI&+],;+#J?0OK301]=M$P`._4ZH? MD;(`T9'=(CSWY<>`)7!X/$_.6+XIDVS/E_IM1:/";V_1])P=SH$-A#.9[T#O M>PCT;ZF*X/TLW=",+QT@2V(AUA%B/!X1^4(S+,KG3/;RQR!OY.&'6R8.XZK? M//7W?`.Q`1QH23ME'P^$$(U(/;;!B7@E60TQ7RN0&H@\UP%V&5N]$IDF:8\YRC[0R&+JB#&(@]X0Y\-M#<]S#H1:9O2.(^#S MGV3()>7^_VWPN*\=Z3U_`E'W'ZIFBJM"S7>ZX_B(\"_"?,B_^?5M6W.\&0UR M>D;E_U\DLS"$6S+YM0@9`=0J2MGH(>+))+B*``2A1+ZKU+^'<)2J!-(4@:83 MOR0+%L%)W M-J5@Z]%JDKX*GH3CEP711'^FK8FZ/XV`I_HT92%'1!2#J3LA$\5(7)2-'O:N MU,&U[TB1LL-_H-6P=F=T2;FQB`Q'C]TY><1MQIJ';-RO=(-1;87AM1?^\`NM_1L!4$99"J$+)X(M]! M.;R3OR?-5G!3%IK1W=SC@AK8#>:N#J*^M(9J.50;;=&_GCJM3*2':.(<;I9$]4F-+@C"Z` MRZ?!AA5!?$/YXEK;PU/T$?7Q3K"'(4%5(>`Q03''XCD'*.BH]=]EB>23L.SS M1/?LD1$?-E312;: MB;KXEITX(LT72/,)7\?''+P8,_D=S%3W00S#0:9A[CM!RK/A"?J(Z+`3[,&I MKKC+GDB7CK3*X0Z`*(DHO$$$]XOR?+NFD3*?N4(,4:^9T)DN#I7"OFX5QR+1 M+(W4:=(-`31VFH@Z:"+@P:WE2IW`L``00E#@``!#D!``#M7=USVSB2?[^J M^Q]XV;K:[(-CQY[))-F9VY(E.ZL:1U))RF3S-$63D,0+16A!RK;FKS\`_!#% M#Z!!D0;DFWF8)#8:[.Y?-SX:C<;/_WA:^]8#(J&'@U]>O7US\\MV/U@`[ M9\-@@?]NC>PU^FA]0@$B=H3)WZW?;'_+?H+_=3V]H_^,/_?1NGKSHVN=G0$Z M^PT%+B9?IL.LLU44;3Z>GS\^/KX)\(/]B,GW\(V#8=W-\)8X*.OK\V_#F?7N MOR\'5Q?T?Y<7;Z_>/"THWP,[HK]E_SZ_>']^\6%^7BZ?W%Q=4%_2\F_]GW@N\?V?_N[1!9%(@@_/@4>K^\RLGV>/4&D^7YY<7% MV_-_?;Z;.2NTML^\@`'BH%NEBN[MAP\?SOEOTZ:EED_WQ$^_<76>LI/U M3'_K"=KG.`F]CR%G[PX[=L3M2?H9J[8%^]=9VNR,_>CL[>79U=LW3Z'[*E4^ MUR#!/IJBA<7^I!:2?77M.00_>,S4J&&LS]GOSRE&VS4*HE[@W@21%^T88&3- M^:4R\`Y7!"U^>;6FI&<,^XMW5Q?LJW^!T$:[#761T%MO?*J3\^:,,N-![&OC MQ:T74!5[MC_!H<<^UO?M,/06'G)E+*OUTAKSU[;/C&*V0B@*)S:A#*Q0Y#FV M+V-83MF%AH=TR%LC!64>$G3!TIC*3?IXO2%HA8+0>T#*3,JZZ(+MOAVN;GW\ M&`X#UR/(B13XK:5MC=$Q6=J!]P?WV#X.0NQ[+O\'=>D)02%E@_\SYRT9?Z%, MDE8Z;TW4&YL$=!(/)XC,5M2/9-S7M6^-H5_1KN$M'SF`YHW#PEAJVQP)R:>C0WIRGRJ1&Y M?1Q&X2S"SO?\+V4L*G?4I@AK+TJF4^HN#$FZ\O20U,_DE*TRB0.N#/JMKS8A M-O55;E<_0=B4T;;&Z`@]YAR"X(#^U8E'%O[%]S)NP1VT-VELUVN;[,:+F4?] M=4&G>`KHH5-32-,_I=-(H]Y:U']TA\-L\)S;][Z<9R%1^\,5C*F:YNW!SD0] MNZ:+>C<_OL"8`Q&WQNIG.["7L0]D$W4R=0?+$7/HB*ZI!BBR/5_*>J/.NK)/ M(,]BJJZ8HT/Z`R*11S&=(6=+Z%R.0CJ$CC<,Z_#FR?&W+G*;R="L\Q8G%-^W M[W$,]I2N"6WBK.CG!W3QXN,-G]26!''K``IX1)DX`-5`W'=MSU7*]J MOHK==+!%"8L[C9[+8N9HLJ5C+>4KUU)]R&OQ(QUO?)K(!N]%Q/PF%S^YHS\X M($%/$0KF._>1W$9^]^Y!.E/L@&5T$()]W_SNCA9&>-V$VT2R/UX?(>;/$#^#B)V05'!.FU:W+#*:-X@><2Q, M7$0H6FF?=!%T8`;E`X:DQ?F&!YG/G)7G9Q:T('BMJLI$;5@B2%Z[E(5GAZ#/ MUU?^D#K,TZ]H)\*@U!0(PEOS4*B16@<,J1QSVFVU]@];`)5^:9+2JV34J6NZ M^_,PE:`K5_9:+V*Z76`4./'1I="Q_6_()D+#KV\-!.%'DT"0R:YOXOV*?/_7`#\&,V2'.$#N,`RW MB(@FX%H2(#+O3$(&I`5]\/R&_2W5(-G=>C[==8E@*34%PO&3>7#42*UQ>1K[ M[Q1M,&$[X3B'2KA*K:$`@O+>/%#$.M"'#;>1/AU,E[DS[2I("@V!2'PP#XE* MB34ZQSZ>PF-BX7@;\\#(G7X;?T9S4#F:`Y M%!RC]MQ2\?5CPI:&8$1RC:%X&+D=KQ&]`HV?SRO#KEW&9!535;/H[*5U9F6T M]._[U#OD6DDZJ17GDS8*S>9M;6&']QRW;7BVM.U-;'#(C\+T)T7+2W[\NT@Z M020W(8=1'^U*S<7KA2'5KUR08CM=85TEO1[Z4XTD[0]LQZ*1+".AH)2::XOV MM@5.C0+,P(@E.[,#/_K'S;^WWH/M\R/`J&\3LJ/+%WYII!XS(+FVX/'Q&"HI MR`Q,DX3#<(H<1!F^]]$(18D5"MQ/2*4M`-V"%P+4809P>P[#.QPLYXBLV4D\ MDRTFUA[>/!5%.1&;#N\YZ0P/\.6VD+>A\/496X9@#! M;R(=3,KU<%2UU1;O/AZ4>M'-@`:(2C-`VH]XM[PVK,""BK)`])?N7:R$6H8Y MMQ&.;)^WU(HB'7\WB$2[B6_'T0&Z8N*IO\*13TRE+8!^/,80=9CA?E-$!?$< M=N^JL<@/.)19;`_%RL0-O%@'QN!$MG2P+YF5$*HZ$BA: M1N[N99HP`[!!,CTG14OJ82HUA()CXK:\1FHS(+FFVPQ6`&<8T-T'"L/Q@E5" MD?J1A`P*EXD;;I!&S``OO5M(UT-3;[F*))EQ"9F8"GQV:B!T$'V8@5S?WGAL M]X'L$(WO?6\9W[J6^IV,#HJ>B;MKF$[,P(]7T6`%,^[E8V556RA.)FZ_ZV4W M`QN5]>`1"\%+$Y,/0"O`DPR3U(P.D$@D@!2*N8F!$;!FS'#/_7(XB/KT3R^" M8"BF@L)G8E0$H@\SD,L-+J`1%8Z+B1&0"FE/?@RMK[HB&#U%1%"`3=R7`[1A MAM^58]W#(#DIG+"[_39BH;HY9N,'2U+#?",[#")$40'$G=O^#M0X M3(P"=*-S,^QIDHY=7$A)RG5E8VAZKHG;3('T9L"3N]XG2X^XP2%;=.:8%IPX`6BAR)NXZX;HQ`\LI*\$6(#>M_OXEL#<; M@C?$8]?GZG&4T4$Q-'$7"=.)&?BU,SEWO1""VX.)V])V=7SJ.R=9\DGSY!RX ME1B^21;JI57\-5S3!CS0DUW-OH)?S;9>'_3UMS^O:K^(R\$&.NH)W`WN^3Y^ M9,YQB\D`;^^CQ=8O7Z:4I_BH=:/[OK<8&'R,:":!VR2OM85,5A/WN4JIJVJS MY0,B]SA$^M=+AT$6.LF-"=>8RW?VQ=>V9%&G>GK]]\2E6(JB3S+%F.&[ASS' M):=ZVVB%B?>':+LLH]-_+_PH\.H482YHO.JD(F`IC?X;XBV`=:@`,X#*1'C(:3< M9YUH39*:.SR(/A8I6":SW@*&A7>6LX#8#Z*`V/XQ8`LOK/T#5!I#8;$<&6/R MC6HM@ M:EC426H&#OP>?]YVT!TX4--]4;)3/PME MU^'&"S["SK`O7#@7&NJ.(:B.895RGGYP-AV<$\-DZ"9XX0F\[Z"1[GB#&F@5\ITZ9-7O MC"G/ZS.$,]C^X0"1&R?"MMSUU[`WS1EC_A*,8?2 M:R]AI[C'5E++Z9O!)]L+[N@X-@X&7KA)SO?'"UF5-0F9]AIXBB,Y1`GJ6'^( ML0[0D@4"]6.=Q!Z#96+%`GPKFFHOJ*<8$*@3]M3GZ$RP6!_,;@$XYAM#D30E MM%,O\,ECR:)6(QS@@K%*8G65%-I+'S8(V`E$/_WA=H0BB(L6FFFO?Z@&8Z60 MI^Z6>XENJ7;BB]-;:J+[P[L)(M=VZ#F2[!7ECK37Z%-#OZ&BS`C(?T6LA!9R M>W0Q;B_1:+N^1V2\*!U'<_[K,5;L1GOE.#6$&RG)N(-[/MGT\9I^844G&;J1 MJSO*_Q%^E'_0G\7'/R-NM\2B\8H/)8&5+KK`.GJI,^PS)-:K(*4X[^I>U%9) M]&![/KN_<8OY22TOLQ;?K'/_=QM&R4,>X\7W M=22V5;Y):!,^RR+\Y_8YV]39,&@G.B$SBW!] M+W;KX\=P2'>N!.4TF>T"WRGL`FEO%N_.C-U?)IW25J^"2N^^CC$T83!2E*]W M7T)$Q]SL(*#G1-Y#/$!+A6S2ESD[Q%HTR]O!AAHS8];H-E9N%E"F[MOW*X]P MCNFRA,X''G_;>\_P'+?FE]U\S:"].=0BNE2[&88U0!0&Q^,@U!O$82O=6]Q. M42G6QRZKQPS@>FNV4/S#CM-AB@]Z"GQ;0J=[(_B,X,)4:`;<6G/!.MM6/2/8 MSY)'-D?$K,3!8?"`$@5G#_SRB,=\90=SM-Y@8I/=<+VQ/<);04RI0:>Z[VQH M,;3&RC=CR.'GR-J&60;94#,A;JC!J$RY%=6`5-5IZB3:Q?P)8 M4L4'0`JUABZKQ+1M#37Z>8FF<.TE^84W3PX*P_$BKGV4OLJF8AK2KDRX:]>V MJ0#U=_JF`T]I:R/Y3R%UR%AC4=?8J5_4KI$X/A1M)U%4V!?49DS*-VNN,S/" MW)1Q!R&7WSAGMS7&B_K[&_5HJ_4"Q;FSR-81H!4?#5'7GAFXEX?'*96=>$Z$ M7*8;E95#D1**;V?!JM;PA6KI](.894NF/Z%37;2;^'80]0*7/43`B_>I#`." M3J!6TEG@JL-10*H[,P:!B;U+#O)[#N60(!YX:P*\:D=0\#L+3;4'?C,=GOZ( M`==@&ZM$N,ET%K=JS634-?="=Q;)4YBM["R$?4%MI\,7?=K:60!T9L;D,D6; M9&@<+^YPL)PCLAZ@>S8:)AMPR,Y"K1?P/9=G'B,@H!7K)JMK[_3GE/Q*BCTV MQAXO9C&Y['4KV-JSAA1J'9VE6[5F'6`]F3$4P.6N*GK7QE10W2_4(#H+.+5F M$.UH^-27&4P%?(`,5VS!_4#W8NRHN++(2+U5J?4"M:$.WY167EHTT=/+M(T> M=1M"=M0;^'.QJD91(H=:0X>/5+=D#36::6P&&VY=E#T2_?\PAM\OX>;P'%5P M6C4')EPK!G$3&+#LG&TW&Y^KR?93-0V#!2;K&"EY[1=H!U"#Z/"A9F6#4-2. M&4O.M.+2Q/8$3\X=MH*"T]T+S8J:+AY6E$4V`XSD#M<^P!6XVM&6O1$>9^VZU]MHA*-O2.*!\!Z@L':W>U?& MJ#BQJBG+#(AS.96],-RND?NV'LW*QE#@NMME'PF<0`4M)X9I*.4W)DL[2$JJ M[`OS,6@"=Y+[U'B1Z,SV]R7[,C5DM?Y^LLZL@1I]N/M^, MYG^=6;-Y;\[_;O5&`VLR'8[ZP\G=SO/A>$0)J4,@ZVVC M,H!K*B2WYXMW5Q? M;T,O0&$X0*%#O$T">))=SXM:^IY##7Y.+>K:%T9>._ZLMK)T*JA7CAO/@H<9 MKT.D";,31`[?)LD&AO?%@6%T,[?NQK.9-;F96K-_]J8WJ=-?:JS]611$OC*M MI]`X%!29`KBQ@$1W94@9*`6_DPIOAL_\BG8%_]Z=)5<66%V-9<`+7ITQE[@J M^].'HC_]>O/-ZO7[XR^C^7#TR9K0N;3_C?Y\>O/;S>C+#?VS/_XT&N9GURN- MCC;UPN\A'>*^!`XBD>T%L--_"9G>9](=%$3QD0IC;CZ;?4I7YH<\&:<;+_9LWJM+*E"26KE)Q` M3*5U(2B`HJX$E?&&GJ]X-D4^2P%AUY]"GD%060XMOHCK7ZGPKD MQ8K`[6C4&)]=>[S\&G_/@J\=4>#DL\`R)[TL.BEUS,_#.8N_S'@`IC_F:\6; M47]X,TL]]5V;GKIG-RSRN^E]O47.,6AQJ-:/5D\]"O+R M\RL-%&B.IR;9>)3WKS8A-A6#;^=^*OOJ596OTNES-A_W?^7.^K4WG?:8YR9^ M^E/;?EIFEO,JV).E<$LI=9[M,\Y6V*<6'[)\AFC'>%-R/X4N=&W0P$A4G_"K MZL@,#QNAQUP`A>"`_M6)#R:XF[TON]D/Y2CDUX.HR70\HG_OW\239.)J[]MT M-=9C.,<5IRD23X,0:GV7(HMS+QEP)_?HRO4TNE%^F?9,7\L;2CC#MFC8+DNK7V?5MJ9 M]3K]V]_^]%.YGR:'3\70<_Q_P&P(I3])3U13CBD9&G3*=NFDK;2H$5-IW4$T M1@^B"3,P.S@.!KN>F$K;:UU'80;1A!F8%8\5P;!)";4]SW44^6`5 M#!^`5-L37$C,#^%O;(_S6R6=DLSF=":VX:%7H0MO#5T>!K*PC,[:-(Q2Q%V.R3)W#EP&R MW>&[4M@&118CM"BEQ4FMUS%QNWO`*O9DVS\QCA8 M,/#\+7L4CY=6!@1&FW:H=6\(P;0XA!ZG.3.&T;T0/3K>NXQA.NKORTC$+]XA MEQ458#/%-DW\;I!,V,6W].Y)C[*:MA5NQN"=9;K4#=NERP`912>C=8$?R3A= MV]H(%\VX2Q[(4!^293WH'(,E2-7Z$4PK9G@']]RSTKJ[SE=*^?$Y>BO?02>N MPS]V7\VKQ(]@I$8XU?`<5+TQZOF<%SX0)UOC/Y`;%\?@N4)J M"Z.V/ZG3;56LI'X%U0T(IJVQ:N1BA_)+OCN[WI62SGJ/-G'CC7GX&PKI>I*5 MCGS:(%9O=H[9C\;;*(SL@#U,K#XE/#]/6M=LK9BK+AS-F,0^VX$=BQEFH8CL M[NR(I9BP)>T`1;;G5TQJI4LJ^_[^&EI9C];KK$\KZ_1OUNNDWU9G.B6))%-? MP[YT9T.QBG'('=!=2+",AU1NP72/\\A_):BX!J77.4L=A7!59A187X;,0=4\ M\^A@`N%I=9B`\R4J#9LRS"I!U]QX2,C&5UM/C-O&$*,<,&/N^ MS9X<2C(UQV3J+5?1:+N^1X0RGX6)^C9[.?=ZEV9T)@T%2!_=L=8#Z3:-H245 M&VPO-T^(.%Z()L1C-6"/-!)I;UI/NCNW#*`RS36',!I0O;"`\M>5YZR*`B3R MB=^N/[9?K:?D79N(NH*/-9::?4SR9587?!A\0S:IN_%8U5#K&7L,B'/[U2:?9;2&J=*,0$KA_+`N8G)9 MJC!0E>G015RDFD&U7(=V(ATU#.8_1%=PK';YGK+`5TU;@](.`,.;4&`S1C@J MU#"@-HX8K_5C5Z&920?YL.&G4DZ=C\("?&2``KRFPRW,2PY:Z\U'/LI1*J0V MPU6^(C9E(;='T:?38K8'Y9'$W&D`3RBJ=R7%;O0F)C=QM49Z,@/B_1`19_24 M']J@JN!\']3(JWQB4ZTCO3FK36!NJ"LC%W.4>VJLD7>??^ZU%Z0G@&F:5^V: MKU1,IVK-E_N(M?^*19W!2KYCI1_JZ.3L**G5%I)-^]9ZZI)L<>;BZ$JQGF MQ5[OJCOH/7D".#O]Z`G91:=ZR&WAC+.OD;U&`[RVO4#52/*49B#]#!X$,IN\ M9O91%)W;K3A2^!FQ[8-@.W783'>A8ZC!%O=,5<*:L2W"Y(4I"XL>2>L7^.TN@P[5:49XHH]]BBN.S]>H12/*$'O2;X`>D(\W/$-Y21!73VU0 MHEP\--^KE7;+`Q"YCJVLYVZ"$`UDDQ8P/*+'-H/W++&`5:B%LU,C49..]!8N M/!K3_'%`4((R84Q(SQ:YC/E4A8>E5.:`1?4(*4`%L4S(L:9CN$E M=F4Q&RFA[MT[U#*+N,$4TM4R/RX:&TZ1@[P'-C[`@>$K6SB]M@2MAO@HBF=2 MN*W$Y`01]@-[B00/(8NI=+L7.#@&$=Z,3=6^,@Q>;W#`DLYKMU&E1P#V98GV MU-ULFNK9A%8K$A":\-[;U'[\3(V+>+8O6.[5-#>B))$4F;KWWJI$-V,,RUB\ M]0(O7"'W$\8N!)Y">S->X&L,4*7TAB$T0H*SF<-66F]L'X]&3M+&F?01CFR_ MD$>O<_*1A_!*[USD2N)U';&K91,Z]Q@9D\NX^TJ\"`WPHV#?6M76B$E',0I7 M+[-APQFKHA$O'JE2R8/H@J.(QHR)IRE(M4HP8^G,,QW*A0IS);"J&[""5D&( MKG?9=F*\V*?OUXZ`I5K.N>X+A0Y3%JSQHKY5PH9UOU8Z&DXY1Z7R M8F)UR&HI'M6E"?'WTSL8:0/&/P])#`O!&WQ($M]\VC.8U+D4GX\(B4X(%Z$< M9IR*U+`H.Q*1D)F!$<#V8("U=`Y2FUH0\@R/@`^RR3,UPMBYD$)WN!5D4?E0 M.4#^CLXPXB]/"':W*HJO)M"=J=U0[R+IS=A>5:<[)0MA0,*VG%AW^K82="J" M=>H],]M'X6>;?$?LZN_U/Z0QF*]L'Z)W"%C1OQE31HGB%&CD'54N?Q=S$#&B-UAMD MA1"8#++-4@PTKKG4VT8K3-CS*U_HU$AXN#26E3\8>B#5E"DIIX%$)P5%3!%; M#])?ISOVS(IZ7$MLU@4&MA^ZMV+8)6C3.]MMQ^"&5TPM"S^&/!SS+2%S\ MI-;2?0:-O=50O`R+RQ69[GJ)6?$IK>6]=5M8K>I?G&7I66."&=!:\=`@*SSU M-699Z'MEH>L6&H+\?"W,:*W&WLW:\5G@>W'V>[@X>1XS+7T3:(WO7[HUUH!A M2&Y>]2/"\CQCA>>$NTX[KDZP4LQ!5NW$A#2KEY(+]V>)@#^SWUH[,&6#\)Q^ M15*D];#9">F^P+D9.6W2#4=8M^/8BT.G:-\.(,53N_F:&390:;^JV[M&\AM1 M=`3*H$ MDW:EF5TA\N`YJ%H_(U;1GS]#SY00SMFMR?SO6=[C"$??4#1%#EX&[!0(X-#M M?U+[@`!-<^I<[2_?4`D1),M<594&[F6\LC)AW*1Q8R:I]D=?,EZG7S+2C]V MT+[[(HPMZ$!:H;'5;V@]&W?1^YU[M4'TE#U7?I53K6FK'8BA6TI%N##>4@K2C[95/KD/:F]=7B[DP" MJ$5S[2",V-L:[$V5?#8-O MR"95SLU:5C74FI1Y'#9U(IGNDM$4V2$.;C%ABP^ZE)SC$0Y0$A94'9EEG6G- M8.QN8(;I4"GHD?R&_8_ET]"?_!]02P,$%`````@`G88)0VN`7Z"D"@``7%H` M`!$`'`!M=FES+3(P,3,P-C,P+GAS9%54"0`#J58%4JE6!5)U>`L``00E#@`` M!#D!``#M7%MSXC@6?MZMVO^@I6IK,K5%N'72"9/,%"$DS7;`%*:O+U/&%D0; MVZ(E.X'Y]7LD7S"V!88DU=22?N@VUKE_1YYC&X(MJTFNJ9FN>M.Z&^H;SBX MB6ZQBYGA4?8;^FS8OGA#OUX-[^!G(+^)&LGIV*6/QA-E#_S8I,7$Z=1G)HYE]3YW=73ZK_IUHPI_U:NUQO%\`G9? M&QZTBM^5ZEFE>CZJUILG[YOULX):/,/S>:RE.C^K5AM5^%.,O4>X&3/_^P>? M\??S(?DZU=PS_^;[AWE/,^H??HPUZ^EDML#?[2OOR_?SL>G\^&O1^V_+^OZ] MOG#_X[FUV^G0[`X9HK])87,R2) M3RI!XPHIR24]#4A)1.KS\M0P9C'MQ.!C21LV5$0*E*NU1+!D<8C(* M+Z"?0J]R)'GUM"'&`QL[V/5N*'.N\<3P;8#CAV_89$*P54*>P:;8$QG,9X:) M-PN,>H+ANA0Z#+2';\2[V8Q`CX`7?[L0J=,4D1V!_4@\P'"@%"_:*]"C?&%K MR[4ZKD>\A>A>S)%*2HA8EZ6U%$(M&"$56WA"7"*M@PY<0V44L28?#=="@1R4 M$'1128M("/8YMC3W=_D\8YB#&,ET!R]"QI!$P60:MNG;V_$L3WJN#>*QQT=K0C]]5!Q2.1Z M%Q97#LYT@?"U.NKOUD4];N"(3I`V$\LPX#O8O$\$5H/D8VWJ@(?WV.7D$2L0 M4!*J,3DICLF*8'1'^1LVVJ1M\/L;FS[QKFL1ADTO`TJ60HW&Z19H@%@DY1XJ M"AJ;&B[Y2YJV#!3\@'71(.%J8G)>AC"`Z7DBU#B^%^LKJ(1LRGV&X4>OU6_= M=GJ=_N@7'>FCUD@^HU;_&@V&W7Z[.[CKZ$B[06VMKVMWW>O6J*M!_8/ZU,.H M=J@0=PSF0A7/!YCI]S`-!ZAEWJJ!.$L#T>^,T)VFZVC0&2+]0VO8B8)#SN?._U/'?BWK=WVN\FNT3A4U+HNQ-NC;!%`LORI MC'>MFHYWMP]Q'6G#;U$TWQUJ-,7:!A8VTK0AML5\VZ;HZ%J5X>_ MG@X_A+S7'8EI69?S,LS$8A3JP.0,4W.(P>DA8T!=F=\0Y"\&8P8L@>00_WZ) M@I)"C4,C#P=(>GVDM3]*(+ZTAL.60"7$X/VA8M#'3XEIEU$7'LU@+2K#?!8` ML9E,C<:[['KIR\J4/-3Z\-SN!/TD1.3L4!'1?<2;CO)Y$'?5,]9P0A)*2#AZ$GN$:TV".C3>(PBTC=]H7:R&//.)K[!G$ M#D'9CD4-4J:*7@K^A2=V$X]BX2B6_BLZ"A4<+'*IP7X%(D6;$HMZIL+.FPG> M(KX252C8'C'S"(P?.C9]!OHQAPI"F\GO/YVY:?L6MM8!LZ4(-7Z9FCP/OX0V MM%0G/Z.'"E&D\:U_0>%HV\:8!N/-$%PSF'D/V%SC1VS3F:S:IPS+,6H%XUT8 MU!3)ER@F-*!8Q1N2D/_C'T]_ MW6M9XM(''OBP<(3B`QF$LEC)'0__>.*OX2]UZ&>(+D?9FFN(5Q6>+$F=GB=HM\ M=\_PY+(D[F&4H^L1?X)KQW/'CDB$Z#7W923&Z6B$BB,14)QGI&3N\X`0.A-; M,YA7(N,C`1[Q!'OR5!\2>B!M*B_ALFV,MW496+#]BK[>"?DOZB1DW[9.IA+V ME5QM+[6\J,/0=;9U>+6WO9*_U[&2I+OA!:3*\@92^#M]2^D"'*?,0V[FQM.Z MVVS!/;P[:DI1:UC$KW+$5Q:ORK5ZN5$[GG-K:>DV1BS#L)T1$=\.1N1?TRNH M/F(0>D^VTLBQ>3RECY!&9.6ZFT)Q+H]X*"^9B^I?>X-PG?Y:8U MV=M_NYLC9>U@3X&+CT62(\G9#QA%DIR+Y*R=/M.8W0S99$5X>5(NK\3P^*,64D:*Y9AZTB(V'L7XYC'?#&TB0NU31CR"+5&MPQ&ZN`2:M.BCD'7I4`6`9+-'@P8M?RU M#B@H?KK]NF%CWC/8`Q8%17!KW8;U;LMR8%[@7K`J#7=Y5AW;C?6G>SS$8!HQ M/6S)A?B03.\]ONK9>I*?[D%X#HL/L8G)H[!EY7O&D/"'57^V8?CIWJV[E-P: MQ>D' MXAX'3>/@/W6Z+)D,6R05""@-(*/8XD5Z0K%CK]GTWY9O[W)>?:I4N0A>0[F_ M[FV"L@#AWCDG*^/,`G[]<<5,$?`L&7L7DHW']-+^;\&P=\[F8[TPL*W`L``00E#@``!#D!``!02P$"'@,4````"`"=A@E#IQP^ M2540```:M0``%0`8```````!````I(&W30``;79I&UL550%``.I5@52=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`G88)0S]; M$.IR"P``DG,``!4`&````````0```*2!6UX``&UV:7,M,C`Q,S`V,S!?9&5F M+GAM;%54!0`#J58%4G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`)V&"4-U MXZ)>DB\``(QT`@`5`!@```````$```"D@1QJ``!M=FES+3(P,3,P-C,P7VQA M8BYX;6Q55`4``ZE6!5)U>`L``00E#@``!#D!``!02P$"'@,4````"`"=A@E# M'M7';4D@``!&S@$`%0`8```````!````I(']F0``;79I&UL550%``.I5@52=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`G88) M0VN`7Z"D"@``7%H``!$`&````````0```*2!E;H``&UV:7,M,C`Q,S`V,S`N M>'-D550%``.I5@52=7@+``$$)0X```0Y`0``4$L%!@`````&``8`&@(``(3% $```````` ` end XML 30 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Statement of Cash Flows [Abstract]    
Net loss $ (7,090) $ (14,774)
Adjustments to reconcile net loss to net cash used in operations:    
Depreciation 486 880
Amortization of intangible assets 79 92
Gain on disposal of property and equipment (2) (1)
Realizeld loss on sale of short-term investments 0 32
Non-cash stock-based compensation expense 481 854
Inventory write-downs 303 1,094
Non-cash deferred rent 0 (88)
Change in:    
Accounts receivable, net 27 (95)
Costs and estimated earnings in excess of billings on uncompleted contracts 0 58
Inventory 150 2,294
Other current assets 899 301
Other assets 4 12
Accounts payable (1,046) (2,976)
Accrued liabilities (771) (726)
Deferred revenue (581) 0
Billings in excess of costs and estimated earnings on uncompleted contracts 765 31
Net cash used in operating activities (6,296) (13,012)
Cash flows from investing activities    
Sales of investment securities 0 11
Decrease in restricted cash 1 350
Proceeds on sale of property and equipment 2 1
Purchases of property and equipment (86) (400)
Net cash used in investing activities (83) (38)
Cash flows from financing activities    
Principal payments under capital leases and long-term debt (75) (66)
Net proceeds from issuance of common stock and warrants 5,607 14,805
Net cash provided by (used in) financing activities 5,532 14,739
Net increase (decrease) in cash and cash equivalents (847) 1,689
Cash and cash equivalents, at beginning of period 6,850 13,075
Cash and cash equivalents, at end of period 6,003 14,764
Supplemental disclosure of cash flow information    
Cash paid for interest 8 17
Supplemental schedule of non-cash investing and financing activities    
Other non-cash additions to property and equipment 386 12
Warrant liability $ 3,755 $ 0

XML 31 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
NET LOSS PER SHARE - Note 2
6 Months Ended
Jun. 30, 2013
Earnings Per Share [Abstract]  
Net Loss Per Share - Note 2

2. NET LOSS PER SHARE

Basic net loss per share is calculated using the weighted-average number of common shares outstanding during the reporting periods. Diluted net loss per share is calculated using the weighted-average number of common shares outstanding and taking into account the dilutive effect of all potentially dilutive securities, including common stock equivalents and convertible securities outstanding. Potentially dilutive common stock equivalents primarily consist of warrants, employee stock options and nonvested equity shares. Diluted net loss per share for the three and six months ended June 30, 2013 and 2012 is equal to basic net loss per share because the effect of all potential common stock outstanding during the periods, including options, warrants and nonvested equity shares is anti-dilutive. The components of basic and diluted net loss per share were as follows (in thousands, except loss per share data):

      Three Months Ended     Six Months Ended
      June 30,     June 30,
      2013     2012     2013     2012
Numerator:                        
Net loss available for common shareholders - basic and diluted   $ (3,436)   $ (4,971)   $ (7,090)   $ (14,774)
                         
Denominator:                        
Weighted-average common shares outstanding - basic and diluted       26,493      19,167      25,870      18,097 
                         
Net loss per share - basic and diluted     $ (0.13)   $ (0.26)   $ (0.27)   $ (0.82)

 

We excluded the following convertible securities from diluted net loss per share, as the effect of including them would have been anti-dilutive:

      Three Months Ended     Six Months Ended
      June 30,     June 30,
      2013     2012     2013     2012
Publicly Traded Warrants Exercisable     753,000      753,000      753,000      753,000 
Options and Private Warrants Exercisable     7,612,000      5,302,000      7,612,000      5,302,000 
Nonvested Equity Shares     215,000      80,000      215,000      80,000 
                         
Total     8,580,000      6,135,000      8,580,000      6,135,000 

 

 

 

XML 32 R11.xml IDEA: SHARE-BASED COMPENSATION - Note 5 2.4.0.80011 - Disclosure - SHARE-BASED COMPENSATION - Note 5truefalsefalse1false falsefalseFrom2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:001true 1mvis_DisclosureOfCompensationRelatedCostsmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>5. SHARE-BASED COMPENSATION </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We use the straight-line attribution method to allocate the fair value of share-based compensation awards over the requisite service period for each award. The following table shows the amount of stock-based compensation expense included in the consolidated statements of operations:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Three Months Ended</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Six Months Ended</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Cost of contract revenue</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">4,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">4,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">10,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Cost of product revenue</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Research and development expense</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(72,000)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">87,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">88,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">224,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Sales, marketing, general and administrative expense</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">168,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">390,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">388,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">600<font style="font-size: 10pt">,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Total share-based employee compensation expense</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">96,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">481,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">481,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">854,000&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><u>&#160;Options Activity and Positions</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The following table summarizes shares, weighted average exercise price, weighted average remaining contractual term and aggregate intrinsic value of options outstanding and options exercisable as of June 30, 2013:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Remaining</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Contractual</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Aggregate</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Term</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Intrinsic</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">Options</font></td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Shares</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>(years)</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Value</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Outstanding as of June 30, 2013</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,255,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">12.63&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6.9&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">376,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Exercisable as of June 30, 2013</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">770,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">18.80&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5.6&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">97,000&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">As of June 30, 2013, our unamortized share-based employee compensation was $941,000 which we plan to amortize over the next 1.9 years and our unamortized nonvested equity share-based employee compensation was $366,000 which we plan to amortize over the next 0.9 years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 false0falseSHARE-BASED COMPENSATION - Note 5UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/CompensationRelatedCostsStockCompensation12 XML 33 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
SHARE-BASED COMPENSATION - Note 5
6 Months Ended
Jun. 30, 2013
Disclosure Of Compensation Related Costs  
Share-Based Compensation - Note 5

5. SHARE-BASED COMPENSATION

We use the straight-line attribution method to allocate the fair value of share-based compensation awards over the requisite service period for each award. The following table shows the amount of stock-based compensation expense included in the consolidated statements of operations:

      Three Months Ended     Six Months Ended
      June 30,     June 30,
      2013     2012     2013     2012
Cost of contract revenue   $   $ 4,000    $ 4,000    $ 10,000 
Cost of product revenue             1,000      20,000 
Research and development expense     (72,000)     87,000      88,000      224,000 
Sales, marketing, general and administrative expense     168,000      390,000      388,000      600,000 
Total share-based employee compensation expense   $ 96,000    $ 481,000    $ 481,000    $ 854,000 

 

 Options Activity and Positions

The following table summarizes shares, weighted average exercise price, weighted average remaining contractual term and aggregate intrinsic value of options outstanding and options exercisable as of June 30, 2013:

              Weighted      
              Average      
          Weighted   Remaining      
          Average   Contractual     Aggregate
          Exercise   Term     Intrinsic
Options   Shares     Price   (years)     Value
Outstanding as of June 30, 2013   1,255,000    $ 12.63    6.9    $ 376,000 
                     
Exercisable as of June 30, 2013   770,000    $ 18.80    5.6    $ 97,000 

As of June 30, 2013, our unamortized share-based employee compensation was $941,000 which we plan to amortize over the next 1.9 years and our unamortized nonvested equity share-based employee compensation was $366,000 which we plan to amortize over the next 0.9 years.

 

 

XML 34 R14.xml IDEA: NEW ACCOUNTING PRONOUNCEMENTS - Note 8 2.4.0.80014 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS - Note 8truefalsefalse1false falsefalseFrom2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:001true 1mvis_NotesToFinancialStatementsAbstractmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdoptedus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>8. NEW ACCOUNTING PRONOUNCEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In July 2012, the Financial Accounting Standards Board (&#34;FASB&#34;) issued guidance that will allow an entity to first assess qualitative factors to determine whether it is necessary to perform a quantitative impairment test for indefinite-lived intangible assets. Under this guidance, an entity would not be required to calculate the fair value of an indefinite-lived intangible asset unless the entity determines, based on qualitative assessment, that it is not more likely than not, the indefinite-lived intangible asset is impaired. This guidance is effective for impairment tests performed for fiscal years beginning after September 15, 2012, with early adoption permitted. We do not expect the implementation of this guidance will have a material impact on our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In February 2013, the FASB issued guidance that requires disclosure of amounts reclassified out of accumulated other comprehensive income in its entirety, by component, on the face of the statement of operations or in the notes thereto. Amounts that are not required to be reclassified in their entirety to net income must be cross-referenced to other disclosures that provide additional detail. This standard is effective prospectively for annual and interim reporting periods beginning after December 15, 2012. We do not expect the implementation of this guidance will have a material impact on our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section S99 -Paragraph 5 -Subparagraph (SAB TOPIC 11.M) -URI http://asc.fasb.org/extlink&oid=26874127&loc=d3e31137-122693 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 11 -Section M false0falseNEW ACCOUNTING PRONOUNCEMENTS - Note 8UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/NewAccountingPronouncements-Note812 XML 35 R2.xml IDEA: Consolidated Balance Sheets 2.4.0.80002 - Statement - Consolidated Balance SheetstruefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$AsOf2013-06-30http://www.sec.gov/CIK0000065770instant2013-06-30T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$AsOf2012-12-31http://www.sec.gov/CIK0000065770instant2012-12-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_StatementOfFinancialPositionAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse60030006003USD$falsetruefalse2truefalsefalse68500006850USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585 false23false 2us-gaap_AccountsReceivableNetCurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse10880001088falsefalsefalse2truefalsefalse11150001115falsefalsefalsexbrli:monetaryItemTypemonetaryAmount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3-4) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 3 -Subparagraph a(1) -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 4 -Article 5 false24false 2us-gaap_ReceivablesLongTermContractsOrProgramsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1200012falsefalsefalse2truefalsefalse1200012falsefalsefalsexbrli:monetaryItemTypemonetaryAmount to be collected within one year of the balance sheet date (or one operating cycle, if longer) from customers in accordance with the contractual provisions of long-term contracts or programs including amounts billed and unbilled as of the balance sheet date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3(c)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 3 -Subparagraph c -Article 5 false25false 2us-gaap_InventoryNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse4400044falsefalsefalse2truefalsefalse497000497falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 35 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 false26false 2us-gaap_OtherAssetsCurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse305000305falsefalsefalse2truefalsefalse12210001221falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate carrying amount, as of the balance sheet date, of current assets not separately disclosed in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.8) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 8 -Article 5 false27false 2us-gaap_AssetsCurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse74520007452falsefalsefalse2truefalsefalse96950009695falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.9) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 9 -Article 5 true28false 2us-gaap_PropertyPlantAndEquipmentNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse11910001191falsefalsefalse2truefalsefalse12050001205falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.13) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 13 -Subparagraph a -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 8 -Article 7 false29false 2us-gaap_RestrictedCashAndCashEquivalentsNoncurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse435000435falsefalsefalse2truefalsefalse436000436falsefalsefalsexbrli:monetaryItemTypemonetaryCash and equivalents whose use in whole or in part is restricted for the long-term, generally by contractual agreements or regulatory requirements.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false210false 2us-gaap_IntangibleAssetsNetExcludingGoodwillus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse15010001501falsefalsefalse2truefalsefalse15800001580falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph ((a)(1),(b)) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 false211false 2us-gaap_OtherAssetsNoncurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1800018falsefalsefalse2truefalsefalse2200022falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.17) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 17 -Article 5 false212false 2us-gaap_Assetsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse1059700010597falsefalsefalse2truefalsefalse1293800012938falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 true213false 2us-gaap_AccountsPayableCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse21060002106falsefalsefalse2truefalsefalse30350003035falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Subparagraph a -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false214false 2us-gaap_AccruedLiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse32530003253falsefalsefalse2truefalsefalse40070004007falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false215false 2us-gaap_DeferredRevenueus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2800028falsefalsefalse2truefalsefalse609000609falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 13 -Section A Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response) -URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780 false216false 2us-gaap_BillingsInExcessOfCostCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse863000863falsefalsefalse2truefalsefalse9800098falsefalsefalsexbrli:monetaryItemTypemonetaryLiability attributable to (i) billings in excess of costs under the percentage of completion contract accounting method representing the difference between contractually invoiced amounts (billings) and revenue recognized based, for example, on costs incurred to estimated total costs at period end or (ii) contractually invoiced amounts (billings) in excess of costs incurred and accumulated under the completed contract accounting method that are expected to be realized within one year or one operating cycle, whichever is longer, from the reporting date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 35 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6802688&loc=d3e57788-111642 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 35 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6802688&loc=d3e57807-111642 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 35 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6802688&loc=d3e57795-111642 false217false 2us-gaap_WarrantsAndRightsOutstandingus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse37550003755falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryValue of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph i -Article 4 false218false 2us-gaap_CapitalLeaseObligationsCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse4300043falsefalsefalse2truefalsefalse4800048falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of capital lease obligation due within one year or the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735 false219false 2us-gaap_SecuredDebtCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1700017falsefalsefalse2truefalsefalse6700067falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 20 -Article 5 false220false 2us-gaap_LiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse1006500010065falsefalsefalse2truefalsefalse78640007864falsefalsefalsexbrli:monetaryItemTypemonetaryTotal obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.21) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 21 -Article 5 true221false 2us-gaap_CapitalLeaseObligationsNoncurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse2000020falsefalsefalsexbrli:monetaryItemTypemonetaryAmount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false222false 2us-gaap_DeferredRentCreditNoncurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse330000330falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryFor a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 25 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=7501430&loc=d3e39927-112707 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.26(c)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false223false 2us-gaap_Liabilitiesus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse1039500010395falsefalsefalse2truefalsefalse78840007884falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19-26) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 true224false 2us-gaap_CommitmentsAndContingenciesus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00&nbsp;&nbsp;falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.25) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 25 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 7 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 17 -Article 9 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.17) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.(a),19) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910 false225false 2us-gaap_PreferredStockValueus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false226false 2us-gaap_CommonStockValueus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2800028falsefalsefalse2truefalsefalse2500025falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false227false 2us-gaap_AdditionalPaidInCapitalCommonStockus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse444795000444795falsefalsefalse2truefalsefalse442560000442560falsefalsefalsexbrli:monetaryItemTypemonetaryValue received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.30(a)(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false228false 2us-gaap_RetainedEarningsUnappropriatedus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-444621000-444621falsefalsefalse2truefalsefalse-437531000-437531falsefalsefalsexbrli:monetaryItemTypemonetaryA segregation of retained earnings which is available for dividend distribution. Earnings not paid out as dividends but instead reinvested in the core business or used to pay off debt. Unappropriated profit is part of shareholder equity. Also called cumulative distributions or earned surplus or accumulated earnings or unappropriated profit.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.30(a)(3)(ii)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.23(4)) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 24 -Subparagraph a(4) -Article 7 false229false 2us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse202000202falsefalsefalse2truefalsefalse50540005054falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568447-111683 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568740-111683 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4I -URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4590271-111686 true230false 2us-gaap_LiabilitiesAndStockholdersEquityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse1059700010597USD$falsetruefalse2truefalsefalse1293800012938USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.32) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 25 -Article 7 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 32 -Article 5 true2falseConsolidated Balance Sheets (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/StatementOfFinancialPositionClassified230 XML 36 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
KEY ACCOUNTING POLICY - REVENUE RECOGNITION - Note 3
6 Months Ended
Jun. 30, 2013
Risks and Uncertainties [Abstract]  
KEY ACCOUNTING POLICY - REVENUE RECOGNITION - Note 3

3. KEY ACCOUNTING POLICY - REVENUE RECOGNITION

We evaluate the performance criteria and terms of our collaborative research and development agreements to determine whether revenue should be recognized under a performance-based method or milestone method. Significant items included in our evaluation are the following:

  • the nature of our obligation under the agreement,
  • whether provisions leading to variable revenues exist
  • whether any payments are required to be repaid,
  • whether the deliverables should be treated as one unit of accounting or separated into multiple units,
  • whether substantive milestones exist,
  • whether milestone payments are commensurate with either our level of effort or the increase in value of the customer's rights, and
  • whether a licensing agreement exists.

In March 2013, we entered into and began work under a $4.6 million collaborative research and development agreement with a customer researching and developing commercial applications for our technology. Our contributions under the collaborative agreement include research services, components, and prototype devices and fixtures. Development revenues to be realized are subject to successful completion of the deliverables as defined in the collaborative research and development agreement.

Based on the terms of this agreement, we recognize development revenue as work progresses on the agreement and as our customer accepts the deliverables using a proportional method based on the lesser of the cumulative proportion of total planned costs to be incurred under the agreement or the cash payments received plus outstanding billings for work accepted by the customer. Since our collaborative agreements generally require some level of technology development, the actual costs required to complete a contract can vary from our estimates. The proportional revenue recognition method we use for collaborative research and development agreements includes adjustments for revisions to estimated total agreement costs. Each period, we evaluate total estimated costs for each agreement and include any significant revisions in the period we become aware of changes in estimated total costs. The costs for work performed under collaborative research and development agreements are expensed in the periods incurred and included in the Statement of Operations in research and development expense.

For the three and six months ended June 30, 2013, two commercial customers accounted for approximately 93% and 89% of our total revenue. The accounts receivable balance from these customers was approximately 98% of our net accounts receivable balance at June 30, 2013.

 

 

XML 37 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Narrative) (Details) (USD $)
6 Months Ended
Jun. 30, 2013
Employee Stock Options
 
Unrecognized compensation cost related to share-based compensation $ 941,000
Weighted-average service period, years 1 year 10 months 24 days
Restricted Stock Rights
 
Unrecognized compensation cost related to share-based compensation $ 366,000
Weighted-average service period, years 0 years 10 months 24 days
XML 38 R24.xml IDEA: Inventory Components (Details) 2.4.0.80024 - Disclosure - Inventory Components (Details)truefalsefalse1false USDfalsefalse$AsOf2013-06-30http://www.sec.gov/CIK0000065770instant2013-06-30T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$AsOf2012-12-31http://www.sec.gov/CIK0000065770instant2012-12-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1mvis_InventoryComponentsDetailsAbstractmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_InventoryRawMaterialsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1100011000USD$falsetruefalse2truefalsefalse361000361000USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 6 -Subparagraph a -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(a)(4)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false23false 2us-gaap_InventoryFinishedGoodsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse3300033000falsefalsefalse2truefalsefalse136000136000falsefalsefalsexbrli:monetaryItemTypemonetaryAmount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 6 -Subparagraph a -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(a)(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false24false 2us-gaap_InventoryNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse4400044000USD$falsetruefalse2truefalsefalse497000497000USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 35 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 true2falseInventory Components (Details) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/InventoryComponentsDetails24 XML 39 R10.xml IDEA: INVENTORY - Note 4 2.4.0.80010 - Disclosure - INVENTORY - Note 4truefalsefalse1false falsefalseFrom2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:001true 1mvis_InventoryDisclosuremvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_InventoryDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>4. INVENTORY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Inventory consists of the following:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>&#160;&#160;&#160; June 30, &#160;&#160;&#160;</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Raw materials</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">11,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">361,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Finished goods</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">33,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">136,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">44,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">497,000&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The inventory at June 30, 2013 and December 31, 2012 consisted of components supplied under our &#34;Image by PicoP<sup>&#174;</sup>&#34; ingredient brand business model, and finished goods primarily composed of our accessory pico projectors. Inventory is stated at the lower of cost or market. Management periodically assesses the need to provide for obsolescence of inventory and adjusts the carrying value of inventory to its net realizable value when required. In addition, we reduce the value of our inventory to our estimated scrap value when management determines that it is not probable that the inventory will be consumed through normal production during the next twelve months. During the six months ended June 30, 2013, we recorded inventory write-downs of $303,000. In 2012, we recorded inventory write-downs of $1,094,000. At June 30, 2013 and December 31, 2012, we have aggregate write-downs recorded of $10,279,000 and $9,916,000, respectively, offsetting inventory on hand deemed to be obsolete or scrap inventory.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 6 -Subparagraph a, b, c -Article 5 false0falseINVENTORY - Note 4UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/Inventory12 XML 40 R5.xml IDEA: Consolidated Statements of Comprehensive Loss 2.4.0.80005 - Statement - Consolidated Statements of Comprehensive LosstruefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$From2013-04-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-04-01T00:00:002013-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2012-04-01to2012-06-30http://www.sec.gov/CIK0000065770duration2012-04-01T00:00:002012-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$From2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$From2012-01-01to2012-06-30http://www.sec.gov/CIK0000065770duration2012-01-01T00:00:002012-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-3436000-3436USD$falsetruefalse2truefalsefalse-4971000-4971USD$falsetruefalse3truefalsefalse-7090000-7090USD$falsetruefalse4truefalsefalse-14774000-14774USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 false23true 2us-gaap_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse04false 3us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse-2000-2falsefalsefalse3truefalsefalse00falsefalsefalse4truefalsefalse30003falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e637-108580 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 10A -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=28358780&loc=SL7669646-108580 false25false 3us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTaxus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse3200032falsefalsefalse3truefalsefalse00falsefalsefalse4truefalsefalse3200032falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized loss realized upon the write-down of available-for-sale securities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e637-108580 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e689-108580 false26false 2us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-3436000-3436USD$falsetruefalse2truefalsefalse-4941000-4941USD$falsetruefalse3truefalsefalse-7090000-7090USD$falsetruefalse4truefalsefalse-14739000-14739USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4591552-111686 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683 true2falseConsolidated Statements of Comprehensive Loss (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/StatementOfOtherComprehensiveIncome46 EXCEL 41 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]E8S%E8V$Q9%]F,C`T7S0S,F5?8CDQ,5]E-3!E M-60V8CEB83`B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DM%65]!0T-/54Y424Y'7U!/3$E#65]2159%3E5%7SPO M>#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I% M>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-H87)E0F%S961?0V]M<&5N#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYE=%],;W-S7U!E#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/DEN M=F5N=&]R>5].87)R871I=F5?1&5T86EL#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E-T;V-K0F%S961?0V]M<&5N#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-H M87)E9$)A#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E-H87)E0F%S961?0V]M<&5N#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D-O;6UI=&UE;G1S7V%N9%]#;VYT:6YG96YC:65S7SPO>#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D-O;6UO;E]3=&]C:U]A;F1?5V%R M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C M=%-T#I0#I0 M#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T* M("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I M=&@@36EC'1087)T7V5C,65C83%D7V8R,#1? M-#,R95]B.3$Q7V4U,&4U9#9B.6)A,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL M93HO+R]#.B]E8S%E8V$Q9%]F,C`T7S0S,F5?8CDQ,5]E-3!E-60V8CEB83`O M5V]R:W-H965T'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA2!296=I M'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^665S M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2!# M;VUM;VX@4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^ M43(\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]E8S%E8V$Q9%]F,C`T7S0S,F5?8CDQ,5]E-3!E M-60V8CEB83`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO96,Q96-A M,61?9C(P-%\T,S)E7V(Y,3%?934P935D-F(Y8F$P+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R&-E3PO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF5D(&EN(&YE="!L;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'!E;G-E/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XT.#$\2!W'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA M&-E2!A;F0@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XR/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2`H=7-E9"!I;BD@9FEN86YC:6YG(&%C=&EV:71I M97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E8S%E8V$Q9%]F,C`T7S0S,F5? M8CDQ,5]E-3!E-60V8CEB83`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO96,Q96-A,61?9C(P-%\T,S)E7V(Y,3%?934P935D-F(Y8F$P+U=O'0O:'1M;#L@ M8VAA'0^/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE"!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q,R!A M;F0-"C(P,3(L(&%N9"!#;VYS;VQI9&%T960@4W1A=&5M96YT2!-:6-R;U9I2!T:&4@9FEN86YC:6%L('!O2!I;F-L=61E9`T*:6X@9FEN86YC:6%L M('-T871E;65N=',@<')E<&%R960@:6X@86-C;W)D86YC92!W:71H(&=E;F5R M86QL>2!A8V-E<'1E9"!A8V-O=6YT:6YG('!R:6YC:7!L97,@:&%V92!B965N M(&-O;F1E;G-E9"!O65A2!T:')O=6=H('1H92!S86QE(&]F(&-O;6UO;B!S=&]C M:RP@8V]N=F5R=&EB;&4@<')E9F5R6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6EN9R!D979E;&]P;65N="!P2!F'!E8W1E9"!T;R!F=7)T:&5R('1H92!D979E;&]P;65N=`T*;V8@;W5R M('1E8VAN;VQO9VEE2!R97%U:7)E(&%D9&ET:6]N86P@ M:6YV97-T;65N=',@8GD@=7,N/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E&5R8VES92!P&5R8VES86)L92!B96=I;FYI;F<@;VX@=&AE(&1A=&4@;V8@:7-S M=6%N8V4N($5A8V@@=V%R&-H86YG960I('=I=&@@82!V86QU92!D M971E&5R8VES960@9F]R(&-A7,@86YD('1H90T*879E2!D;VQL M87(@=F]L=6UE(&]V97(@=&AA="!P97)I;V0@:7,@97%U86P@=&\@;W(@97AC M965D'!R97-S:6YG('-U8G-T86YT:6%L(&1O=6)T(&%B;W5T(&]U6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA65E('-T;V-K(&]P M=&EO;G,@86YD(&YO;G9E&-E M<'0@;&]S6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS M<&%N/3-$-"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/CQF;VYT('-T M>6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!C;VQS<&%N/3-$-"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/DIU;F4@,S`L/"]B/CPO9F]N M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)V)O6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C(P,3,\+V(^ M/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1EF4Z(#$P<'0G/CQB/C(P,3(\ M+V(^/"]F;VYT/CPO=&0^/"]T6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)V)A8VMGF4Z(#$P<'0G/DYE M="!L;W-S(&%V86EL86)L92!F;W(@8V]M;6]N('-H87)E:&]L9&5R6QE/3-$ M)V)A8VMG'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA M;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^ M/"]T9#X-"B`@("`\=&0@6QE M/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V)A M8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O M;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V)A8VMG6QE M/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[ M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W M:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/C(V+#0Y,R8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V)O6QE/3-$)V)A8VMG'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K M9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R M.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V)A8VMG6QE/3-$ M)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)V)A8VMGF4Z(#$P<'0G/DYE M="!L;W-S('!E6QE/3-$)V)A8VMG6QE/3-$)V)O6QE M/3-$)V)A8VMG6QE/3-$)V)O6QE/3-$)V)A8VMG M6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/B@P+C(W*3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V)A8VMG6QE M/3-$)V)O'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/B@P+C@R*3PO9F]N=#X\+W1D/CPO='(^#0H\+W1A8FQE/@T*/'`@&-L=61E9"!T:&4@9F]L;&]W:6YG(&-O;G9E6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$-"!S='EL93TS M1"=T97AT+6%L:6=N.B!C96YT97(G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N M/3-$-"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI M9#L@=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/CQB/DIU;F4@,S`L/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)V)O6QE/3-$)V9O M;G0M6QE/3-$)V)O6QE/3-$ M)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q M+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C(P,3,\+V(^/"]F;VYT/CPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0G/CQB/C(P,3(\+V(^/"]F;VYT/CPO=&0^ M/"]T6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@ M6QE/3-$)V)A8VMG'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V)A M8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M="<^/&9O;G0@6QE/3-$)V9O;G0M&5R8VES86)L93PO9F]N M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W M:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M6QE/3-$ M)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M2!3:&%R M97,\+V9O;G0^/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X M="UA;&EG;CH@6QE/3-$ M)V)O6QE/3-$)V)A8VMG M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X M="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$ M)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI M9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/C@P+#`P,"8C,38P.SPO9F]N=#X\+W1D/CPO='(^ M#0H\='(@6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W M:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA M;&EG;CH@6QE/3-$)V)A M8VMG6QE/3-$)V)A8VMG'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O M;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/CPO='(^#0H\='(@6QE/3-$)V)A8VMGF4Z(#$P<'0G/E1O=&%L/"]F;VYT/CPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O M;G0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H M="<^/&9O;G0@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N M.B!R:6=H="<^/&9O;G0@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT M+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`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`X.24@ M;V8@;W5R('1O=&%L(')E=F5N=64N(%1H90T*86-C;W5N=',@F4Z(#$P<'0G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G M/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V)O M6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$ M)V)A8VMG'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@ M6QE/3-$)V9O M;G0M6QE/3-$)V)A8VMGF4Z(#$P<'0G/D9I;FES:&5D(&=O;V1S/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)V)A8VMG'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K M9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2!C;VUP;W-E M9"!O9B!O=7(@86-C97-S;W)Y('!I8V\@<')O:F5C=&]R2!A6EN9PT*=F%L=64@;V8@:6YV96YT;W)Y('1O(&ET2!W:6QL(&)E(&-O;G-U;65D('1H2P@;V9F2X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]E8S%E8V$Q9%]F,C`T7S0S,F5?8CDQ,5]E-3!E-60V8CEB83`-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO96,Q96-A,61?9C(P-%\T,S)E7V(Y M,3%?934P935D-F(Y8F$P+U=O'0O:'1M;#L@8VAA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L M"!-;VYT:',@16YD960\ M+V(^/"]F;VYT/CPO=&0^/"]T6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(&-E M;G1E6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E'0M86QI9VXZ M(&-E;G1E6QE/3-$ M)V)O6QE/3-$)V9O;G0M6QE M/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W9E M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T M9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@ M6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C$P+#`P,"8C M,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@6QE/3-$)V)A8VMGF4Z(#$P<'0G M/D-O6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O M;G0@6QE/3-$)V)A8VMG'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H="<^/&9O;G0@6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD M+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B@W,BPP,#`I/"]F;VYT/CPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H="<^/&9O;G0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@ M=&5X="UA;&EG;CH@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/C@X+#`P,"8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@ M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M6QE/3-$)V)A8VMGF4Z(#$P<'0G/E-A;&5S+"!M87)K M971I;F'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG M;CH@6QE/3-$)V)O6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG M;CH@6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/C,X."PP,#`F(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O M;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V)O6QE/3-$ M)V9O;G0M'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD M+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE M/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O M;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$ M)V9O;G0M6QE/3-$ M)V)A8VMG'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG6QE/3-$ M)V)O'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C@U M-"PP,#`F(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/"]T86)L93X-"CQP('-T M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE&5R8VES92!P&5R8VES86)L92!A6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B8C,38P M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1EF4Z M(#$P<'0G/CQB/E=E:6=H=&5D/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE M/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0G/CQB/E)E;6%I;FEN M9SPO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$)V)OF4Z(#$P<'0G/D]P M=&EO;G,\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E'0M86QI9VXZ M(&-E;G1EF4Z(#$P<'0G/CQB/BAY M96%R6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1EF4Z(#$P<'0G M/CQB/E9A;'5E/"]B/CPO9F]N=#X\+W1D/CPO='(^#0H\='(@6QE/3-$)V)A M8VMGF4Z(#$P<'0G/D]U='-T86YD:6YG(&%S(&]F($IU;F4@,S`L(#(P,3,\+V9O M;G0^/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0G/C8N.28C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@ M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/C,W-BPP,#`F(S$V,#L\+V9O;G0^/"]T9#X\+W1R M/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V)A M8VMG6QE/3-$)V)A8VMG'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@ M=&5X="UA;&EG;CH@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@ M6QE/3-$)V)A8VMGF4Z(#$P<'0G/D5X97)C:7-A8FQE(&%S(&]F($IU;F4@,S`L M(#(P,3,\+V9O;G0^/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@ M6QE/3-$)V)A8VMG'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B0\+V9O M;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UEF5D('-H87)E+6)AF4@;W9E M65AF4@;W9E M65A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!L96=A;"!P6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE0T*=&5C:&YO;&]G>2X@ M5V4@<&5R:6]D:6-A;&QY(&%S&EM871E;'D@)#4P,"PP,#`@86YD("0V,S0L M,#`P+"!R97-P96-T:79E;'DL#0IA8V-R=65D(&9O6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2`R,#$S+"!W92!R86ES960@)#4N.#4@;6EL;&EO M;B!B969O&EM871E;'D@)#,V M,BPP,#`@9G)O;2!T:&4@65A&-H86YG960@9'5R:6YG(&ET&5R8VES92!P&-E961S("0S,#`L,#`P M+CPO<#X-"@T*/'`@2!G:79E;B!T M:&%T('1H92!W87)R86YT2!L;V-K('5P('!E2!A(&YE M9V]T:6%T960@9F]R;75L82!I;F-L=61E9"!I;B!T:&4@=V%R&-H86YG92!F96%T=7)E.R!H;W=E=F5R('1H M92!A9V=R96=A=&4@9F%I&-H86YG92!F;W)M=6QA(&EN('1H92!A9W)E96UE;G0N#0I$=64@=&\@ M=&AE(&QI;6ET:6YG('!R;W9I6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE2!T;R!P97)F;W)M(&$@<75A;G1I=&%T:79E(&EM<&%I2!D971E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE"!M;VYT:',@96YD960@2G5N92`S,"P@ M,C`Q,R!A;F0@,C`Q,B!H879E(&)E96X@<')E<&%R960@8GD@36EC&-H86YG92!#;VUM:7-S:6]N M("AT:&4@)B,S-#M314,F(S,T.RDN(%1H92!Y96%R+65N9"!C;VYD96YS960@ M8F%L86YC92!S:&5E="!D871A('=A"!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q,R!A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'1E;G0L(&9R;VT@ M8V]N=')A8W0@6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!P"!O9B!R979E;G5E2!U M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2`R,#$S+"!W92!R86ES960@)#4N.#4@;6EL;&EO;B!B M969O&EM871E;'D@)#,V,BPP M,#`@9G)O;2!T:&4@65A&-H86YG960@9'5R:6YG(&ET&5R8VES92!P&-E961S("0S,#`L,#`P+CPO M<#X-"@T*/'`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`@("`\=&%B;&4@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE&-E<'0@;&]S6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$-"!S M='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/CQF;VYT('-T>6QE/3-$)V9O M;G0M6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1E6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C M;VQS<&%N/3-$-"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P M="!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/CQB/DIU;F4@,S`L/"]B/CPO9F]N=#X\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)V)O6QE M/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C(P,3,\+V(^/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0G/CQB/C(P,3(\+V(^/"]F;VYT M/CPO=&0^/"]T6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)V)A8VMGF4Z(#$P<'0G/DYE="!L;W-S(&%V M86EL86)L92!F;W(@8V]M;6]N('-H87)E:&]L9&5R6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@ M("`\=&0@6QE/3-$)V9O;G0M M6QE/3-$)W9E6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD M+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET M93L@=&5X="UA;&EG;CH@6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X\+W1R/@T* M/'1R('-T>6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X\+W1R M/@T*/'1R('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X M="UA;&EG;CH@6QE/3-$ M)V)O'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C(V M+#0Y,R8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K M9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M6QE M/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@ M9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K M9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V)O6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O M;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@ M=&5X="UA;&EG;CH@6QE M/3-$)V)A8VMG6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O M=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)V)A8VMGF4Z(#$P<'0G/DYE="!L;W-S('!E M6QE M/3-$)V)A8VMG6QE/3-$)V)O6QE/3-$)V)A8VMG M6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/B@P+C(V*3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V)A8VMG6QE M/3-$)V)O'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/B@P+C(W*3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O M=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V)A8VMG6QE/3-$)V)O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE&-L=61E9"!T:&4@9F]L M;&]W:6YG(&-O;G9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!C;VQS<&%N/3-$-"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT M97(G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$-"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@8V5N M=&5R)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/DIU;F4@ M,S`L/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)V)O6QE/3-$)V9O;G0M6QE M/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA M;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/CQB/C(P,3,\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1EF4Z(#$P M<'0G/CQB/C(P,3(\+V(^/"]F;VYT/CPO=&0^/"]T6QE/3-$)V9O;G0M M6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@ M6QE/3-$)V)A8VMG'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V)A M8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V9O;G0M&5R8VES86)L93PO9F]N=#X\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@ M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H="<^/&9O;G0@'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O M;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V)O6QE/3-$)V)A8VMG'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C@P M+#`P,"8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@6QE/3-$)V)A8VMG M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@ M6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K M9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA M;&EG;CH@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)V)A M8VMGF4Z(#$P<'0G/E1O=&%L/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U M8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U M<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O M;G0@6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]E8S%E8V$Q9%]F,C`T7S0S,F5?8CDQ,5]E-3!E-60V8CEB83`-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO96,Q96-A,61?9C(P-%\T,S)E7V(Y M,3%?934P935D-F(Y8F$P+U=O'0O:'1M;#L@8VAA2`H5&%B M;&5S*3QB2!486)L97,\+W-T6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/CQF M;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V)A M8VMG'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE M/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M M6QE/3-$)V)A8VMGF4Z(#$P<'0G/D9I;FES:&5D(&=O;V1S/"]F;VYT/CPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K M9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O M=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$ M)VUA'10 M87)T7V5C,65C83%D7V8R,#1?-#,R95]B.3$Q7V4U,&4U9#9B.6)A,`T*0V]N M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]E8S%E8V$Q9%]F,C`T7S0S,F5? M8CDQ,5]E-3!E-60V8CEB83`O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$-"!S='EL93TS M1"=T97AT+6%L:6=N.B!C96YT97(G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N M/3-$-"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI M9#L@=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/CQB/DIU;F4@,S`L/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)V)O6QE/3-$)V9O M;G0M6QE/3-$)V)O6QE/3-$ M)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q M+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C(P,3,\+V(^/"]F;VYT/CPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0G/CQB/C(P,3(\+V(^/"]F;VYT/CPO=&0^ M/"]T6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/C0L,#`P)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)V)A8VMG'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD M+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE M/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG6QE/3-$ M)V9O;G0M6QE/3-$)V)A8VMG M6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG M;CH@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/C(P+#`P,"8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@6QE/3-$)V)A M8VMGF4Z(#$P<'0G/E)E'!E;G-E/"]F M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)A8VMG'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^ M/&9O;G0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA M;&EG;CH@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/C(R-"PP,#`F(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE M/3-$)W9E6QE M/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S M;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M M6QE/3-$)V)A8VMG M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/C,Y,"PP,#`F(S$V,#L\+V9O;G0^/"]T9#X- M"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V)O6QE/3-$)V)A8VMG'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)V)A8VMGF4Z(#$P<'0G/E1O=&%L M('-H87)E+6)A65E(&-O;7!E;G-A=&EO;B!E>'!E;G-E/"]F M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)A8VMG'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B0\ M+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B0\+V9O M;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE&5R8VES92!P&5R8VES86)L92!A6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$ M)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0G/CQB/E)E;6%I;FEN9SPO M8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1E6QE M/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)V)OF4Z(#$P<'0G/D]P=&EO M;G,\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E'0M86QI9VXZ(&-E M;G1EF4Z(#$P<'0G/CQB/BAY96%R M6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1EF4Z(#$P<'0G/CQB M/E9A;'5E/"]B/CPO9F]N=#X\+W1D/CPO='(^#0H\='(@6QE/3-$)V)A8VMG MF4Z M(#$P<'0G/D]U='-T86YD:6YG(&%S(&]F($IU;F4@,S`L(#(P,3,\+V9O;G0^ M/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/C8N.28C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0G/C,W-BPP,#`F(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T* M/'1R('-T>6QE/3-$)W9E6QE/3-$)V)A8VMG M6QE/3-$)V)A8VMG'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X M="UA;&EG;CH@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE M/3-$)V)A8VMGF4Z(#$P<'0G/D5X97)C:7-A8FQE(&%S(&]F($IU;F4@,S`L(#(P M,3,\+V9O;G0^/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V)A8VMG'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^ M/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K M9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&-E<'0@4&5R(%-H M87)E(&1A=&$L('5N;&5S&5R8VES M86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^36%Y(#,Q+`T* M"0DR,#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'`@2!G:79E M;B!T:&%T('1H92!W87)R86YT2!L;V-K('5P('!E2!A M(&YE9V]T:6%T960@9F]R;75L82!I;F-L=61E9"!I;B!T:&4@=V%R&-H86YG92!F96%T=7)E('=E2`Q+#0Y,"PP,#`@&-H86YG92!F96%T=7)E.R!H;W=E=F5R M('1H92!A9V=R96=A=&4@9F%I&-H86YG92!F;W)M=6QA(&EN#0IT:&4@86=R965M96YT+B!$=64@ M=&\@=&AE(&QI;6ET:6YG('!R;W9I6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E M8S%E8V$Q9%]F,C`T7S0S,F5?8CDQ,5]E-3!E-60V8CEB83`-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO96,Q96-A,61?9C(P-%\T,S)E7V(Y,3%? M934P935D-F(Y8F$P+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]E8S%E8V$Q9%]F,C`T7S0S,F5?8CDQ,5]E-3!E-60V M8CEB83`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO96,Q96-A,61? M9C(P-%\T,S)E7V(Y,3%?934P935D-F(Y8F$P+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M2!42!3:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E8S%E8V$Q M9%]F,C`T7S0S,F5?8CDQ,5]E-3!E-60V8CEB83`-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO96,Q96-A,61?9C(P-%\T,S)E7V(Y,3%?934P935D M-F(Y8F$P+U=O'0O:'1M;#L@8VAA7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!W2!A;&QO=V%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]E8S%E8V$Q9%]F,C`T7S0S,F5?8CDQ,5]E M-3!E-60V8CEB83`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO96,Q M96-A,61?9C(P-%\T,S)E7V(Y,3%?934P935D-F(Y8F$P+U=O'0O:'1M;#L@8VAA2!3=&%T96UE;G0@ M3V8@3W!E'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65E(&-O;7!E;G-A=&EO;B!E>'!E;G-E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!!;F0@4&]S:71I;VX@1&5T86EL'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!P'0^-B!Y96%R&5R M8VES92!P7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^,2!Y96%R(#$P(&UO;G1H'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$65A65A7,\'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!F;W(@;&]S'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$6EN M9R!W87)R86YT65A65A&5R M8VES92!P2!P;VEN="!W:&5N#0IT:&4@&5R8VES92!P'!I2!B92!I&-H86YG92!P2!E>&5R8VES960L('=E('=O M=6QD(&)E(')E<75I6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE XML 42 R4.xml IDEA: Consolidated Statements of Operations 2.4.0.80004 - Statement - Consolidated Statements of OperationstruefalseIn Thousands, except Per Share data, unless otherwise specifiedfalse1false USDfalsefalse$From2013-04-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-04-01T00:00:002013-06-30T00:00:00sharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli0perShareItemTypeDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2012-04-01to2012-06-30http://www.sec.gov/CIK0000065770duration2012-04-01T00:00:002012-06-30T00:00:00sharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli0perShareItemTypeDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$From2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:00sharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli0perShareItemTypeDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$From2012-01-01to2012-06-30http://www.sec.gov/CIK0000065770duration2012-01-01T00:00:002012-06-30T00:00:00sharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli0perShareItemTypeDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_IncomeStatementAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_SalesRevenueGoodsNetus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse917000917USD$falsetruefalse2truefalsefalse750000750USD$falsetruefalse3truefalsefalse21360002136USD$falsetruefalse4truefalsefalse22790002279USD$falsetruefalsexbrli:monetaryItemTypemonetaryAggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(a)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false23false 2us-gaap_ContractsRevenueus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse7300073falsefalsefalse2truefalsefalse545000545falsefalsefalse3truefalsefalse355000355falsefalsefalse4truefalsefalse746000746falsefalsefalsexbrli:monetaryItemTypemonetaryRevenue earned during the period arising from products sold or services provided under the terms of a contract, not elsewhere specified in the taxonomy. May include government contracts, construction contracts, and any other contract related to a particular project or product.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false24false 2us-gaap_OtherSalesRevenueNetus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse880000880falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse11800001180falsefalsefalse4truefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryRevenues from the sale of other goods or rendering of other services, not elsewhere specified in the taxonomy; net of (reduced by) sales adjustments, returns, allowances, and discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(a),(d)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false25false 2us-gaap_Revenuesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse18700001870falsefalsefalse2truefalsefalse12950001295falsefalsefalse3truefalsefalse36710003671falsefalsefalse4truefalsefalse30250003025falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 true26false 2us-gaap_CostOfGoodsSoldus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse837000837falsefalsefalse2truefalsefalse-281000-281falsefalsefalse3truefalsefalse15010001501falsefalsefalse4truefalsefalse38940003894falsefalsefalsexbrli:monetaryItemTypemonetaryTotal costs related to goods produced and sold during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 2 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2(a)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false27false 2us-gaap_ContractRevenueCostus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse2600026falsefalsefalse2truefalsefalse248000248falsefalsefalse3truefalsefalse163000163falsefalsefalse4truefalsefalse403000403falsefalsefalsexbrli:monetaryItemTypemonetaryCosts incurred and are directly related to generating contract revenues.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2(e)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false28false 2us-gaap_CostOfRevenueus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse863000863falsefalsefalse2truefalsefalse-33000-33falsefalsefalse3truefalsefalse16640001664falsefalsefalse4truefalsefalse42970004297falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate cost of goods produced and sold and services rendered during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 2 -Article 5 true29false 2us-gaap_GrossProfitus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse10070001007falsefalsefalse2truefalsefalse13280001328falsefalsefalse3truefalsefalse20070002007falsefalsefalse4truefalsefalse-1272000-1272falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1,2) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 true210false 2us-gaap_ResearchAndDevelopmentExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse23390002339falsefalsefalse2truefalsefalse32270003227falsefalsefalse3truefalsefalse45910004591falsefalsefalse4truefalsefalse71670007167falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 985 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 730 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373 false211false 2us-gaap_SellingGeneralAndAdministrativeExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse21010002101falsefalsefalse2truefalsefalse30640003064falsefalsefalse3truefalsefalse45040004504falsefalsefalse4truefalsefalse63520006352falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 4 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 30 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6386349&loc=d3e3636-108311 false212false 2us-gaap_GainLossOnDispositionOfAssetsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse00falsefalsefalse2truefalsefalse-1000-1falsefalsefalse3truefalsefalse-2000-2falsefalsefalse4truefalsefalse-1000-1falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 false213false 2us-gaap_OperatingExpensesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse44400004440falsefalsefalse2truefalsefalse62900006290falsefalsefalse3truefalsefalse90930009093falsefalsefalse4truefalsefalse1351800013518falsefalsefalsexbrli:monetaryItemTypemonetaryGenerally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.No definition available.true214false 2us-gaap_OperatingIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-3433000-3433falsefalsefalse2truefalsefalse-4962000-4962falsefalsefalse3truefalsefalse-7086000-7086falsefalsefalse4truefalsefalse-14790000-14790falsefalsefalsexbrli:monetaryItemTypemonetaryThe net result for the period of deducting operating expenses from operating revenues.No definition available.true215false 2us-gaap_OtherNonoperatingExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-3000-3falsefalsefalse2truefalsefalse-9000-9falsefalsefalse3truefalsefalse-4000-4falsefalsefalse4truefalsefalse1600016falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate amount of other expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating expense recognized during the period. Such amounts may include: (a) unusual costs, (b) loss on foreign exchange transactions, (c) losses on securities (net of profits), and (d) miscellaneous other expense items.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 9 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.9) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false216false 2us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-3436000-3436USD$falsetruefalse2truefalsefalse-4971000-4971USD$falsetruefalse3truefalsefalse-7090000-7090USD$falsetruefalse4truefalsefalse-14774000-14774USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 true217false 2us-gaap_IncomeLossFromContinuingOperationsPerBasicShareus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-0.13-0.13USD$falsetruefalse2truefalsefalse-0.26-0.26USD$falsetruefalse3truefalsefalse-0.27-0.27USD$falsetruefalse4truefalsefalse-0.82-0.82USD$falsetruefalsenum:perShareItemTypedecimalThe amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.23) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 false318false 2us-gaap_WeightedAverageNumberOfSharesOutstandingBasicus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2649300026493falsefalsefalse2truefalsefalse1916700019167falsefalsefalse3truefalsefalse2587000025870falsefalsefalse4truefalsefalse1809700018097falsefalsefalsexbrli:sharesItemTypesharesNumber of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Weighted-Average Number of Common Shares Outstanding -URI http://asc.fasb.org/extlink&oid=6528421 false1falseConsolidated Statements of Operations (USD $)ThousandsThousandsNoRoundingUnKnowntruefalsefalseSheethttp://microvision.com/role/StatementOfIncome418 XML 43 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 HtmlAndXml 46 145 1 false 11 0 false 5 false false R1.htm 0001 - Document - Document and Entity Information Sheet http://microvision.com/role/DocumentAndEntityInformation Document and Entity Information R1.xml true false R2.htm 0002 - Statement - Consolidated Balance Sheets Sheet http://microvision.com/role/StatementOfFinancialPositionClassified Consolidated Balance Sheets R2.xml false false R3.htm 0003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://microvision.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) R3.xml false false R4.htm 0004 - Statement - Consolidated Statements of Operations Sheet http://microvision.com/role/StatementOfIncome Consolidated Statements of Operations R4.xml false false R5.htm 0005 - Statement - Consolidated Statements of Comprehensive Loss Sheet http://microvision.com/role/StatementOfOtherComprehensiveIncome Consolidated Statements of Comprehensive Loss R5.xml false false R6.htm 0006 - Statement - Consolidated Statements of Cash Flows Sheet http://microvision.com/role/StatementOfCashFlowsIndirect Consolidated Statements of Cash Flows R6.xml false false R7.htm 0007 - Disclosure - MANAGEMENT'S STATEMENT AND PRINCIPLES OF CONSOLIDATION - Note 1 Sheet http://microvision.com/role/OrganizationConsolidationAndPresentationOfFinancialStatements MANAGEMENT'S STATEMENT AND PRINCIPLES OF CONSOLIDATION - Note 1 R7.xml false false R8.htm 0008 - Disclosure - NET LOSS PER SHARE - Note 2 Sheet http://microvision.com/role/EarningsPerShare NET LOSS PER SHARE - Note 2 R8.xml false false R9.htm 0009 - Disclosure - KEY ACCOUNTING POLICY - REVENUE RECOGNITION - Note 3 Sheet http://microvision.com/role/KeyAccountingPolicy-RevenueRecognition-Note3 KEY ACCOUNTING POLICY - REVENUE RECOGNITION - Note 3 R9.xml false false R10.htm 0010 - Disclosure - INVENTORY - Note 4 Sheet http://microvision.com/role/Inventory INVENTORY - Note 4 R10.xml false false R11.htm 0011 - Disclosure - SHARE-BASED COMPENSATION - Note 5 Sheet http://microvision.com/role/CompensationRelatedCostsStockCompensation SHARE-BASED COMPENSATION - Note 5 R11.xml false false R12.htm 0012 - Disclosure - COMMITMENTS AND CONTINGENCIES - Note 6 Sheet http://microvision.com/role/CommitmentAndContingencies COMMITMENTS AND CONTINGENCIES - Note 6 R12.xml false false R13.htm 0013 - Disclosure - COMMON STOCK AND WARRANTS - Note 7 Sheet http://microvision.com/role/CommonStockAndWarrants-Note7 COMMON STOCK AND WARRANTS - Note 7 R13.xml false false R14.htm 0014 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS - Note 8 Sheet http://microvision.com/role/NewAccountingPronouncements-Note8 NEW ACCOUNTING PRONOUNCEMENTS - Note 8 R14.xml false false R15.htm 0015 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://microvision.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) R15.xml false false R16.htm 0016 - Disclosure - Net Loss Per Share (Tables) Sheet http://microvision.com/role/NetLossPerShareTables Net Loss Per Share (Tables) R16.xml false false R17.htm 0017 - Disclosure - Inventory (Tables) Sheet http://microvision.com/role/InventoryTables Inventory (Tables) R17.xml false false R18.htm 0018 - Disclosure - Share-Based Compensation (Tables) Sheet http://microvision.com/role/Share-BasedCompensationTables Share-Based Compensation (Tables) R18.xml false false R19.htm 0019 - Disclosure - Management's Statement (Financing Narrative) (Details) Sheet http://microvision.com/role/ManagementsStatementFinancingNarrativeDetails Management's Statement (Financing Narrative) (Details) R19.xml false false R20.htm 0020 - Disclosure - Net Loss Per Share (Details) Sheet http://microvision.com/role/NetLossPerShareDetails Net Loss Per Share (Details) R20.xml false false R21.htm 0021 - Disclosure - Net Loss Per Share (Convertible Securities and Options Excluded) (Details) Sheet http://microvision.com/role/NetLossPerShareConvertibleSecuritiesAndOptionsExcludedDetails Net Loss Per Share (Convertible Securities and Options Excluded) (Details) R21.xml false false R22.htm 0022 - Disclosure - Collaborative Research and Development Agreement (Details) Sheet http://microvision.com/role/CollaborativeResearchAndDevelopmentAgreementDetails Collaborative Research and Development Agreement (Details) R22.xml false false R23.htm 0023 - Disclosure - Concentration of Customers (Narrative) (Details) Sheet http://microvision.com/role/ConcentrationOfCustomersNarrativeDetails Concentration of Customers (Narrative) (Details) R23.xml false false R24.htm 0024 - Disclosure - Inventory Components (Details) Sheet http://microvision.com/role/InventoryComponentsDetails Inventory Components (Details) R24.xml false false R25.htm 0025 - Disclosure - Inventory (Narrative) (Details) Sheet http://microvision.com/role/InventoryNarrativeDetails Inventory (Narrative) (Details) R25.xml false false R26.htm 0026 - Disclosure - Stock-Based Compensation (Schedule Of Stock-Based Compensation Expense By Statement Of Operations) (Details) Sheet http://microvision.com/role/Stock-BasedCompensationScheduleOfStock-BasedCompensationExpenseByStatementOfOperationsDetails Stock-Based Compensation (Schedule Of Stock-Based Compensation Expense By Statement Of Operations) (Details) R26.xml false false R27.htm 0027 - Disclosure - Shared-Based Compensation (Options Activity and Position) (Details) Sheet http://microvision.com/role/Shared-BasedCompensationOptionsActivityAndPositionDetails Shared-Based Compensation (Options Activity and Position) (Details) R27.xml false false R28.htm 0028 - Disclosure - Share-Based Compensation (Narrative) (Details) Sheet http://microvision.com/role/Share-BasedCompensationNarrativeDetails Share-Based Compensation (Narrative) (Details) R28.xml false false R29.htm 0029 - Disclosure - Commitments and Contingencies (Adverse Purchase Commitments Narrative) (Details) Sheet http://microvision.com/role/CommitmentsAndContingenciesAdversePurchaseCommitmentsNarrativeDetails Commitments and Contingencies (Adverse Purchase Commitments Narrative) (Details) R29.xml false false R30.htm 0030 - Disclosure - Common Stock and Warrants (Narrative) (Details) Sheet http://microvision.com/role/CommonStockAndWarrantsNarrativeDetails Common Stock and Warrants (Narrative) (Details) R30.xml false false All Reports Book All Reports 'Monetary' elements on report '0025 - Disclosure - Inventory (Narrative) (Details)' had a mix of different decimal attribute values. Process Flow-Through: 0002 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Jun. 30, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 0003 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 0004 - Statement - Consolidated Statements of Operations Process Flow-Through: 0005 - Statement - Consolidated Statements of Comprehensive Loss Process Flow-Through: 0006 - Statement - Consolidated Statements of Cash Flows mvis-20130630.xml mvis-20130630.xsd mvis-20130630_cal.xml mvis-20130630_def.xml mvis-20130630_lab.xml mvis-20130630_pre.xml true true XML 44 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (Parenthetical) (USD $)
In Thousands, except Share data, unless otherwise specified
Jun. 30, 2013
Dec. 31, 2012
Current assets    
Allowance for doubtful accounts receivable, current $ 347 $ 332
Stockholders equity    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 25,000,000 25,000,000
Preferred stock, shares issued 0 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 27,925,000 25,237,000
Common stock, shares outstanding 27,925,000 25,237,000
XML 45 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
NEW ACCOUNTING PRONOUNCEMENTS - Note 8
6 Months Ended
Jun. 30, 2013
Notes to Financial Statements  
NEW ACCOUNTING PRONOUNCEMENTS - Note 8

8. NEW ACCOUNTING PRONOUNCEMENTS

In July 2012, the Financial Accounting Standards Board ("FASB") issued guidance that will allow an entity to first assess qualitative factors to determine whether it is necessary to perform a quantitative impairment test for indefinite-lived intangible assets. Under this guidance, an entity would not be required to calculate the fair value of an indefinite-lived intangible asset unless the entity determines, based on qualitative assessment, that it is not more likely than not, the indefinite-lived intangible asset is impaired. This guidance is effective for impairment tests performed for fiscal years beginning after September 15, 2012, with early adoption permitted. We do not expect the implementation of this guidance will have a material impact on our financial statements.

In February 2013, the FASB issued guidance that requires disclosure of amounts reclassified out of accumulated other comprehensive income in its entirety, by component, on the face of the statement of operations or in the notes thereto. Amounts that are not required to be reclassified in their entirety to net income must be cross-referenced to other disclosures that provide additional detail. This standard is effective prospectively for annual and interim reporting periods beginning after December 15, 2012. We do not expect the implementation of this guidance will have a material impact on our financial statements.

 

 

 

XML 46 R20.xml IDEA: Net Loss Per Share (Details) 2.4.0.80020 - Disclosure - Net Loss Per Share (Details)truefalseIn Thousands, except Per Share data, unless otherwise specifiedfalse1false USDfalsefalse$From2013-04-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-04-01T00:00:002013-06-30T00:00:00sharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli0perShareItemTypeDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2012-04-01to2012-06-30http://www.sec.gov/CIK0000065770duration2012-04-01T00:00:002012-06-30T00:00:00sharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli0perShareItemTypeDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$From2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:00sharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli0perShareItemTypeDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$From2012-01-01to2012-06-30http://www.sec.gov/CIK0000065770duration2012-01-01T00:00:002012-06-30T00:00:00sharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli0perShareItemTypeDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1mvis_NetLossPerShareDetailsAbstractmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-3436000-3436USD$falsetruefalse2truefalsefalse-4971000-4971USD$falsetruefalse3truefalsefalse-7090000-7090USD$falsetruefalse4truefalsefalse-14774000-14774USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 false23false 2us-gaap_WeightedAverageNumberOfSharesOutstandingBasicus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2649300026493falsefalsefalse2truefalsefalse1916700019167falsefalsefalse3truefalsefalse2587000025870falsefalsefalse4truefalsefalse1809700018097falsefalsefalsexbrli:sharesItemTypesharesNumber of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Weighted-Average Number of Common Shares Outstanding -URI http://asc.fasb.org/extlink&oid=6528421 false14false 2us-gaap_IncomeLossFromContinuingOperationsPerBasicShareus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-0.13-0.13USD$falsetruefalse2truefalsefalse-0.26-0.26USD$falsetruefalse3truefalsefalse-0.27-0.27USD$falsetruefalse4truefalsefalse-0.82-0.82USD$falsetruefalsenum:perShareItemTypedecimalThe amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.23) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 false3falseNet Loss Per Share (Details) (USD $)ThousandsThousandsNoRoundingUnKnowntruefalsefalseSheethttp://microvision.com/role/NetLossPerShareDetails44 XML 47 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Comprehensive Loss (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Statement of Comprehensive Income [Abstract]        
Net loss $ (3,436) $ (4,971) $ (7,090) $ (14,774)
Other comprehensive gain (loss):        
Unrealized gain (loss) on investment securities, available-for-sale 0 (2) 0 3
Less: reclassification adjustment for losses realized in net loss 0 32 0 32
Comprehensive loss $ (3,436) $ (4,941) $ (7,090) $ (14,739)
XML 48 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2013
Dec. 31, 2012
Statement of Financial Position [Abstract]    
Cash and cash equivalents $ 6,003 $ 6,850
Accounts receivable, net of allowance of $347 and $332 1,088 1,115
Costs and estimated earnings in excess of billings on uncompleted contracts 12 12
Inventory 44 497
Other current assets 305 1,221
Total current assets 7,452 9,695
Property and equipment, net 1,191 1,205
Restricted cash 435 436
Intangible assets 1,501 1,580
Other assets 18 22
Total assets 10,597 12,938
Accounts payable 2,106 3,035
Accrued liabilities 3,253 4,007
Deferred revenue 28 609
Billings in excess of costs and estimated earnings on uncompleted contracts 863 98
Warrant liability 3,755 0
Current portion of capital lease obligations 43 48
Current portion of long-term debt 17 67
Total current liabilities 10,065 7,864
Capital lease obligations, net of current portion 0 20
Deferred rent, net of current portion 330 0
Total liabilities 10,395 7,884
Commitments and contingencies (Note 7)     
Preferred stock, par value $.001; 25,000 shares authorized; 0 and 0 shares issued and outstanding 0 0
Common stock, par value $.001; 100,000 shares authorized; 27,925 and 25,237 shares issued and outstanding 28 25
Additional paid-in capital 444,795 442,560
Accumulated deficit (444,621) (437,531)
Total shareholders' equity 202 5,054
Total liabilities and shareholders' equity $ 10,597 $ 12,938
XML 49 R7.xml IDEA: MANAGEMENT'S STATEMENT AND PRINCIPLES OF CONSOLIDATION - Note 1 2.4.0.80007 - Disclosure - MANAGEMENT'S STATEMENT AND PRINCIPLES OF CONSOLIDATION - Note 1truefalsefalse1false falsefalseFrom2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:001true 1mvis_OrganizationConsolidationAbstractAddedmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>1. MANAGEMENT'S STATEMENT AND PRINCIPLES OF CONSOLIDATION&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><u>Management's Statement</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The Consolidated Balance Sheet as of June 30, 2013, the Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended June 30, 2013 and 2012, and Consolidated Statements of Cash Flows for the six months ended June 30, 2013 and 2012 have been prepared by MicroVision, Inc. (&#34;we&#34; or &#34;us&#34;) and have not been audited. In the opinion of management, all adjustments necessary to state fairly the financial position at June 30, 2013 and the results of operations, comprehensive loss and cash flows for all periods presented have been made and consist of normal recurring adjustments. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the rules of the Securities and Exchange Commission (the &#34;SEC&#34;). The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. You should read these condensed consolidated financial statements in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012. The results of operations for the three and six months ended June 30, 2013 are not necessarily indicative of the operating results that may be attained for the entire fiscal year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We have incurred significant losses since inception. We have funded operations to date primarily through the sale of common stock, convertible preferred stock, warrants, the issuance of convertible debt and, to a lesser extent, from contract revenues, collaborative research and development agreements and product sales. At June 30, 2013, we had $6.0 million in cash and cash equivalents and a working capital deficit of $2.6 million.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Based on our current operating plan, we anticipate that we have sufficient cash and cash equivalents to fund our operations through October of 2013. We will require additional cash to fund our operating plan past that time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We plan to obtain additional cash through the issuance of equity or debt securities. There can be no assurance that additional cash will be available or that, if available, it will be available on terms acceptable to us on a timely basis. If adequate funds are not available on a timely basis, we intend to consider limiting our operations substantially to extend our funds as we pursue other financing opportunities and business relationships. This limitation of operations could include delaying development projects and reductions in staff and operating costs, including research and development, and capital expenditures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We are introducing new technology into an emerging market which creates significant uncertainty about our ability to accurately project revenue, costs and cash flows. Our capital requirements will depend on many factors, including, but not limited to, the rate at which we can, directly or through arrangements with OEMs, introduce products incorporating the PicoP display engine and image capture technologies and the market acceptance and competitive position of such products. If revenues are less than anticipated, if the mix of revenues vary from anticipated amounts or if expenses exceed the amounts budgeted, we may require additional capital earlier than expected to further the development of our technologies, for expenses associated with product development, and to respond to competitive pressures or to meet unanticipated development difficulties. In addition, our operating plan provides for the development of strategic relationships with systems and equipment manufacturers that may require additional investments by us.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In May 2013, we raised $5.85 million before issuance costs of approximately $362,000 from the sale of 2.6 million shares of common stock and warrants to purchase up to an aggregate of 2.0 million shares of our common stock in a registered direct offering. The warrants have an exercise price of $2.886 per share, a five year term, and are exercisable beginning on the date of issuance. Each warrant to purchase a share of common stock may also be exchanged during its term for a number of shares of common stock (but not more than one share of common stock for each warrant so exchanged) with a value determined by a negotiated formula if, among other things, our common stock is then trading at a price at or lower than the warrant exercise price per share. Subject to limitations in the warrants, we may require the warrants be exercised for cash if the closing bid price of our stock is over $3.61 for 20 consecutive trading days and the average daily dollar volume over that period is equal to or exceeds $300,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We have received a report from our independent registered public accounting firm regarding the consolidated financial statements for the year ended December 31, 2012 that includes an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. These consolidated financial statements are prepared assuming the Company will continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><u>Principles of Consolidation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Our condensed consolidated financial statements include the accounts of MicroVision, Inc. and MicroVision Innovations Singapore Pte. Ltd. (&#34;MicroVision Singapore&#34;), a wholly owned foreign subsidiary. MicroVision Singapore was incorporated in April 2011 and is engaged in operational support functions for MicroVision, Inc. There were no material intercompany accounts and transactions during the three and six months ended June 30, 2013.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.No definition available.false0falseMANAGEMENT'S STATEMENT AND PRINCIPLES OF CONSOLIDATION - Note 1UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/OrganizationConsolidationAndPresentationOfFinancialStatements12 XML 50 R17.xml IDEA: Inventory (Tables) 2.4.0.80017 - Disclosure - Inventory (Tables)truefalsefalse1false falsefalseFrom2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:001true 1mvis_InventoryTablesAbstractmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_ScheduleOfInventoryCurrentTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Inventory consists of the following:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>&#160;&#160;&#160; June 30, &#160;&#160;&#160;</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Raw materials</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">11,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">361,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Finished goods</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">33,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">136,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">44,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">497,000&#160;</font></td></tr> </table> <p style="margin: 0">&#160;</p> <p style="margin: 0">&#160;</p> <p style="margin: 0">&#160;</p> <p style="margin: 0"></p>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 2 -Paragraph 6 -Subparagraph a,b,c -Article 5 false0falseInventory (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/InventoryTables12 XML 51 R16.xml IDEA: Net Loss Per Share (Tables) 2.4.0.80016 - Disclosure - Net Loss Per Share (Tables)truefalsefalse1false falsefalseFrom2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:001true 1mvis_NetLossPerShareTablesAbstractmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The components of basic and diluted net loss per share were as follows (in thousands, except loss per share data):</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Three Months Ended</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Six Months Ended</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Numerator:</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Net loss available for common shareholders - basic and diluted</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(3,436)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(4,971)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(7,090)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(14,774)</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Denominator:</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Weighted-average common shares outstanding - basic and diluted &#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">26,493&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">19,167&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">25,870&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">18,097&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Net loss per share - basic and diluted &#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(0.13)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(0.26)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(0.27)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(0.82)</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 false03false 2us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We excluded the following convertible securities from diluted net loss per share, as the effect of including them would have been anti-dilutive:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Three Months Ended</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Six Months Ended</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Publicly Traded Warrants Exercisable</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">753,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">753,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">753,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">753,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Options and Private Warrants Exercisable</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">7,612,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5,302,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">7,612,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5,302,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Nonvested Equity Shares</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">80,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">80,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Total</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,580,000&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,135,000&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,580,000&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,135,000&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 false0falseNet Loss Per Share (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/NetLossPerShareTables13 XML 52 R27.xml IDEA: Shared-Based Compensation (Options Activity and Position) (Details) 2.4.0.80027 - Disclosure - Shared-Based Compensation (Options Activity and Position) (Details)truefalsefalse1false USDfalsefalseFrom2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:00sharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli0perShareItemTypeDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$1true 1mvis_OptionsActivityAndPositionDetailsAbstractmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse12550001255000falsefalsefalsexbrli:sharesItemTypesharesNumber of options outstanding, including both vested and non-vested options.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i)-(ii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false13false 2us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse12.6312.63USD$falsetruefalsenum:perShareItemTypedecimalWeighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false34false 2us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse006 years 10 months 24 daysfalsefalsefalsexbrli:durationItemTypenaWeighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false05false 2us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse376000376000USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false26false 2us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse770000770000falsefalsefalsexbrli:sharesItemTypesharesThe number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false17false 2us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse18.8018.80USD$falsetruefalsenum:perShareItemTypedecimalThe weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false38false 2us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse005 years 7 months 6 daysfalsefalsefalsexbrli:durationItemTypenaWeighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false09false 2us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1us-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse9700097000USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false2falseShared-Based Compensation (Options Activity and Position) (Details) (USD $)NoRoundingNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://microvision.com/role/Shared-BasedCompensationOptionsActivityAndPositionDetails19 XML 53 R18.xml IDEA: Share-Based Compensation (Tables) 2.4.0.80018 - Disclosure - Share-Based Compensation (Tables)truefalsefalse1false falsefalseFrom2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:001true 1mvis_SharebasedCompensationTablesAbstractmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The following table shows the amount of stock-based compensation expense included in the consolidated statements of operations:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Three Months Ended</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="text-align: center"><font style="font-size: 10pt"><b>Six Months Ended</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2013</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2012</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Cost of contract revenue</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">4,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">4,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">10,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Cost of product revenue</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Research and development expense</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(72,000)</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">87,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">88,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">224,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Sales, marketing, general and administrative expense</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">168,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">390,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">388,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">600<font style="font-size: 10pt">,000&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="background-color: white"><font style="font-size: 10pt">Total share-based employee compensation expense</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">96,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">481,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">481,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">854,000&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false03false 2us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The following table summarizes shares, weighted average exercise price, weighted average remaining contractual term and aggregate intrinsic value of options outstanding and options exercisable as of June 30, 2013:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Remaining</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Contractual</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Aggregate</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Term</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Intrinsic</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">Options</font></td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Shares</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>(years)</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Value</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Outstanding as of June 30, 2013</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,255,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">12.63&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6.9&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">376,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white"><font style="font-size: 10pt">Exercisable as of June 30, 2013</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">770,000&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">18.80&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5.6&#160;</font></td> <td style="background-color: white; text-align: right">&#160;</td> <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">97,000&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the following for fully vested share options (or share units) and share options expected to vest at the date of the latest statement of financial position: the number, weighted-average exercise price (or conversion ratio), aggregate intrinsic value (except for nonpublic entities), and weighted-average remaining contractual term of options (or share units) outstanding.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false0falseShare-Based Compensation (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/Share-BasedCompensationTables13 XML 54 R3.xml IDEA: Consolidated Balance Sheets (Parenthetical) 2.4.0.80003 - Statement - Consolidated Balance Sheets (Parenthetical)truefalseIn Thousands, except Share data, unless otherwise specifiedfalse1false USDfalsefalse$AsOf2013-06-30http://www.sec.gov/CIK0000065770instant2013-06-30T00:00:000001-01-01T00:00:00sharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli0perShareItemTypeDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$AsOf2012-12-31http://www.sec.gov/CIK0000065770instant2012-12-31T00:00:000001-01-01T00:00:00sharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli0perShareItemTypeDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 2us-gaap_AssetsCurrentAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 3us-gaap_AllowanceForDoubtfulAccountsReceivableCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse347000347USD$falsetruefalse2truefalsefalse332000332USD$falsetruefalsexbrli:monetaryItemTypemonetaryA valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 4 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=28368275&loc=d3e5074-111524 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.4) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false23true 2us-gaap_StockholdersEquityAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse04false 3us-gaap_PreferredStockParOrStatedValuePerShareus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse0.0010.001USD$falsetruefalse2truefalsefalse0.0010.001USD$falsetruefalsenum:perShareItemTypedecimalFace amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false35false 3us-gaap_PreferredStockSharesAuthorizedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2500000025000000falsefalsefalse2truefalsefalse2500000025000000falsefalsefalsexbrli:sharesItemTypesharesThe maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false16false 3us-gaap_PreferredStockSharesIssuedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesTotal number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false17false 3us-gaap_CommonStockParOrStatedValuePerShareus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse0.0010.001USD$falsetruefalse2truefalsefalse0.0010.001USD$falsetruefalsenum:perShareItemTypedecimalFace amount or stated value per share of common stock.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false38false 3us-gaap_CommonStockSharesAuthorizedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse100000000100000000falsefalsefalse2truefalsefalse100000000100000000falsefalsefalsexbrli:sharesItemTypesharesThe maximum number of common shares permitted to be issued by an entity's charter and bylaws.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false19false 3us-gaap_CommonStockSharesIssuedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2792500027925000falsefalsefalse2truefalsefalse2523700025237000falsefalsefalsexbrli:sharesItemTypesharesTotal number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false110false 3us-gaap_CommonStockSharesOutstandingus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2792500027925000falsefalsefalse2truefalsefalse2523700025237000falsefalsefalsexbrli:sharesItemTypesharesNumber of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false1falseConsolidated Balance Sheets (Parenthetical) (USD $)ThousandsNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://microvision.com/role/BalanceSheetsParenthetical210 XML 55 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies (Adverse Purchase Commitments Narrative) (Details) (USD $)
Jun. 30, 2013
Dec. 31, 2012
Commitments And Contingencies Adverse Purchase Commitments Narrative Details    
Accrued liability for loss on commitments to purchase materials to support production of PicoP based products $ 500,000 $ 634,000
XML 56 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Concentration of Customers (Narrative) (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2013
Customer Revenue Concentration
   
Concentration Risk, Percentage 93.00% 89.00%
Accounts Receivable Concentration
   
Concentration Risk, Percentage   98.00%
XML 57 R30.xml IDEA: Common Stock and Warrants (Narrative) (Details) 2.4.0.80030 - Disclosure - Common Stock and Warrants (Narrative) (Details)truefalseShare data in Millions, except Per Share data, unless otherwise specifiedfalse1false USDfalsefalse$From2013-05-01to2013-05-31http://www.sec.gov/CIK0000065770duration2013-05-01T00:00:002013-05-31T00:00:00sharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170perShareItemTypeDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$1true 1mvis_CommonStockAndWarrantsNarrativeDetailsAbstractmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_StockIssuedDuringPeriodSharesNewIssuesus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse26000002.6falsefalsefalsexbrli:sharesItemTypesharesNumber of new stock issued during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30 -Article 5 false13false 2us-gaap_StockIssuedDuringPeriodValueNewIssuesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse58500005850000USD$falsetruefalsexbrli:monetaryItemTypemonetaryEquity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 false24false 2us-gaap_PaymentsOfStockIssuanceCostsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse362000362000USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe cash outflow for cost incurred directly with the issuance of an equity security.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585 false25false 2us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse20000002.0falsefalsefalsexbrli:sharesItemTypesharesNumber of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(2)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph i -Subparagraph 2 -Article 4 false16false 2us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2.8862.886USD$falsetruefalseus-types:perUnitItemTypedecimalExercise price per share or per unit of warrants or rights outstanding.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(4)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph i -Subparagraph 4 -Article 4 false37false 2us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisableus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse002013-05-31falsefalsetruexbrli:dateItemTypedateDate the warrants or rights are exercisable, in CCYY-MM-DD format.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(3)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph i -Subparagraph 3 -Article 4 false08false 2mvis_WarrantTermInYearsmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse005 years 0 months 0 daysfalsefalsefalseus-types:durationStringItemTypenormalizedstringNo authoritative reference available.No definition available.false09false 2us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployeesus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Based on the terms of the agreement, we have determined that the warrant instruments should be classified as a liability given that the warrants could result in the issuance of a variable number of common shares based on a conditional exercise provision that is outside of our control at any point when the share price of our common stock is equal to or less than the stated exercise price of $2.886 per share. At the date of issuance, and as of June 30, 2013, our common stock was trading at a value less than the stated exercise price, as such upon expiration of the 45 day lock up period, the holders may elect to exchange the warrants for a variable number of shares of common stock as determined by a negotiated formula included in the warrant agreement. However, the agreement contains a limit that restricts the number of shares that may be issued under this exchange provision, such that we will not issue any more common shares than could be issued on a one-for-one basis upon exercise of the warrants. As of June 30, 2013, based upon the terms of the agreement and the quoted market price of our common stock, if the exchange feature were to be fully exercised, we would be required to issue approximately 1,490,000 shares of common stock, equal to an estimated fair market value of $3,755,000, which we believe is the best indication of the fair value of the warrant obligation as of June 30, 2013. Changes in the market value of our common stock will increase or decrease the number of shares to be issued under this exchange feature; however the aggregate fair market value of shares to be issued under this provision will not change significantly due to the negotiated and fixed exchange formula in the agreement. Due to the limiting provisions on the exchange agreement, the maximum number of shares of common stock that we could be required to issue is 1,976,352.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>falsefalsefalsexbrli:stringItemTypestringDescription of the purpose of issuing warrants to nonemployees.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666 false0falseCommon Stock and Warrants (Narrative) (Details) (USD $)NoRoundingHundredThousandsNoRoundingUnKnowntruefalsefalseSheethttp://microvision.com/role/CommonStockAndWarrantsNarrativeDetails19 XML 58 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
COMMON STOCK AND WARRANTS - Note 7
6 Months Ended
Jun. 30, 2013
Common Stock And Warrants - Note 7  
COMMON STOCK AND WARRANTS - Note 7

7. COMMON STOCK AND WARRANTS

In May 2013, we raised $5.85 million before issuance costs of approximately $362,000 from the sale of 2.6 million shares of common stock and warrants to purchase up to an aggregate of 2.0 million shares of our common stock in a registered direct offering. The warrants have an exercise price of $2.886 per share, a five year term, and are exercisable beginning on the date of issuance. Each warrant to purchase a share of common stock may also be exchanged during its term for a number of shares of common stock (but not more than one share of common stock for each warrant so exchanged) with a value determined by a negotiated formula if, among other things, our common stock is then trading at a price at or lower than the warrant exercise price per share. Subject to limitations in the warrants, we may require the warrants be exercised for cash if the closing bid price of our stock is over $3.61 for 20 consecutive trading days and the average daily dollar volume over that period is equal to or exceeds $300,000.

Based on the terms of the agreement, we have determined that the warrant instruments should be classified as a liability given that the warrants could result in the issuance of a variable number of common shares based on a conditional exercise provision that is outside of our control at any point when the share price of our common stock is equal to or less than the stated exercise price of $2.886 per share. At the date of issuance, and as of June 30, 2013, our common stock was trading at a value less than the stated exercise price, as such upon expiration of the 45 day lock up period, the holders may elect to exchange the warrants for a variable number of shares of common stock as determined by a negotiated formula included in the warrant agreement. However, the agreement contains a limit that restricts the number of shares that may be issued under this exchange provision, such that we will not issue any more common shares than could be issued on a one-for-one basis upon exercise of the warrants. As of June 30, 2013, based upon the terms of the agreement and the quoted market price of our common stock, if the exchange feature were to be fully exercised, we would be required to issue approximately 1,490,000 shares of common stock, equal to an estimated fair market value of $3,755,000, which we believe is the best indication of the fair value of the warrant obligation as of June 30, 2013. Changes in the market value of our common stock will increase or decrease the number of shares to be issued under this exchange feature; however the aggregate fair market value of shares to be issued under this provision will not change significantly due to the negotiated and fixed exchange formula in the agreement. Due to the limiting provisions on the exchange agreement, the maximum number of shares of common stock that we could be required to issue is 1,976,352.

At each balance sheet date, we will evaluate the fair value of the warrants and any change in value will be recorded as a non-operating gain or loss on the statement of operations. We will re-assess the appropriate valuation model for determining the estimated fair value of the warrant instruments, which may include a binomial valuation model to take into consideration the other features of the warrants. Determination of the fair market value of the warrant instruments includes consideration of Level 3 inputs. Level 3 inputs are unobservable inputs for which there is little or no market data, which requires us to develop our own assumptions, which are significant to the measurement of the fair values.

 

XML 59 R21.xml IDEA: Net Loss Per Share (Convertible Securities and Options Excluded) (Details) 2.4.0.80021 - Disclosure - Net Loss Per Share (Convertible Securities and Options Excluded) (Details)truefalsefalse1false falsefalseFrom2013-04-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-04-01T00:00:002013-06-30T00:00:00sharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli02false falsefalseFrom2012-04-01to2012-06-30http://www.sec.gov/CIK0000065770duration2012-04-01T00:00:002012-06-30T00:00:00sharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli03false falsefalseFrom2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:00sharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli04false falsefalseFrom2012-01-01to2012-06-30http://www.sec.gov/CIK0000065770duration2012-01-01T00:00:002012-06-30T00:00:00sharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli01false 4us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse85800008580000falsefalsefalse2truefalsefalse61350006135000falsefalsefalse3truefalsefalse85800008580000falsefalsefalse4truefalsefalse61350006135000falsefalsefalsexbrli:sharesItemTypesharesSecurities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Antidilution -URI http://asc.fasb.org/extlink&oid=6505113 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Diluted Earnings Per Share -URI http://asc.fasb.org/extlink&oid=6510752 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Contingent Stock Agreement -URI http://asc.fasb.org/extlink&oid=6508534 false12false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5false truefalseFrom2013-04-01to2013-06-30_WarrantMemberhttp://www.sec.gov/CIK0000065770duration2013-04-01T00:00:002013-06-30T00:00:00falsefalsePublicly Traded Warrants Exercisableus-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_WarrantMemberus-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxisexplicitMembersharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli0nanafalse03false 4us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse753000753000falsefalsefalse2truefalsefalse753000753000falsefalsefalse3truefalsefalse753000753000falsefalsefalse4truefalsefalse753000753000falsefalsefalsexbrli:sharesItemTypesharesSecurities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Antidilution -URI http://asc.fasb.org/extlink&oid=6505113 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Diluted Earnings Per Share -URI http://asc.fasb.org/extlink&oid=6510752 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Contingent Stock Agreement -URI http://asc.fasb.org/extlink&oid=6508534 false14false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse9false truefalseFrom2013-04-01to2013-06-30_StockCompensationPlanMemberhttp://www.sec.gov/CIK0000065770duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseOptions and Private Warrants Exercisableus-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_StockCompensationPlanMemberus-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxisexplicitMembersharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli0nanafalse05false 4us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse76120007612000falsefalsefalse2truefalsefalse53020005302000falsefalsefalse3truefalsefalse76120007612000falsefalsefalse4truefalsefalse53020005302000falsefalsefalsexbrli:sharesItemTypesharesSecurities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Antidilution -URI http://asc.fasb.org/extlink&oid=6505113 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Diluted Earnings Per Share -URI http://asc.fasb.org/extlink&oid=6510752 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Contingent Stock Agreement -URI http://asc.fasb.org/extlink&oid=6508534 false16false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse13false truefalseFrom2013-04-01to2013-06-30_RestrictedStockMemberhttp://www.sec.gov/CIK0000065770duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseNonvested Equity Sharesus-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_RestrictedStockMemberus-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxisexplicitMembersharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli0nanafalse07false 4us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse215000215000falsefalsefalse2truefalsefalse8000080000falsefalsefalse3truefalsefalse215000215000falsefalsefalse4truefalsefalse8000080000falsefalsefalsexbrli:sharesItemTypesharesSecurities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Antidilution -URI http://asc.fasb.org/extlink&oid=6505113 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Diluted Earnings Per Share -URI http://asc.fasb.org/extlink&oid=6510752 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Contingent Stock Agreement -URI http://asc.fasb.org/extlink&oid=6508534 false1falseNet Loss Per Share (Convertible Securities and Options Excluded) (Details)UnKnownNoRoundingUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/NetLossPerShareConvertibleSecuritiesAndOptionsExcludedDetails47 XML 60 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Common Stock and Warrants (Narrative) (Details) (USD $)
Share data in Millions, except Per Share data, unless otherwise specified
1 Months Ended
May 31, 2013
Common Stock And Warrants Narrative Details  
Number of shares of common stock issued 2.6
Cash received from stock sale, before issuance costs $ 5,850,000
Stock issuance costs $ 362,000
Common shares underlying warrants 2.0
Warrant exercise price, per share $ 2.886
Date from which warrants are exercisable May 31, 2013
Warrant term, in years 5 years 0 months 0 days
Warrant terms and provisions

Based on the terms of the agreement, we have determined that the warrant instruments should be classified as a liability given that the warrants could result in the issuance of a variable number of common shares based on a conditional exercise provision that is outside of our control at any point when the share price of our common stock is equal to or less than the stated exercise price of $2.886 per share. At the date of issuance, and as of June 30, 2013, our common stock was trading at a value less than the stated exercise price, as such upon expiration of the 45 day lock up period, the holders may elect to exchange the warrants for a variable number of shares of common stock as determined by a negotiated formula included in the warrant agreement. However, the agreement contains a limit that restricts the number of shares that may be issued under this exchange provision, such that we will not issue any more common shares than could be issued on a one-for-one basis upon exercise of the warrants. As of June 30, 2013, based upon the terms of the agreement and the quoted market price of our common stock, if the exchange feature were to be fully exercised, we would be required to issue approximately 1,490,000 shares of common stock, equal to an estimated fair market value of $3,755,000, which we believe is the best indication of the fair value of the warrant obligation as of June 30, 2013. Changes in the market value of our common stock will increase or decrease the number of shares to be issued under this exchange feature; however the aggregate fair market value of shares to be issued under this provision will not change significantly due to the negotiated and fixed exchange formula in the agreement. Due to the limiting provisions on the exchange agreement, the maximum number of shares of common stock that we could be required to issue is 1,976,352.

 

 

XML 61 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Net Loss Per Share (Tables)
6 Months Ended
Jun. 30, 2013
Net Loss Per Share Tables  
Net Loss Per Share (Tables)

The components of basic and diluted net loss per share were as follows (in thousands, except loss per share data):

      Three Months Ended     Six Months Ended
      June 30,     June 30,
      2013     2012     2013     2012
Numerator:                        
Net loss available for common shareholders - basic and diluted   $ (3,436)   $ (4,971)   $ (7,090)   $ (14,774)
                         
Denominator:                        
Weighted-average common shares outstanding - basic and diluted       26,493      19,167      25,870      18,097 
                         
Net loss per share - basic and diluted     $ (0.13)   $ (0.26)   $ (0.27)   $ (0.82)

 

 

 

Anti-dilutive securities

We excluded the following convertible securities from diluted net loss per share, as the effect of including them would have been anti-dilutive:

      Three Months Ended     Six Months Ended
      June 30,     June 30,
      2013     2012     2013     2012
Publicly Traded Warrants Exercisable     753,000      753,000      753,000      753,000 
Options and Private Warrants Exercisable     7,612,000      5,302,000      7,612,000      5,302,000 
Nonvested Equity Shares     215,000      80,000      215,000      80,000 
                         
Total     8,580,000      6,135,000      8,580,000      6,135,000 

 

 

XML 62 R22.xml IDEA: Collaborative Research and Development Agreement (Details) 2.4.0.80022 - Disclosure - Collaborative Research and Development Agreement (Details)truefalseIn Millions, unless otherwise specifiedfalse1false USDfalsefalse$AsOf2013-06-30http://www.sec.gov/CIK0000065770instant2013-06-30T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1mvis_CollaborativeResearchAndDevelopmentAgreementDetailsAbstractmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2mvis_DateOfCollaborativeResearchAndDevelopmentAgreementmvis_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00March 2013falsefalsefalsexbrli:stringItemTypestringDate of collaborative research and development agreementNo definition available.false03false 2mvis_AmountOfCollaborativeResearchAndDevelopmentAgreementmvis_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse46000004.6USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of collaborative research and development agreementNo definition available.false2falseCollaborative Research and Development Agreement (Details) (USD $)HundredThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/CollaborativeResearchAndDevelopmentAgreementDetails13 XML 63 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
COMMITMENTS AND CONTINGENCIES - Note 6
6 Months Ended
Jun. 30, 2013
Commitments And Contingencies Disclosure Footnote  
Commitments and Contingencies - Note 6

6. COMMITMENTS AND CONTINGENCIES

Litigation

We are subject to various claims and pending or threatened lawsuits in the normal course of business. We are not currently party to any legal proceedings that management believes are reasonably possible to have a material adverse effect on our consolidated financial position, results of operations or cash flows.

Adverse purchase commitments

We have periodically entered into noncancelable purchase contracts in order to ensure the availability of materials to support production of products based on our PicoP display technology. We periodically assess the need to provide for impairment on these purchase contracts and record a loss on purchase commitments when required. As of June 30, 2013 and December 31, 2012 we had approximately $500,000 and $634,000, respectively, accrued for adverse purchase commitments related to these purchase contracts.

 

 

XML 64 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
MANAGEMENT'S STATEMENT AND PRINCIPLES OF CONSOLIDATION - Note 1
6 Months Ended
Jun. 30, 2013
Organization Consolidation Abstract  
Management's Statement and Principles of Consolidation - Note 1

1. MANAGEMENT'S STATEMENT AND PRINCIPLES OF CONSOLIDATION 

Management's Statement

The Consolidated Balance Sheet as of June 30, 2013, the Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended June 30, 2013 and 2012, and Consolidated Statements of Cash Flows for the six months ended June 30, 2013 and 2012 have been prepared by MicroVision, Inc. ("we" or "us") and have not been audited. In the opinion of management, all adjustments necessary to state fairly the financial position at June 30, 2013 and the results of operations, comprehensive loss and cash flows for all periods presented have been made and consist of normal recurring adjustments. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the rules of the Securities and Exchange Commission (the "SEC"). The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. You should read these condensed consolidated financial statements in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012. The results of operations for the three and six months ended June 30, 2013 are not necessarily indicative of the operating results that may be attained for the entire fiscal year.

We have incurred significant losses since inception. We have funded operations to date primarily through the sale of common stock, convertible preferred stock, warrants, the issuance of convertible debt and, to a lesser extent, from contract revenues, collaborative research and development agreements and product sales. At June 30, 2013, we had $6.0 million in cash and cash equivalents and a working capital deficit of $2.6 million.

Based on our current operating plan, we anticipate that we have sufficient cash and cash equivalents to fund our operations through October of 2013. We will require additional cash to fund our operating plan past that time.

We plan to obtain additional cash through the issuance of equity or debt securities. There can be no assurance that additional cash will be available or that, if available, it will be available on terms acceptable to us on a timely basis. If adequate funds are not available on a timely basis, we intend to consider limiting our operations substantially to extend our funds as we pursue other financing opportunities and business relationships. This limitation of operations could include delaying development projects and reductions in staff and operating costs, including research and development, and capital expenditures.

We are introducing new technology into an emerging market which creates significant uncertainty about our ability to accurately project revenue, costs and cash flows. Our capital requirements will depend on many factors, including, but not limited to, the rate at which we can, directly or through arrangements with OEMs, introduce products incorporating the PicoP display engine and image capture technologies and the market acceptance and competitive position of such products. If revenues are less than anticipated, if the mix of revenues vary from anticipated amounts or if expenses exceed the amounts budgeted, we may require additional capital earlier than expected to further the development of our technologies, for expenses associated with product development, and to respond to competitive pressures or to meet unanticipated development difficulties. In addition, our operating plan provides for the development of strategic relationships with systems and equipment manufacturers that may require additional investments by us.

In May 2013, we raised $5.85 million before issuance costs of approximately $362,000 from the sale of 2.6 million shares of common stock and warrants to purchase up to an aggregate of 2.0 million shares of our common stock in a registered direct offering. The warrants have an exercise price of $2.886 per share, a five year term, and are exercisable beginning on the date of issuance. Each warrant to purchase a share of common stock may also be exchanged during its term for a number of shares of common stock (but not more than one share of common stock for each warrant so exchanged) with a value determined by a negotiated formula if, among other things, our common stock is then trading at a price at or lower than the warrant exercise price per share. Subject to limitations in the warrants, we may require the warrants be exercised for cash if the closing bid price of our stock is over $3.61 for 20 consecutive trading days and the average daily dollar volume over that period is equal to or exceeds $300,000.

We have received a report from our independent registered public accounting firm regarding the consolidated financial statements for the year ended December 31, 2012 that includes an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. These consolidated financial statements are prepared assuming the Company will continue as a going concern.

Principles of Consolidation

Our condensed consolidated financial statements include the accounts of MicroVision, Inc. and MicroVision Innovations Singapore Pte. Ltd. ("MicroVision Singapore"), a wholly owned foreign subsidiary. MicroVision Singapore was incorporated in April 2011 and is engaged in operational support functions for MicroVision, Inc. There were no material intercompany accounts and transactions during the three and six months ended June 30, 2013.

 

 

 

XML 65 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 66 R13.xml IDEA: COMMON STOCK AND WARRANTS - Note 7 2.4.0.80013 - Disclosure - COMMON STOCK AND WARRANTS - Note 7truefalsefalse1false falsefalseFrom2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:001true 1mvis_CommonStockAndWarrantsNote7Abstractmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_StockholdersEquityNoteDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>7. COMMON STOCK AND WARRANTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In May 2013, we raised $5.85 million before issuance costs of approximately $362,000 from the sale of 2.6 million shares of common stock and warrants to purchase up to an aggregate of 2.0 million shares of our common stock in a registered direct offering. The warrants have an exercise price of $2.886 per share, a five year term, and are exercisable beginning on the date of issuance. Each warrant to purchase a share of common stock may also be exchanged during its term for a number of shares of common stock (but not more than one share of common stock for each warrant so exchanged) with a value determined by a negotiated formula if, among other things, our common stock is then trading at a price at or lower than the warrant exercise price per share. Subject to limitations in the warrants, we may require the warrants be exercised for cash if the closing bid price of our stock is over $3.61 for 20 consecutive trading days and the average daily dollar volume over that period is equal to or exceeds $300,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Based on the terms of the agreement, we have determined that the warrant instruments should be classified as a liability given that the warrants could result in the issuance of a variable number of common shares based on a conditional exercise provision that is outside of our control at any point when the share price of our common stock is equal to or less than the stated exercise price of $2.886 per share. At the date of issuance, and as of June 30, 2013, our common stock was trading at a value less than the stated exercise price, as such upon expiration of the 45 day lock up period, the holders may elect to exchange the warrants for a variable number of shares of common stock as determined by a negotiated formula included in the warrant agreement. However, the agreement contains a limit that restricts the number of shares that may be issued under this exchange provision, such that we will not issue any more common shares than could be issued on a one-for-one basis upon exercise of the warrants. As of June 30, 2013, based upon the terms of the agreement and the quoted market price of our common stock, if the exchange feature were to be fully exercised, we would be required to issue approximately 1,490,000 shares of common stock, equal to an estimated fair market value of $3,755,000, which we believe is the best indication of the fair value of the warrant obligation as of June 30, 2013. Changes in the market value of our common stock will increase or decrease the number of shares to be issued under this exchange feature; however the aggregate fair market value of shares to be issued under this provision will not change significantly due to the negotiated and fixed exchange formula in the agreement. Due to the limiting provisions on the exchange agreement, the maximum number of shares of common stock that we could be required to issue is 1,976,352.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">At each balance sheet date, we will evaluate the fair value of the warrants and any change in value will be recorded as a non-operating gain or loss on the statement of operations. We will re-assess the appropriate valuation model for determining the estimated fair value of the warrant instruments, which may include a binomial valuation model to take into consideration the other features of the warrants. Determination of the fair market value of the warrant instruments includes consideration of Level 3 inputs. Level 3 inputs are unobservable inputs for which there is little or no market data, which requires us to develop our own assumptions, which are significant to the measurement of the fair values.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 4.E) -URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 4 -Subparagraph (SAB TOPIC 4.C) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Article 4 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section C Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section E Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(d),(e)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Preferred Stock -URI http://asc.fasb.org/extlink&oid=6521494 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644 Reference 16: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644 Reference 17: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644 Reference 18: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph d -Article 4 Reference 19: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656 false0falseCOMMON STOCK AND WARRANTS - Note 7UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/CommonStockAndWarrants-Note712 XML 67 R23.xml IDEA: Concentration of Customers (Narrative) (Details) 2.4.0.80023 - Disclosure - Concentration of Customers (Narrative) (Details)truefalsefalse1false falsefalseFrom2013-04-01to2013-06-30_us-gaap_CustomerConcentrationRiskMemberhttp://www.sec.gov/CIK0000065770duration2013-04-01T00:00:002013-06-30T00:00:00YearStandardhttp://www.xbrl.org/2003/instancepurexbrli02false falsefalseFrom2013-01-01to2013-06-30_us-gaap_CustomerConcentrationRiskMemberhttp://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:00YearStandardhttp://www.xbrl.org/2003/instancepurexbrli01false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse1false truefalseFrom2013-04-01to2013-06-30_us-gaap_CustomerConcentrationRiskMemberhttp://www.sec.gov/CIK0000065770duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseCustomer Revenue Concentrationus-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_CustomerConcentrationRiskMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberYearStandardhttp://www.xbrl.org/2003/instancepurexbrli0nanafalse02false 4us-gaap_ConcentrationRiskPercentage1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truetruefalse0.930.93falsefalsefalse2truetruefalse0.890.89falsefalsefalsenum:percentItemTypepureFor an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13531-108611 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592 false03false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3false truefalseFrom2013-01-01to2013-06-30_custom_AccountsReceivableConcentrationRiskMemberhttp://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseAccounts Receivable Concentrationus-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldimvis_AccountsReceivableConcentrationRiskMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberYearStandardhttp://www.xbrl.org/2003/instancepurexbrli0nanafalse04false 4us-gaap_ConcentrationRiskPercentage1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2truetruefalse0.980.98falsefalsefalsenum:percentItemTypepureFor an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13531-108611 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592 false0falseConcentration of Customers (Narrative) (Details)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/ConcentrationOfCustomersNarrativeDetails24 XML 68 R26.xml IDEA: Stock-Based Compensation (Schedule Of Stock-Based Compensation Expense By Statement Of Operations) (Details) 2.4.0.80026 - Disclosure - Stock-Based Compensation (Schedule Of Stock-Based Compensation Expense By Statement Of Operations) (Details)truefalsefalse1false USDfalsefalse$From2013-04-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-04-01T00:00:002013-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2012-04-01to2012-06-30http://www.sec.gov/CIK0000065770duration2012-04-01T00:00:002012-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$From2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$From2012-01-01to2012-06-30http://www.sec.gov/CIK0000065770duration2012-01-01T00:00:002012-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1false 4us-gaap_AllocatedShareBasedCompensationExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse9600096000USD$falsetruefalse2truefalsefalse481000481000USD$falsetruefalse3truefalsefalse481000481000USD$falsetruefalse4truefalsefalse854000854000USD$falsetruefalsexbrli:monetaryItemTypemonetaryRepresents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F false22false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5false USDtruefalse$From2013-04-01to2013-06-30_CostOfContractRevenueMemberhttp://www.sec.gov/CIK0000065770duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseCost of contract revenueus-gaap_IncomeStatementLocationAxisxbrldihttp://xbrl.org/2006/xbrldimvis_CostOfContractRevenueMemberus-gaap_IncomeStatementLocationAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse03false 4us-gaap_AllocatedShareBasedCompensationExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse00USD$falsefalsefalse2truefalsefalse40004000USD$falsefalsefalse3truefalsefalse40004000USD$falsefalsefalse4truefalsefalse1000010000USD$falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F false24false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse9false USDtruefalse$From2013-04-01to2013-06-30_CostOfProductRevenueMemberhttp://www.sec.gov/CIK0000065770duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseCost of product revenueus-gaap_IncomeStatementLocationAxisxbrldihttp://xbrl.org/2006/xbrldimvis_CostOfProductRevenueMemberus-gaap_IncomeStatementLocationAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse05false 4us-gaap_AllocatedShareBasedCompensationExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse00USD$falsefalsefalse2truefalsefalse00USD$falsefalsefalse3truefalsefalse10001000USD$falsefalsefalse4truefalsefalse2000020000USD$falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F false26false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse13false USDtruefalse$From2013-04-01to2013-06-30_ResearchAndDevelopmentExpenseMemberhttp://www.sec.gov/CIK0000065770duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseResearch and development expenseus-gaap_IncomeStatementLocationAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_ResearchAndDevelopmentExpenseMemberus-gaap_IncomeStatementLocationAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse07false 4us-gaap_AllocatedShareBasedCompensationExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-72000-72000USD$falsefalsefalse2truefalsefalse8700087000USD$falsefalsefalse3truefalsefalse8800088000USD$falsefalsefalse4truefalsefalse224000224000USD$falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F false28false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse17false USDtruefalse$From2013-04-01to2013-06-30_SalesMarketingGeneralAndAdministrativeExpenseMemberhttp://www.sec.gov/CIK0000065770duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseSales, marketing, general and administrative expenseus-gaap_IncomeStatementLocationAxisxbrldihttp://xbrl.org/2006/xbrldimvis_SalesMarketingGeneralAndAdministrativeExpenseMemberus-gaap_IncomeStatementLocationAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse09false 4us-gaap_AllocatedShareBasedCompensationExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse168000168000USD$falsetruefalse2truefalsefalse390000390000USD$falsetruefalse3truefalsefalse388000388000USD$falsetruefalse4truefalsefalse600000600000USD$falsetruefalsexbrli:monetaryItemTypemonetaryRepresents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F false2falseStock-Based Compensation (Schedule Of Stock-Based Compensation Expense By Statement Of Operations) (Details) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/Stock-BasedCompensationScheduleOfStock-BasedCompensationExpenseByStatementOfOperationsDetails49 XML 69 R28.xml IDEA: Share-Based Compensation (Narrative) (Details) 2.4.0.80028 - Disclosure - Share-Based Compensation (Narrative) (Details)truefalsefalse1false USDfalsefalseFrom2013-01-01to2013-06-30_EmployeeStockOptionMemberhttp://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$1false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse1false USDtruefalseFrom2013-01-01to2013-06-30_EmployeeStockOptionMemberhttp://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseEmployee Stock Optionsus-gaap_AwardTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_EmployeeStockOptionMemberus-gaap_AwardTypeAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$nanafalse02false 4us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse941000941000USD$falsetruefalsexbrli:monetaryItemTypemonetaryUnrecognized cost of unvested share-based compensation awards.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false23false 4us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse001 year 10 months 24 daysfalsefalsefalsexbrli:durationItemTypenaWeighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false04false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2false USDtruefalseFrom2013-01-01to2013-06-30_RestrictedStockRightsMemberhttp://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseRestricted Stock Rightsus-gaap_AwardTypeAxisxbrldihttp://xbrl.org/2006/xbrldimvis_RestrictedStockRightsMemberus-gaap_AwardTypeAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$nanafalse05false 4us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse366000366000USD$falsetruefalsexbrli:monetaryItemTypemonetaryUnrecognized cost of unvested share-based compensation awards.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false26false 4us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse000 years 10 months 24 daysfalsefalsefalsexbrli:durationItemTypenaWeighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false0falseShare-Based Compensation (Narrative) (Details) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/Share-BasedCompensationNarrativeDetails16 XML 70 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Management's Statement (Financing Narrative) (Details) (USD $)
Share data in Millions, except Per Share data, unless otherwise specified
1 Months Ended
May 31, 2013
Managements Statement Financing Narrative Details  
Number of shares of common stock issued 2.6
Cash received from stock sale, before issuance costs $ 5,850,000
Stock issuance costs $ 362,000
Common shares underlying warrants 2.0
Warrant exercise price, per share $ 2.886
Date from which warrants are exercisable May 31, 2013
Warrant term, in years 5 years 0 months 0 days
Warrant terms and provisions

Based on the terms of the agreement, we have determined that the warrant instruments should be classified as a liability given that the warrants could result in the issuance of a variable number of common shares based on a conditional exercise provision that is outside of our control at any point when the share price of our common stock is equal to or less than the stated exercise price of $2.886 per share. At the date of issuance, and as of June 30, 2013, our common stock was trading at a value less than the stated exercise price, as such upon expiration of the 45 day lock up period, the holders may elect to exchange the warrants for a variable number of shares of common stock as determined by a negotiated formula included in the warrant agreement. However, the agreement contains a limit that restricts the number of shares that may be issued under this exchange provision, such that we will not issue any more common shares than could be issued on a one-for-one basis upon exercise of the warrants. As of June 30, 2013, based upon the terms of the agreement and the quoted market price of our common stock, if the exchange feature were to be fully exercised, we would be required to issue approximately 1,490,000 shares of common stock, equal to an estimated fair market value of $3,755,000, which we believe is the best indication of the fair value of the warrant obligation as of June 30, 2013. Changes in the market value of our common stock will increase or decrease the number of shares to be issued under this exchange feature; however the aggregate fair market value of shares to be issued under this provision will not change significantly due to the negotiated and fixed exchange formula in the agreement. Due to the limiting provisions on the exchange agreement, the maximum number of shares of common stock that we could be required to issue is 1,976,352.

 

 

XML 71 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2013
Notes to Financial Statements  
Management's Statement

Management's Statement

 

The Consolidated Balance Sheet as of June 30, 2013, the Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended June 30, 2013 and 2012, and Consolidated Statements of Cash Flows for the six months ended June 30, 2013 and 2012 have been prepared by MicroVision, Inc. ("we" or "us") and have not been audited. In the opinion of management, all adjustments necessary to state fairly the financial position at June 30, 2013 and the results of operations, comprehensive loss and cash flows for all periods presented have been made and consist of normal recurring adjustments. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the rules of the Securities and Exchange Commission (the "SEC"). The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. You should read these condensed consolidated financial statements in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012. The results of operations for the three and six months ended June 30, 2013 are not necessarily indicative of the operating results that may be attained for the entire fiscal year.

 

 

Going Concern

We have incurred significant losses since inception. We have funded operations to date primarily through the sale of common stock, convertible preferred stock, warrants, the issuance of convertible debt and, to a lesser extent, from contract revenues, collaborative research and development agreements and product sales. At June 30, 2013, we had $6.0 million in cash and cash equivalents and a working capital deficit of $2.6 million.

Based on our current operating plan, we anticipate that we have sufficient cash and cash equivalents to fund our operations through October of 2013. We will require additional cash to fund our operating plan past that time.

We plan to obtain additional cash through the issuance of equity or debt securities. There can be no assurance that additional cash will be available or that, if available, it will be available on terms acceptable to us on a timely basis. If adequate funds are not available on a timely basis, we intend to consider limiting our operations substantially to extend our funds as we pursue other financing opportunities and business relationships. This limitation of operations could include delaying development projects and reductions in staff and operating costs, including research and development, and capital expenditures.

We are introducing new technology into an emerging market which creates significant uncertainty about our ability to accurately project revenue, costs and cash flows. Our capital requirements will depend on many factors, including, but not limited to, the rate at which we can, directly or through arrangements with OEMs, introduce products incorporating the PicoP display engine and image capture technologies and the market acceptance and competitive position of such products. If revenues are less than anticipated, if the mix of revenues vary from anticipated amounts or if expenses exceed the amounts budgeted, we may require additional capital earlier than expected to further the development of our technologies, for expenses associated with product development, and to respond to competitive pressures or to meet unanticipated development difficulties. In addition, our operating plan provides for the development of strategic relationships with systems and equipment manufacturers that may require additional investments by us.

In May 2013, we raised $5.85 million before issuance costs of approximately $362,000 from the sale of 2.6 million shares of common stock and warrants to purchase up to an aggregate of 2.0 million shares of our common stock in a registered direct offering. The warrants have an exercise price of $2.886 per share, a five year term, and are exercisable beginning on the date of issuance. Each warrant to purchase a share of common stock may also be exchanged during its term for a number of shares of common stock (but not more than one share of common stock for each warrant so exchanged) with a value determined by a negotiated formula if, among other things, our common stock is then trading at a price at or lower than the warrant exercise price per share. Subject to limitations in the warrants, we may require the warrants be exercised for cash if the closing bid price of our stock is over $3.61 for 20 consecutive trading days and the average daily dollar volume over that period is equal to or exceeds $300,000.

We have received a report from our independent registered public accounting firm regarding the consolidated financial statements for the year ended December 31, 2012 that includes an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. These consolidated financial statements are prepared assuming the Company will continue as a going concern.

 

 

Principles of Consolidation

Principles of Consolidation

 

Our condensed consolidated financial statements include the accounts of MicroVision, Inc. and MicroVision Innovations Singapore Pte. Ltd. ("MicroVision Singapore"), a wholly owned foreign subsidiary. MicroVision Singapore was incorporated in April 2011 and is engaged in operational support functions for MicroVision, Inc. There were no material intercompany accounts and transactions during the three and six months ended June 30, 2013.

 

 

Net Loss Per Share

Net Loss Per Share

 

Basic net loss per share is calculated using the weighted-average number of common shares outstanding during the reporting periods. Diluted net loss per share is calculated using the weighted-average number of common shares outstanding and taking into account the dilutive effect of all potentially dilutive securities, including common stock equivalents and convertible securities outstanding. Potentially dilutive common stock equivalents primarily consist of warrants, employee stock options and nonvested equity shares.

 

 

Revenue recognition

We evaluate the performance criteria and terms of our collaborative research and development agreements to determine whether revenue should be recognized under a performance-based method or milestone method. Significant items included in our evaluation are the following:

  • the nature of our obligation under the agreement,
  • whether provisions leading to variable revenues exist
  • whether any payments are required to be repaid,
  • whether the deliverables should be treated as one unit of accounting or separated into multiple units,
  • whether substantive milestones exist,
  • whether milestone payments are commensurate with either our level of effort or the increase in value of the customer's rights, and
  • whether a licensing agreement exists.

In March 2013, we entered into and began work under a $4.6 million collaborative research and development agreement with a customer researching and developing commercial applications for our technology. Our contributions under the collaborative agreement include research services, components, and prototype devices and fixtures. Development revenues to be realized are subject to successful completion of the deliverables as defined in the collaborative research and development agreement.

Based on the terms of this agreement, we recognize development revenue as work progresses on the agreement and as our customer accepts the deliverables using a proportional method based on the lesser of the cumulative proportion of total planned costs to be incurred under the agreement or the cash payments received plus outstanding billings for work accepted by the customer. Since our collaborative agreements generally require some level of technology development, the actual costs required to complete a contract can vary from our estimates. The proportional revenue recognition method we use for collaborative research and development agreements includes adjustments for revisions to estimated total agreement costs. Each period, we evaluate total estimated costs for each agreement and include any significant revisions in the period we become aware of changes in estimated total costs. The costs for work performed under collaborative research and development agreements are expensed in the periods incurred and included in the Statement of Operations in research and development expense.

 

 

Share-based Compensation

We use the straight-line attribution method to allocate the fair value of share-based compensation awards over the requisite service period for each award.

 

 

Fair Value Measurement, Warrants

At each balance sheet date, we will evaluate the fair value of the warrants and any change in value will be recorded as a non-operating gain or loss on the statement of operations. We will re-assess the appropriate valuation model for determining the estimated fair value of the warrant instruments, which may include a binomial valuation model to take into consideration the other features of the warrants. Determination of the fair market value of the warrant instruments includes consideration of Level 3 inputs. Level 3 inputs are unobservable inputs for which there is little or no market data, which requires us to develop our own assumptions, which are significant to the measurement of the fair values.

 

 

XML 72 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Collaborative Research and Development Agreement (Details) (USD $)
In Millions, unless otherwise specified
Jun. 30, 2013
Collaborative Research And Development Agreement Details  
Date of collaborative research and development agreement March 2013
Amount of collaborative research and development agreement $ 4.6
XML 73 R15.xml IDEA: Summary of Significant Accounting Policies (Policies) 2.4.0.80015 - Disclosure - Summary of Significant Accounting Policies (Policies)truefalsefalse1false falsefalseFrom2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:001true 1mvis_NotesToFinancialStatementsAbstractmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_BasisOfAccountingPolicyPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Management's Statement</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The Consolidated Balance Sheet as of June 30, 2013, the Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended June 30, 2013 and 2012, and Consolidated Statements of Cash Flows for the six months ended June 30, 2013 and 2012 have been prepared by MicroVision, Inc. (&#34;we&#34; or &#34;us&#34;) and have not been audited. In the opinion of management, all adjustments necessary to state fairly the financial position at June 30, 2013 and the results of operations, comprehensive loss and cash flows for all periods presented have been made and consist of normal recurring adjustments. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the rules of the Securities and Exchange Commission (the &#34;SEC&#34;). The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. You should read these condensed consolidated financial statements in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012. The results of operations for the three and six months ended June 30, 2013 are not necessarily indicative of the operating results that may be attained for the entire fiscal year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).No definition available.false03false 2us-gaap_LiquidityDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We have incurred significant losses since inception. We have funded operations to date primarily through the sale of common stock, convertible preferred stock, warrants, the issuance of convertible debt and, to a lesser extent, from contract revenues, collaborative research and development agreements and product sales. At June 30, 2013, we had $6.0 million in cash and cash equivalents and a working capital deficit of $2.6 million.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Based on our current operating plan, we anticipate that we have sufficient cash and cash equivalents to fund our operations through October of 2013. We will require additional cash to fund our operating plan past that time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We plan to obtain additional cash through the issuance of equity or debt securities. There can be no assurance that additional cash will be available or that, if available, it will be available on terms acceptable to us on a timely basis. If adequate funds are not available on a timely basis, we intend to consider limiting our operations substantially to extend our funds as we pursue other financing opportunities and business relationships. This limitation of operations could include delaying development projects and reductions in staff and operating costs, including research and development, and capital expenditures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We are introducing new technology into an emerging market which creates significant uncertainty about our ability to accurately project revenue, costs and cash flows. Our capital requirements will depend on many factors, including, but not limited to, the rate at which we can, directly or through arrangements with OEMs, introduce products incorporating the PicoP display engine and image capture technologies and the market acceptance and competitive position of such products. If revenues are less than anticipated, if the mix of revenues vary from anticipated amounts or if expenses exceed the amounts budgeted, we may require additional capital earlier than expected to further the development of our technologies, for expenses associated with product development, and to respond to competitive pressures or to meet unanticipated development difficulties. In addition, our operating plan provides for the development of strategic relationships with systems and equipment manufacturers that may require additional investments by us.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In May 2013, we raised $5.85 million before issuance costs of approximately $362,000 from the sale of 2.6 million shares of common stock and warrants to purchase up to an aggregate of 2.0 million shares of our common stock in a registered direct offering. The warrants have an exercise price of $2.886 per share, a five year term, and are exercisable beginning on the date of issuance. Each warrant to purchase a share of common stock may also be exchanged during its term for a number of shares of common stock (but not more than one share of common stock for each warrant so exchanged) with a value determined by a negotiated formula if, among other things, our common stock is then trading at a price at or lower than the warrant exercise price per share. Subject to limitations in the warrants, we may require the warrants be exercised for cash if the closing bid price of our stock is over $3.61 for 20 consecutive trading days and the average daily dollar volume over that period is equal to or exceeds $300,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We have received a report from our independent registered public accounting firm regarding the consolidated financial statements for the year ended December 31, 2012 that includes an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. These consolidated financial statements are prepared assuming the Company will continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for reporting when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). Disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities. If management's plans alleviate the substantial doubt about the entity's ability to continue as a going concern, disclosure of the principal conditions and events that initially raised the substantial doubt about the entity's ability to continue as a going concern would be expected to be considered. Disclose whether operations for the current or prior years generated sufficient cash to cover current obligations, whether waivers were obtained from creditors relating to the company's default under the provisions of debt agreements and possible effects of such conditions and events, such as: whether there is a possible need to obtain additional financing (debt or equity) or to liquidate certain holdings to offset future cash flow deficiencies. Disclose appropriate parent company information when parent is dependent upon remittances from subsidiaries to satisfy its obligations.No definition available.false04false 2us-gaap_ConsolidationPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Principles of Consolidation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Our condensed consolidated financial statements include the accounts of MicroVision, Inc. and MicroVision Innovations Singapore Pte. Ltd. (&#34;MicroVision Singapore&#34;), a wholly owned foreign subsidiary. MicroVision Singapore was incorporated in April 2011 and is engaged in operational support functions for MicroVision, Inc. There were no material intercompany accounts and transactions during the three and six months ended June 30, 2013.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02, 03 -Article 3A Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2197480 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 860 -SubTopic 40 -Section 45 -URI http://asc.fasb.org/section&trid=2197723 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2196966 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 325 -SubTopic 20 -URI http://asc.fasb.org/subtopic&trid=2197087 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.3A-02) -URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355033-122828 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=16385135&loc=d3e33801-111570 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph k -Article 1 false05false 2us-gaap_EarningsPerSharePolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Net Loss Per Share</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Basic net loss per share is calculated using the weighted-average number of common shares outstanding during the reporting periods. Diluted net loss per share is calculated using the weighted-average number of common shares outstanding and taking into account the dilutive effect of all potentially dilutive securities, including common stock equivalents and convertible securities outstanding. Potentially dilutive common stock equivalents primarily consist of warrants, employee stock options and nonvested equity shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2144384 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257 false06false 2us-gaap_RevenueRecognitionPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We evaluate the performance criteria and terms of our collaborative research and development agreements to determine whether revenue should be recognized under a performance-based method or milestone method. Significant items included in our evaluation are the following:</p> <ul style="list-style-type: disc"> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">the nature of our obligation under the agreement,</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether provisions leading to variable revenues exist</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether any payments are required to be repaid,</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether the deliverables should be treated as one unit of accounting or separated into multiple units,</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether substantive milestones exist,</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether milestone payments are commensurate with either our level of effort or the increase in value of the customer's rights, and</font></li> <li style="margin: 0; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">whether a licensing agreement exists.</font></li> </ul> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><font style="font: 10pt Times New Roman, Times, Serif">In March 2013, we entered into and began work under a $4.6 million collaborative research and development agreement with a customer researching and developing commercial applications for our technology. Our contributions under the collaborative agreement include research services, components, and prototype devices and fixtures. Development revenues to be realized are subject to successful completion of the deliverables as defined in the collaborative research and development agreement.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">Based on the terms of this agreement, we recognize development revenue as work progresses on the agreement and as our customer accepts the deliverables using a proportional method based on the lesser of the cumulative proportion of total planned costs to be incurred under the agreement or the cash payments received plus outstanding billings for work accepted by the customer. Since our collaborative agreements generally require some level of technology development, the actual costs required to complete a contract can vary from our estimates. The proportional revenue recognition method we use for collaborative research and development agreements includes adjustments for revisions to estimated total agreement costs. Each period, we evaluate total estimated costs for each agreement and include any significant revisions in the period we become aware of changes in estimated total costs. The costs for work performed under collaborative research and development agreements are expensed in the periods incurred and included in the Statement of Operations in research and development expense.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 13 -Section B -Paragraph Question 1 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 13.B.Q1) -URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18823-107790 false07false 2us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicyus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">We use the straight-line attribution method to allocate the fair value of share-based compensation awards over the requisite service period for each award.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b),(f) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2228939 false08false 2us-gaap_FairValueMeasurementPolicyPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">At each balance sheet date, we will evaluate the fair value of the warrants and any change in value will be recorded as a non-operating gain or loss on the statement of operations. We will re-assess the appropriate valuation model for determining the estimated fair value of the warrant instruments, which may include a binomial valuation model to take into consideration the other features of the warrants. Determination of the fair market value of the warrant instruments includes consideration of Level 3 inputs. Level 3 inputs are unobservable inputs for which there is little or no market data, which requires us to develop our own assumptions, which are significant to the measurement of the fair values.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.No definition available.false0falseSummary of Significant Accounting Policies (Policies)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/SummaryOfSignificantAccountingPoliciesPolicies18 XML 74 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Net Loss Per Share (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Net Loss Per Share Details        
Net loss available for common shareholders - basic and diluted $ (3,436) $ (4,971) $ (7,090) $ (14,774)
Weighted-average shares outstanding - basic and diluted 26,493 19,167 25,870 18,097
Net loss per share - basic and diluted $ (0.13) $ (0.26) $ (0.27) $ (0.82)
XML 75 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
6 Months Ended
Jun. 30, 2013
Aug. 06, 2013
Document And Entity Information    
Entity Registrant Name Microvision Inc  
Entity Central Index Key 0000065770  
Document Type 10-Q  
Document Period End Date Jun. 30, 2013  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   27,939,000
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2013  
XML 76 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Net Loss Per Share (Convertible Securities and Options Excluded) (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Anti-dilutive shares 8,580,000 6,135,000 8,580,000 6,135,000
Publicly Traded Warrants Exercisable
       
Anti-dilutive shares 753,000 753,000 753,000 753,000
Options and Private Warrants Exercisable
       
Anti-dilutive shares 7,612,000 5,302,000 7,612,000 5,302,000
Nonvested Equity Shares
       
Anti-dilutive shares 215,000 80,000 215,000 80,000
XML 77 R1.xml IDEA: Document and Entity Information 2.4.0.80001 - Document - Document and Entity Informationtruefalsefalse1false falsefalseFrom2013-01-01to2013-06-30http://www.sec.gov/CIK0000065770duration2013-01-01T00:00:002013-06-30T00:00:002false falsefalseAsOf2013-08-06http://www.sec.gov/CIK0000065770instant2013-08-06T00:00:000001-01-01T00:00:00sharesItemTypeStandardhttp://www.xbrl.org/2003/instancesharesxbrli01true 1mvis_DocumentAndEntityInformationAbstractmvis_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2dei_EntityRegistrantNamedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Microvision Incfalsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:normalizedStringItemTypenormalizedstringThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false03false 2dei_EntityCentralIndexKeydei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse000000065770falsefalsefalse2falsefalsefalse00falsefalsefalsedei:centralIndexKeyItemTypenaA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false04false 2dei_DocumentTypedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse0010-Qfalsefalsefalse2falsefalsefalse00falsefalsefalsedei:submissionTypeItemTypestringThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".No definition available.false05false 2dei_DocumentPeriodEndDatedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse002013-06-30falsefalsetrue2falsefalsefalse00falsefalsefalsexbrli:dateItemTypedateThe end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.No definition available.false06false 2dei_AmendmentFlagdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:booleanItemTypenaIf the value is true, then the document is an amendment to previously-filed/accepted document.No definition available.false07false 2dei_CurrentFiscalYearEndDatedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00--12-31falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:gMonthDayItemTypemonthdayEnd date of current fiscal year in the format --MM-DD.No definition available.false08false 2dei_EntityWellKnownSeasonedIssuerdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Nofalsefalsefalse2falsefalsefalse00falsefalsefalsedei:yesNoItemTypenaIndicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.No definition available.false09false 2dei_EntityVoluntaryFilersdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Nofalsefalsefalse2falsefalsefalse00falsefalsefalsedei:yesNoItemTypenaIndicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.No definition available.false010false 2dei_EntityCurrentReportingStatusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Yesfalsefalsefalse2falsefalsefalse00falsefalsefalsedei:yesNoItemTypenaIndicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.No definition available.false011false 2dei_EntityFilerCategorydei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Smaller Reporting Companyfalsefalsefalse2falsefalsefalse00falsefalsefalsedei:filerCategoryItemTypestringIndicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.No definition available.false012false 2dei_EntityCommonStockSharesOutstandingdei_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2truefalsefalse2793900027939000falsefalsefalsexbrli:sharesItemTypesharesIndicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.No definition available.false113false 2dei_DocumentFiscalPeriodFocusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Q2falsefalsefalse2falsefalsefalse00falsefalsefalsedei:fiscalPeriodItemTypenaThis is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.No definition available.false014false 2dei_DocumentFiscalYearFocusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse002013falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:gYearItemTypepositiveintegerThis is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.No definition available.false0falseDocument and Entity InformationUnKnownNoRoundingUnKnownUnKnowntruefalsefalseSheethttp://microvision.com/role/DocumentAndEntityInformation214